UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
È Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended June 30, 2019
or
‘ Transition Report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
for the transition period from
to
.
Commission File No. 0-22818
THE HAIN CELESTIAL GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
1111 Marcus Avenue
Lake Success, New York
(Address of principal executive offices)
22-3240619
(I.R.S. Employer
Identification No.)
11042
(Zip Code)
Registrant’s telephone number, including area code: (516) 587-5000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Common Stock, par value $.01 per share
Trading Symbol(s)
HAIN
Name of each exchange on which registered
The NASDAQ® Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes È No ‘
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes ‘ No È
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes È No ‘
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405
of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to
submit such files).
Yes È No ‘
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or
an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging
growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Non-accelerated filer
È
‘
Accelerated filer
Smaller reporting company
‘
‘
Emerging growth company
‘
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ‘
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
Yes ‘ No È
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant based upon the closing price of the
registrant’s common stock, as quoted on the NASDAQ Global Select Market on December 31, 2018, the last business day of the registrant’s most
recently completed second fiscal quarter, was $1,458,202,287.
As of August 22, 2019, there were 104,218,650 shares outstanding of the registrant’s Common Stock, par value $.01 per share.
Portions of The Hain Celestial Group, Inc. Definitive Proxy Statement for the 2019 Annual Meeting of Stockholders are incorporated by reference
into Part III of this Annual Report on Form 10-K.
DOCUMENTS INCORPORATED BY REFERENCE
THE HAIN CELESTIAL GROUP, INC.
Table of Contents
Business
Risk Factors
Unresolved Staff Comments
Properties
Legal Proceedings
Mine Safety Disclosures
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities
Selected Financial Data
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information
Directors, Executive Officers and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
Certain Relationships and Related Transactions, and Director Independence
Principal Accountant Fees and Services
Exhibits and Financial Statement Schedules
Form 10-K Summary
PART I
Item 1.
Item 1A.
Item 1B.
Item 2.
Item 3.
Item 4.
PART II
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
PART III
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
PART IV
Item 15.
Item 16.
Exhibit Index
Signatures
Pageg
4
14
23
24
25
27
28
30
32
54
55
104
104
107
108
108
108
108
108
108
109
110
112
2
Cautionary Note Regarding Forward Looking Information
This Annual Report on Form 10-K for the fiscal year ended June 30, 2019 (the “Form 10-K”) contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995, relating to our business and financial outlook, which
are based on our current beliefs, assumptions, expectations, estimates, forecasts and projections about future events only as of the
date of this Form 10-K, and are not statements of historical fact. We make such forward-looking statements pursuant to the “safe
harbor” provisions of the Private Securities Litigation Reform Act of 1995.
Many of our forward-looking statements include discussions of trends and anticipated developments under the “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of this Form 10-K. In some
cases, you can identify forward-looking statements by terminology such as the use of “may,” “will,” “should,” “expects,” “plans,”
“anticipates,” “believes,” “estimates,” “projects,” “intends,” “predicts,” “potential,” or “continue” and similar expressions, or the
negative of those expressions. These forward-looking statements include, among other things, our beliefs or expectations relating
to our business strategy, growth strategy, market price, brand portfolio and product performance, the seasonality of our business
and our results of operations and financial condition. These forward-looking statements are not guarantees of our future performance
and involve risks, uncertainties, estimates and assumptions that are difficult to predict. Therefore, our actual outcomes and results
may differ materially from those expressed in these forward-looking statements. You should not place undue reliance on any of
these forward-looking statements. Further, any forward-looking statement speaks only as of the date hereof, unless it is specifically
otherwise stated to be made as of a different date. We undertake no obligation to further update any such statement, or the risk
factors described in Item 1A under the heading “Risk Factors,” to reflect new information, the occurrence of future events or
circumstances or otherwise.
ff
The forward-looking statements in this filing do not constitute guarantees or promises of future performance. Factors that could
cause or contribute to such differences may include, but are not limited to, the impact of competitive products and changes to the
competitive environment, changes to consumer preferences, political uncertainty in the United Kingdom and the negotiation of
its exit from the European Union, consolidation of customers or the loss of a significant customer, reliance on independent
distributors, general economic and financial market conditions, risks associated with our international sales and operations, our
ability to manage our supply chain effectively, volatility in the cost of commodities, ingredients, freight and fuel, our ability to
execute and realize cost savings initiatives, including stock-keeping unit (“SKU”) rationalization plans, the impact of our debt
and our credit agreements on our financial condition and our business, our ability to manage our financial reporting and internal
control system processes, potential liabilities due to legal claims, government investigations and other regulatory enforcement
actions, costs incurred due to pending and future litigation, potential liability, including in connection with indemnification
obligations to our current and former officers and members of our Board of Directors that may not be covered by insurance,
potential liability if our products cause illness or physical harm, impairments in the carrying value of goodwill or other intangible
assets, our ability to consummate divestitures, our ability to integrate past acquisitions, the availability of organic ingredients,
disruption of operations at our manufacturing facilities, loss of one or more independent co-packers, disruption of our transportation
systems, risks relating to the protection of intellectual property, the risk of liabilities and claims with respect to environmental
matters, the reputation of our brands, our reliance on independent certification for a number of our products and other risks described
in Part I, Item 1A, “Risk Factors” as well as in other reports that we file in the future.
a
3
PART I
THE HAIN CELESTIAL GROUP, INC.
Item 1.
Business
Overview
The Hain Celestial Group, Inc., a Delaware corporation (collectively, along with its subsidiaries, the “Company,” and herein
referred to as “Hain Celestial,” “we,” “us” and “our”), was founded in 1993 and is headquartered in Lake Success, New York. The
Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet. The Company
continues to be a leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and
exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing
sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial
sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce
retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide.
The Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-
for-you” products, with many recognized brands in the various market categories it serves, including Almond Dream®, Arrowhead
Mills®, Bearitos®, Better Bean®, BluePrint®, Casbah®, Celestial Seasonings®, Clarks™, Coconut Dream®, Cully & Sully®, Danival®,
DeBoles®, Earth’s Best®, Ella’s Kitchen®, Europe’s Best®, Farmhouse Fare™, Frank Cooper’s®, Gale’s®, Garden of Eatin’®, GG
UniqueFiber®, Hain Pure Foods®, Hartley’s®, Health Valley®, Imagine®, Johnson’s Juice Co.™, Joya®, Lima®, Linda McCartney®
(under license), MaraNatha®, Mary Berry (under license), Natumi®, New Covent Garden Soup Co.®, Orchard House®, Rice
Dream®, Robertson’s®, Rudi’s Gluten-Free Bakery™, Rudi’s Organic Bakery®, Sensible Portions®, Spectrum® Organics, Soy
Dream®, Sun-Pat®, Sunripe®, SunSpire®, Terra®, The Greek Gods®, Walnut Acres®, Yorkshire Provender®, Yves Veggie Cuisine®
and William’s™. The Company’s personal care products are marketed under the Alba Botanica®, Avalon Organics®, Earth’s Best®,
JASON®, Live Clean® and Queen Helene® brands.
Historically, the Company divided its business into core platforms, which are defined by common consumer need, route-to-market
or internal advantage and are aligned with the Company’s strategic roadmap to continue its leadership position in the organic and
natural, “better-for-you” products industry. Those core platforms within our United States segment are:
a
•
•
•
•
•
•
Better-for-You Baby, which includes infant foods, infant and toddler formula, toddler and kids foods and diapers that
nurture and care for babies and toddlers, under the Earth’s Best® and Ella’s Kitchen® brands.
Better-for-You Pantry, which includes core consumer staples, such as MaraNatha®, Arrowhead Mills®, Imagine®
and Spectrum® brands.
Better-for-You Snacking, which includes wholesome products for in-between meals, such as Terra®, Sensible
Portions® and Garden of Eatin’® brands.
Fresh Living, which includes yogurt, plant-based proteins and other refrigerated products, such as The Greek Gods®
yogurt and Dream™ plant-based beverage brands.
Pure Personal Care, which includes personal care products focused on providing consumers with cleaner and gentler
ingredients, such as JASON®, Live Clean®, Avalon Organics® and Alba Botanica® brands.
Tea, which includes tea products marketed under the Celestial Seasonings® brand.
Additionally, beginning in fiscal 2017, the Company launched Hain Ventures (formerly known as “Cultivate Ventures”), a venture
unit with a twofold purpose: (i) to strategically invest in the Company’s smaller brands in high potential categories, by giving
these brands a dedicated, creative focus for refresh and relaunch and (ii) to incubate and grow small acquisitions until they reach
the scale required to migrate to the Company’s core platforms.
During fiscal 2019, the Company refined its strategy within the United States segment, focusing on simplifying the Company’s
portfolio and reinvigorating profitable sales growth by discontinuing uneconomic investment, realigning resources to coincide
with industrial brand role, reducing unproductive stock-keeping units (“SKUs”) and brands, and reassessing current pricing
architecture. As part of this initiative, the Company reviewed its product portfolio and divided it into “Get Bigger” and “Get
Better” brand categories.
The Company’s “Get Bigger” brands represent its strongest brands with higher margins, which compete in categories with strong
growth. In order to capitalize on the potential of these brands, the Company began reallocating resources to optimize assortment
and increase share of distribution. In addition, the Company will increase its marketing and innovation investments.
4
The Company’s “Get Better” brands are the brands in which the Company is primarily focused on simplification and expansion
of profit. Some of these are low margin, non-strategic brands that add complexity with minimal benefit to the Company’s operations.
Accordingly, in fiscal 2019, the Company initiated a SKU rationalization, which included the elimination of approximately 350
low velocity SKUs. The elimination of these SKUs is expected to impact sales growth in the next fiscal year, but is expected to
result in expanded profits and a remaining set of core SKUs that will maintain their shelf space in the store.
As part of the Company’s overall strategy, the Company may seek to dispose of businesses and brands that are less profitable or
are otherwise less of a strategic fit within our core portfolio. Accordingly, the Company divested of all of its operations of the
Hain Pure Protein reportable segment (discussed further below) and WestSoy® tofu, seitan and tempeh businesses in the United
States. Additionally, on August 27, 2019, the Company sold the entities comprising its Tilda operating segment and certain other
assets of the Tilda business. See Note 21, Subsequent Event in the Notes to Consolidated Financial Statements included in Item
8 of this Form 10-K for further discussion.
f
t
Productivity and Transformation
As part of the Company’s historical strategic review, it focused on a productivity initiative, which it called “Project Terra.” A key
component of this project was the identification of global cost savings, and the removal of complexity from the business. This
review has included and continues to include streamlining the Company’s manufacturing plants, co-packers and supply chain,
eliminating served categories or brands within those categories, and product rationalization initiatives which are aimed at
eliminating slow moving SKUs.
In fiscal 2019, the Company announced a new transformation initiative, of which one aspect is to identify additional areas of
productivity savings to support sustainable profitable performance.
Discontinued Operations
In March 2018, the Company’s Board of Directors approved a plan to sell all of the operations of the Hain Pure Protein Corporation
(“HPPC”) operating segment, which includes the Plainville Farms and FreeBird businesses, and the EK Holdings, Inc. (“Empire
Kosher” or “Empire”) operating segment, which were reported in the aggregate as the Hain Pure Protein reportable segment. These
dispositions were undertaken to reduce complexity in the Company’s operations and simplify the Company’s brand portfolio, in
addition to allowing additional flexibility to focus on opportunities for growth and innovation in the Company’s more profitable
and faster growing core businesses.
Collectively, these dispositions represented a strategic shift that had a major impact on the Company’s operations and financial
results and have been accounted for as discontinued operations.
On February 15, 2019, the Company completed the sale of substantially all of the assets used primarily for the Plainville Farms
business (a component of HPPC).
On June 28, 2019, the Company completed the sale of the remainder of HPPC and EK Holdings, Inc. which includes the FreeBird
and Empire Kosher businesses.
See Note 5, Discontinued Operations, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K
for additional information.
Chief Executive Officer Succession Plan
On June 24, 2018, the Company entered into a Chief Executive Officer (“CEO”) succession plan, whereby the Company’s former
CEO, Irwin D. Simon, agreed to terminate his employment with the Company upon the hiring of a new CEO. On October 26,
2018, the Company’s Board of Directors appointed Mark L. Schiller as President and CEO, succeeding Mr. Simon. In connection
with the appointment, on October 26, 2018, the Company and Mr. Schiller entered into an employment agreement, which was
approved by the Board, with Mr. Schiller’s employment commencing on November 5, 2018. Accordingly, Mr. Simon’s employment
with the Company terminated on November 4, 2018. See Note 3, Chief Executive Officer Succession Plan, in the Notes to
Consolidated Financial Statements included in Item 8 of this Form 10-K for additional information.
Headcount
As of June 30, 2019, we employed a total of 5,441 full-time employees.
5
Products
During fiscal 2019, we primarily sold our organic, natural, and “better-for-you” products in the following categories: grocery;
snacks; personal care; and tea. We continuously evaluate our existing products for quality, taste, nutritional value and cost and
make improvements where possible. We discontinue products or SKUs when sales of those items do not warrant further production.
Our product categories consist of the following:
Grocery
Grocery products include infant formula, infant, toddler and kids foods, diapers and wipes, rice and grain-based products, plant-
based beverages and frozen desserts (such as soy, rice, oat, almond and coconut), flour and baking mixes, breads, hot and cold
cereals, pasta, condiments, cooking and culinary oils, granolas, cereal bars, canned, chilled fresh, aseptic and instant soups, yogurts,
chilis, chocolate, nut butters, juices including cold-pressed juice, hot-eating desserts, cookies, frozen fruit and vegetables, pre-cut
fresh fruit, refrigerated and frozen plant-based meat-alternative products, jams, fruit spreads, jelly, honey, natural sweeteners and
marmalade products, as well as other food products. Grocery products accounted for approximately 74% of our consolidated net
sales in fiscal 2019, 75% in fiscal 2018 and 74% in fiscal 2017.
Snacks
Our snack products include a variety of potato, root vegetable and other exotic vegetable chips, straws, tortilla chips, whole grain
chips, pita chips and puffs. Snack products accounted for approximately 13% of our consolidated net sales in fiscal 2019, 12%
in fiscal 2018 and 13% in fiscal 2017.
Personal Care
Our personal care products cover a variety of personal care categories including skin, hair and oral care, deodorants, baby care
items, body washes, sunscreens and lotions. Personal care products accounted for approximately 8% of our consolidated net sales
in each of fiscal 2019, 2018 and 2017.
Tea
Under the Celestial Seasonings® brand, we currently offer more than 100 varieties of herbal, green, black, wellness, rooibos and
chai tea. Tea products accounted for approximately 5% of our consolidated net sales in each of 2019, 2018 and 2017.
Seasonality
Certain of our product lines have seasonal fluctuations. Hot tea, baking products, hot cereal, hot-eating desserts and soup sales
are stronger in colder months, while sales of snack foods, sunscreen and certain of our prepared food and personal care products
are stronger in the warmer months. As such, our results of operations and our cash flows for any particular quarter are not indicative
of the results we expect for the full year, and our historical seasonality may not be indicative of future quarterly results of operations.
In recent years, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters.
uu
f
Working Capital
For information relating to our cash flows from operations and working capital items, see “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” in Item 7 of this Form 10-K.
Capital Expenditures
During fiscal 2019, our aggregate capital expenditures from continuing operations were $77.1 million. We expect to spend
approximately $70 million to $80 million for capital projects in fiscal 2020.
Segments
We principally manage our business by geography in seven operating segments: the United States, United Kingdom, Tilda, Ella’s
Kitchen UK, Canada, Europe and Hain Ventures. In addition, we have three reportable segments: United States, United Kingdom
and Rest of World.
6
In fiscal 2018, the Hain Pure Protein operations, including HPPC and Empire, were classified as discontinued operations as
discussed in Note 5, Discontinued Operations in the Notes to Consolidated Financial Statements included in Item 8 of this Form
10-K. Therefore, segment information presented excludes the results of Hain Pure Protein.
On August 27, 2019, we sold our Tilda business as discussed in Note 21, Subsequent Event in the Notes to Consolidated Financial
Statements included in Item 8 of this Form 10-K.
t
Each segment includes the results of operations attributable to its geographic location except for Hain Ventures, which conducts
business in the United States, Canada and Europe which are included in the Rest of World segment.
We use segment net sales and operating income to evaluate segment performance and to allocate resources. We believe this
measure is most relevant in order to analyze segment results and trends. Segment operating income excludes certain general
corporate expenses (which are a component of selling, general and administrative expenses), impairment and acquisition related
expenses, restructuring, integration and other charges.
The following table presents the Company’s net sales by reportable segment for the fiscal years ended June 30, 2019, 2018 and
2017 (amounts in thousands, other than percentages which may not add due to rounding):
United States
United Kingdom
Rest of World
Total
United States Segment:
2019
Fiscal Year Ended June 30,
2018
2017
$
$
1,009,406
44% $
1,084,871
44% $
1,107,806
885,488
407,574
38%
18%
938,029
434,869
38%
18%
851,757
383,942
47%
36%
16%
2,302,468
100% $
2,457,769
100% $
2,343,505
100%
Our products are sold throughout the United States. Our customer base consists principally of specialty and natural food distributors,
supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience
stores. Our products are sold through a combination of direct sales people, brokers and distributors. We believe that our direct
sales people combined with brokers and distributors provide an effective means of reaching a broad and diverse customer base.
Food brokers act as agents for us within designated territories, usually on a non-exclusive basis, and receive commissions. A
portion of our direct sales force is organized into dedicated teams to serve our significant customers.
A significant portion of the products marketed by us are sold through independent food distributors. Food distributors purchase
products from us for resale to retailers.
The brands sold by the United States segment by platform are:
Better-for-You Baby
Our Better-for-You Baby products include infant and toddler formula, infant cereals, jarred baby food, baby food pouches, snacks,
frozen toddler and kids’ foods and diapers under the Earth’s Best®, Earth’s Best Sesame Street (under license) and Ella’s Kitchen®
brands.
Better-for-You Pantry
Our Better-for-You Pantry products include the following natural and organic brands: Spectrum® culinary oils, vinegars and
condiments, Spectrum Essentials® nutritional oils and supplements, MaraNatha® nut butters, Imagine® broths, soups and gravies,
Rudi’s Gluten Free Bakery® and Rudi’s Organic Bakery® breads, buns, bagels and tortillas, Arrowhead Mills® flours, mixes and
cereals, Hain Pure Foods® condiments and Westbrae® vegetarian products.
Better-for-You Snacking
Our Better-for-You snack food products include Terra® varieties of root vegetable chips, potato chips and other exotic vegetable
chips, Garden of Eatin’® tortilla chips, Sensible Portions® snack products including Garden Veggie Straws®, and Garden Veggie
Chips and Apple Straws® and Bearitos®, puffs and other snacks.
7
Fresh Living
Our Fresh Living products include The Greek Gods® Greek-style yogurt and kefir, Almond Dream®, Coconut Dream®, Rice
Dream®, Oat Dream®, Soy Dream® and other DreamTM brand plant-based beverages, yogurt and frozen desserts.
Pure Personal Care
Our Pure Personal Care products include skin, hair and oral care products, deodorants and sun care and baby care items under the
Alba Botanica®, Avalon Organics®, Earth’s Best®, JASON®, Live Clean® and Queen Helene® brands.
Tea
Our tea products are marketed under the Celestial Seasonings® brand and include more than 100 varieties of herbal, green, black,
wellness and rooibos teas, with well-known names and products such as Sleepytime®, Lemon Zinger®, Red Zinger®, Cinnamon
Apple Spice, Bengal Spice® and Country Peach Passion®.
United Kingdom Segment:
In the United Kingdom, our products include frozen and chilled products, including but not limited to soups, fruits and juices,
plant-based and meat-free products, and premium rice and grain-based products as well as ambient products such as jams, fruit
spreads, jellies, honey, marmalades, nut butters, sweeteners, syrups and dessert sauces.
The brands sold by our United Kingdom segment include Ella’s Kitchen® infant and toddler foods, New Covent Garden Soup
Co.® and Yorkshire Provender® chilled soups, Farmhouse Fare™ and Mary Berry™ hot-eating desserts, Johnson’s Juice Co.® juices,
Linda McCartney’s® chilled and frozen plant-based meals, Cully & Sully® chilled soups and ready meals, Hartley’s® jams, fruit
spreads and jellies, William’s™ conserves, Sun-Pat® nut butters, Gale’s® honey, Clarks™ natural sweeteners and Robertson’s®
and Frank Cooper’s® marmalades. We also provide a comprehensive range of private label products to many retailers, convenience
stores and foodservice providers in the following categories: fresh soup, pre-cut fresh fruit, juice, smoothies, chilled desserts,rr
meat-free meals and ambient grocery products.
Our products are principally sold throughout the United Kingdom and Ireland, but are also sold in other parts of the world as well.
Our customer base consists principally of retailers, convenience stores, foodservice providers, business to business, natural food
and ethnic specialty distributors, club stores and wholesalers.
ff
Rest of World Segment
Canada
Our products are sold throughout Canada. Our customer base consists principally of grocery supermarkets, mass merchandisers,
club stores, natural food distributors, personal care distributors, drug store chains and foodservice distributors. Our products are
sold through our own retail direct sales force. We also utilize third-party brokers who receive commissions and sell to foodservice
and retail customers. We utilize a third-party merchandising team for retail execution. As in the United States, a portion of the
products marketed by us are sold through independent distributors.
rr
f
The brands sold in our Canada segment include Yves Veggie Cuisine® refrigerated and frozen meat-alternative products, vegetables
and lentils, Europe’s Best® frozen fruits and vegetables, Earth’s Best® infant formula and food, Casbah® packaged grains,
MaraNatha® nut butters, Spectrum Essentials® cooking and culinary oils, Imagine® aseptic soups, The Greek Gods® Greek-style
yogurt and Robertson’s® marmalades. Our plant-based beverages include Rice Dream®, Soy Dream®, Oat Dream®, Coconut
Dream®, Almond Dream®, and Rice Dream® in refrigerated format, Rice Dream® and Almond Dream® plant-based frozen desserts,
Celestial Seasonings® teas, Terra® chips, Garden of Eatin’® tortilla chips and Sensible Portions® snack products. Our personal
care products include skin, hair and oral care products, deodorants and baby care items under the Avalon Organics®, Alba Botanica®,
JASON® and Live Clean® brands.
8
Europe
Our products sold by the Europe operating segment include Danival®, Dream®, Joya®, Lima® and Natumi®. The Danival® brand
includes organic cooked vegetables, prepared meals, sauces, fruit spreads and desserts. The Lima® brand includes a wide range
of organic products such as soy sauce, plant-based beverages and grain cakes, as well as grains, pasta, cereals, miso, snacks,
sweeteners, spreads, soups and condiments. Our Natumi® and Dream® brands include plant-based beverages, including rice, soy,
oat and spelt. Our Joya® brand includes soy, oat, rice and nut-based drinks as well as plant-based yogurts, desserts, creamers, tofu
and private label products. We also sell our Hartley’s® jams, fruit spreads and jellies, Terra® varieties of root vegetable and potato
chips, and Celestial Seasonings® teas and Linda McCartney’s® chilled and frozen plant-based meals in Europe as well.
Our products are sold in grocery stores and organic food stores throughout Europe. Our products are sold using our own direct
sales force and local distributors.
Hain Ventures
Our products sold by the Hain Ventures operating segment include Better Bean® prepared beans and bean-based dips sold in
refrigerated tubs, BluePrint® cold-pressed juice drinks, DeBoles® pasta, Health Valley® cereal bars and soups, GG UniqueFiber™
crackers, SunSpire® chocolates, Hollywood® oils, Casbah® grain-based products and Yves Veggie Cuisine® plant-based products.
Hain Ventures products are sold throughout the United States. Our customer base consists principally of grocery supermarkets,
mass merchandisers, Direct Store Delivery (“DSD”) distributors and natural food distributors. We utilize a dedicated sales team a
and third-party brokers who receive commissions and sell to grocery supermarkets and natural food stores. A portion of our
BluePrint® products and GG UniqueFiber™ crackers are sold through our own DSD sales force as well as through our Direct to
Consumer business.
Customers
Two of our customers each accounted for more than 10% of our consolidated net sales in each of the last three fiscal years,
respectively. United Natural Foods, Inc., a distributor of products to natural foods supermarkets, independent natural retailers and
other supermarkets and retailers, accounted for approximately 10%, 11% and 11% of our consolidated net sales for the fiscal years aa
ended June 30, 2019, 2018 and 2017, respectively, which were primarily related to the United States segment. Likewise, Walmart
Inc. and its affiliates, Sam’s Club and ASDA, together accounted for approximately 11%, 11% and 12% of our consolidated net
sales for the fiscal years ended June 30, 2019, 2018 and 2017, respectively, which were primarily related to the United States and
United Kingdom segments. No other customer accounted for more than 10% of our net sales in the past three fiscal years.
Foreign Operations
We sell our products to customers in more than 80 countries. International sales represented approximately 54%, 53% and 50%
of our consolidated net sales in fiscal 2019, 2018 and 2017, respectively.
Marketing
We use a combination of trade and consumer promotions to market our products. We use trade advertising and promotion, including
placement fees, cooperative advertising and feature advertising in distribution catalogs. Consumer advertising and sales promotions
are also made via social media and trial use programs. We utilize in-store product demonstrations and sampling in the club store
channel. Our investments in consumer spending are aimed at enhancing brand equity and increasing consumption. These consumer
spending categories include, but are not limited to, coupons, direct mailing, e-consumer relationship programs and other forms of
promotions. Additionally, we maintain separate websites and social media pages for many of our brands featuring product
information regarding the particular brand.
We also utilize sponsorship programs to help create brand awareness. In the United States, our Earth’s Best® brand has an agreement
with PBS Kids and Sesame Workshop, and our Terra Blues® are featured snacks on JetBlue Airways flights. In addition, Sensible
Portions® products, Yves Veggie Cuisine® plant-based burgers and Terra® chips are advertised and sold at Citi Field. There is no
guarantee that these promotional investments are or will be successful.
9
New Product Initiatives Through Research and Development
Innovation, including new product development, is a key component of our growth strategy. We continuously seek to understand
our consumers and develop products that address their desire for organic, natural and better-for-you alternatives to conventional
packaged foods and personal care products. We have a demonstrated track record of extending our product offerings into other
product categories. A team of professional product developers, including microbiologists, nutritionists, food scientists, chefs and
chemists, work to develop products to meet changing consumer needs. Our research and development staff incorporates product
ideas from all areas of our business in order to formulate new products. In addition to developing new products, the research and
development staff routinely reformulates and improves existing products based on advances in ingredients, packaging and
technology. We incurred approximately $11.1 million in company-sponsored research and development activities, consisting
primarily of personnel-related costs, in fiscal 2019, $9.7 million in 2018 and $10.1 million in 2017. In addition to our company-
sponsored research and development activities, in order to quickly and economically introduce our new products to market, we
may partner with contract manufacturers that make our products according to our formulas or other specifications. The Company
also partners with certain customers from time to time on exclusive customer initiatives. The Company’s research and development
expenditures do not include the expenditures on such activities undertaken by co-packers and suppliers who develop numerous
products on behalf of the Company and on their own initiative with the expectation that the Company will accept their new product
ideas and market them under the Company’s brands.
ff
Production
Manufacturing
During fiscal 2019, 2018 and 2017, approximately 59%, 58% and 59%, respectively, of our revenue was derived from products
manufactured at our own facilities.
Our United States segment operates the following manufacturing facilities:
• Boulder, Colorado (two facilities), which produce Celestial Seasonings® teas and Rudi’s Organic Bakery® organic breads,
buns, bagels, tortillas, wraps and soft pretzels and Rudi’s Gluten-Free Bakery® gluten-free products including breads,
buns and tortillas;
• Moonachie, New Jersey, which produces Terra® root vegetable and potato chips;
• Mountville, Pennsylvania, which produces Sensible Portions® snack products;
• Hereford, Texas, which produces Arrowhead Mills® cereals, flours and baking ingredients;
• Ashland, Oregon, which produces MaraNatha® nut butters; and
• Bell, California, which produces Alba Botanica®, Avalon Organics®, JASON® and Earth’s Best® personal care products.
Our United Kingdom segment operates the following manufacturing facilities:
• Histon, England, which produces our ambient grocery products including Hartley’s®, Frank Cooper’s®, Robertson’s® and
Gale’s®;
• Newport, Wales, which produces our Clarks™ sweeteners, syrups and dessert sauces;
• Grimsby, England, which produces our New Covent Garden Soup Co.® chilled soups;
• Clitheroe, England, which produces our Farmhouse Fare® hot-eating desserts;
• Leeds, England, which prepares our fresh fruit products;
Fakenham, England, which produces Linda McCartney’s® meat-free frozen and chilled foods;
•
• Corby, England (two facilities), which produces drinks and desserts and prepares fresh cut fruit;
• Gateshead, England, which prepares fresh cut fruit;
• North Yorkshire, England, which produces Yorkshire Provender® chilled soups; and
• Larvik, Norway, which produces our GG UniqueFiberTM products.
Our Rest of World segment operates the following manufacturing facilities:
• Trenton, Ontario, which produces Yves Veggie Cuisine® plant-based products;
• Vancouver, British Columbia, which produces Yves Veggie Cuisine® plant-based products;
• Mississauga, Ontario, which produces our Live Clean® and other personal care products;
• Troisdorf, Germany, which produces Natumi®, Rice Dream®, Lima®, Joya® and other plant-based beverages;
• Andiran, France, which produces our Danival® organic food products;
• Oberwart, Austria, which produces our Dream®, Lima®, and Joya® plant-based foods and beverages; and
•
Schwerin, Germany, which also produces our Dream®, Lima®, and Joya® plant-based foods and beverages.
10
See “Item 2: Properties” of this Form 10-K for more information on the manufacturing facilities that we operate.
Co-Packers
In addition to the products manufactured in our own facilities, independent third-party manufacturers, who are referred to in our
industry as “co-packers,” manufacture many of our products. In general, utilizing co-packers provides us with the flexibility to
produce a large variety of products and the ability to enter new categories quickly and economically. Our contract manufacturers
have been selected based on their production capabilities, capitalization and their specific product category expertise, and we
expect to continue to partner with them to improve and expand our product offerings. During fiscal 2019, 2018 and 2017,
approximately 41%, 42% and 41%, respectively, of our revenue was derived from products manufactured by co-packers. We
require that our co-packers comply with all applicable regulations and our quality and food safety program requirements, and
compliance is verified through auditing and other activities. Additionally, the co-packers are required to ensure our products are
manufactured in accordance with our finished good specifications to ensure we meet customer expectations.
Suppliers of Ingredients and Packaging
Agricultural commodities and ingredients, including almonds, corn, dairy, fruit and vegetables, oils, rice, soybeans and wheat, are
the principal inputs used in our products. Our certified organic and natural raw materials as well as our packaging materials are
obtained from various suppliers around the world. The Company works with its suppliers to ensure the quality and safety of their
ingredients and that such ingredients meet our specifications and comply with applicable regulations. These assurances are
supported by our purchasing contracts, supplier expectations manual and technical assessments, including questionnaires, scientific
data, certifications, affidavits, certificates of analysis and analytical testing, where required. Our purchasers and quality team visit
major suppliers around the world to procure competitively priced, quality ingredients that meet our specifications.
We maintain long-term relationships with many of our suppliers. Purchase arrangements with ingredient suppliers are generally
made annually. Purchases are made through purchase orders or contracts, and price, delivery terms and product specifications
vary.
Competition
We operate in a highly competitive environment. Our products compete with both large mainstream conventional packaged goods
companies and natural and organic packaged foods companies. Many of these competitors enjoy significantly greater resources.
Large mainstream conventional packaged goods competitors include Campbell Soup Company, Mondelez International, Inc.,
General Mills, Inc., Danone S.A., The J.M. Smucker Company, Kellogg Company, The Kraft Heinz Company, Nestle S.A.,
PepsiCo, Inc., The Hershey Company, Conagra Brands, Inc. and Unilever, and conventional personal care products companies
with whom we compete include, but are not limited to, The Proctor & Gamble Company, Johnson & Johnson and Colgate-Palmolive
Company. Certain of these large mainstream conventional packaged foods and personal care companies compete with us by
selling both conventional products and natural and/or organic products. Natural and organic packaged foods competitors include
Chobani LLC, Nature’s Bounty Inc., Clif Bar & Company and Amy’s Kitchen. In addition to these competitors, in each of our
categories we compete with many regional and small, local niche brands. Given limited retailer shelf space and merchandising
events, competitors actively support their respective brands with marketing, advertising and promotional spending. In addition,
most retailers market similar items under their own private label, which compete for the same shelf space.
Competitive factors in the packaged foods industry include product quality and taste, brand awareness and loyalty, product variety,
interesting or unique product names, product packaging and package design, shelf space, reputation, price, advertising, promotion
and nutritional claims.
11
Trademarks
We believe that brand awareness is a significant component in a consumer’s decision to purchase one product over another in
highly competitive consumer products industries. Our trademarks and brand names for the product lines referred to herein are
registered in the United States, Canada, the United Kingdom and European Union and a number of other foreign countries, and
we intend to keep these filings current and seek protection for new trademarks to the extent consistent with business needs. We WW
also copyright certain of our artwork and package designs. We own the trademarks for our principal products, including Alba
Botanica®, Almond Dream®, Arrowhead Mills®, Avalon Organics®, Bearitos®, Better Bean®, BluePrint®, Casbah®, Celestial
Seasonings®, Coconut Dream®, Cully & Sully®, Clarks™, Danival®, DeBoles®, Earth’s Best®, Earth’s Best TenderCare®, Ella’s
Kitchen®, Europe’s Best®, Farmhouse Fare™, Frank Cooper’s®, Gale’s®, Garden of Eatin’®, Hain Pure Foods®, Hartley’s®, Health
Valley®, Imagine®, JASON®, Johnson’s Juice Co.®, Joya®, Kosher Valley®, Lima®, Live Clean®, MaraNatha®, Natumi®, New
Covent Garden Soup Co.®, Nile Spice®, Orchard House®, Queen Helene®, Rice Dream®, Robertson’s®, Rudi’s Organic Bakery®,
Sensible Portions®, Soy Dream®, Spectrum®, Sun-Pat®, Sunripe®, SunSpire®, Terra®, The Greek Gods®, Walnut Acres Organic®,
Westbrae®, WestSoy®, William’s™, Yorkshire Provender® and Yves Veggie Cuisine®. We also have trademarks for many of our
best-selling Celestial Seasonings teas, including Country Peach Passion®, Lemon Zinger®, Mandarin Orange Spice®, Raspberry
Zinger®, Red Zinger®, Sleepytime®, Tension Tamer® and Wild Berry Zinger®.
We also market products under brands licensed under trademark license agreements, including Linda McCartney’s™, Mary Berry®,
Rose’s®, the Sesame Street name and logo and other Sesame Workshop intellectual property on certain of our Earth’s Best®
products, and the Paddington Bear image on certain of our Robertson’s® products.
Government Regulation
We are subject to extensive regulations in the United States by federal, state and local government authorities. In the United States,
the federal agencies governing the manufacture, marketing and distribution of our products include, among others, the Federal
Trade Commission (“FTC”), the United States Food & Drug Administration (“FDA”), the United States Department of Agriculture
(“USDA”), the United States Environmental Protection Agency (“EPA”) and the Occupational Safety and Health Administration
(“OSHA”). Under various statutes, these agencies prescribe and establish, among other things, the requirements and standards
for quality, safety and representation of our products to the consumer in labeling and advertising.
d
Internationally, we are subject to the laws and regulatory authorities of the foreign jurisdictions in which we manufacture and sell
our products, including the Food Standards Agency in the United Kingdom, the Canadian Food Inspection Agency in Canada and
European Food Safety Authority which supports the European Commission, as well as individual country, province, state and
local regulations.
d
Quality Control
We utilize a comprehensive food safety and quality management program, which employs strict manufacturing procedures, expert
technical knowledge on food safety science, employee training, ongoing process innovation, use of quality ingredients and both
internal and independent auditing.
In the United States, each of our own manufacturing facilities has a Food Safety Plan (“FSP”), which focuses on preventing food
safety risks and is compliant with the requirements set forth under the Food Safety and Modernization Act (“FSMA”). In addition,
each facility has at least one Preventive Controls Qualified Individual (“PCQI”) who has successfully completed training in the
development and application of risk-based preventive controls at least equivalent to that received under a standardized curriculum
recognized by the FDA.
All of our Hain-owned manufacturing sites and a significant number of our co-packers are certified against a standard recognized
by the Global Food Safety Initiative (“GFSI”) including Safe Quality Foods (“SQF”) and British Retail Consortium (“BRC”).
These standards are integrated food safety and quality management protocols designed specifically for the food sector and offer
a comprehensive methodology to manage food safety and quality. Certification provides an independent and external validation
that a product, process or service complies with applicable regulations and standards.
In addition to third-party inspections of our co-packers, we have instituted audits to address topics such as allergen control;
ingredient, packaging and product specifications; and sanitation. Under FSMA, each of our contract manufacturers is required to
have a FSP, a Hazard Analysis Critical Control Plant (“HACCP”) plan or a hazard analysis critical control points plan that identifies
critical pathways for contaminants and mandates control measures that must be used to prevent, eliminate or reduce relevant food-
borne hazards.
12
Independent Certification
In the United States, our organic products are certified in accordance with the USDA’s National Organic Program through Quality
Assurance International (“QAI”), a third-party certifying agency. For products marketed as organic outside of the United States,
we use accredited certifying agencies to ensure compliance with country-specific government regulations for selling organic
products or reciprocity, where available.
Many of our products are certified kosher under the supervision of accredited agencies including The Union of Orthodox Jewish
Congregations and “KOF-K” Kosher Supervision.
We also work with other non-governmental organizations such as NSF International, which developed the NSF/ANSI 305 Standard
for Personal Care Products Containing Organic Ingredients and provides third-party certification through QAI for our personal
care products in the absence of an established government regulation for these products. In addition, we work with other
nongovernmental organizations such as the Gluten Free Intolerance Group, Whole Grain Council and the Non-GMO Project.
Currently all of our Hain-owned facilities are GFSI compliant and audited by external certification bodies. 90% of our FDA
regulated food facilities have achieved a GFSI certification.
Available Information
The following information can be found, free of charge, in the “Investor Relations” section of our corporate website at
http://www.hain.com:
p
•
•
•
our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all amendments to
those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities
and Exchange Commission (“SEC”);
our policies related to corporate governance, including our Code of Business Conduct and Ethics (“Code of Ethics”)
applying to our directors, officers and employees (including our principal executive officer and principal financial and
accounting officers) that we have adopted to meet the requirements set forth in the rules and regulations of the SEC and
Nasdaq; and
the charters of the Audit, Compensation and Corporate Governance and Nominating Committees of our Board of Directors.
If the Company ever were to amend or waive any provision of its Code of Ethics that applies to the Company’s principal executive
officer, principal financial officer, principal accounting officer or any person performing similar functions, the Company intends
to satisfy its disclosure obligations, if any, with respect to any such waiver or amendment by posting such information on its
website set forth above rather than by filing a Current Report on Form 8-K.
13
Item 1A.
Risk Factors
Our business, operations and financial condition are subject to various risks and uncertainties. The most significant of these risks
include those described below; however, there may be additional risks and uncertainties not presently known to us or that we
currently consider immaterial. If any of the following risks and uncertainties develop into actual events, our business, financial
condition or results of operations could be materially adversely affected. In such case, the trading price of our common stock
could decline, and you may lose all or part of your investment. These risk factors should be read in conjunction with the other
information in this Annual Report on Form 10-K and in the other documents that we file from time to time with the SEC.
Our markets are highly competitive.
We operate in highly competitive geographic and product markets. Numerous brands and products compete for limited retailer
shelf space, where competition is based on product quality, brand recognition, brand loyalty, price, product innovation, promotional
activity, availability and taste among other things. Retailers also market competitive products under their own private labels,
which are generally sold at lower prices and compete with some of our products.
Some of our markets are dominated by multinational corporations with greater resources and more substantial operations than us.
We may not be able to successfully compete for sales to distributors or retailers that purchase from larger competitors that have
greater financial, managerial, sales and technical resources. Conventional food companies, including but not limited to Campbell
Soup Company, Mondelez International, Inc., General Mills, Inc., Danone S. A., The J.M. Smucker Company, Kellogg Company,
The Kraft Heinz Company, Nestle S.A., PepsiCo, Inc., The Hershey Company, Conagra Brands, Inc., and Unilever, and conventional
personal care products companies, including but not limited to The Procter & Gamble Company, Johnson & Johnson and Colgate-
Palmolive Company, may be able to use their resources and scale to respond to competitive pressures and changes in consumer
preferences by introducing new products or reformulating their existing products, reducing prices or increasing promotional
activities. We also compete with other organic and natural packaged food brands and companies, which may be more innovative
and able to bring new products to market faster and may be better able to quickly exploit and serve niche markets. As a result of
this competition, retailers may take actions that negatively affect us. Consequently, we may need to increase our marketing,
advertising and promotional spending to protect our existing market share, which may result in an adverse impact on our profitability.
a
t
Our growth and continued success depend upon consumer preferences for our products, which could change.
Our business is primarily focused on sales of organic, natural and “better-for-you” products which, if consumer demand for such
categories were to decrease, could harm our business. While we continue to diversify our product offerings, developing new
products entails risks, and demand for our products may not continue at current levels or increase in the future. The success of
our innovation and product improvement effort is affected by our ability to anticipate changes in consumers’ preferences, the level
of funding that can be made available, the technical capability of our research and development staff in developing, formulating
and testing product prototypes, including complying with governmental regulations, and the success of our management in
introducing the resulting improvements in a timely manner. In addition, we may see a substantial shift in consumption towards
the e-commerce channel. Typically, products sold via the e-commerce channel have lower margins than those sold in traditional
brick and mortar retailers and present unique challenges in order fulfillment. If we are unsuccessful in implementing product
improvements or introducing new products that satisfy the demands of consumers, our business could be harmed.
In addition, we have other product categories that are subject to evolving consumer preferences. Consumer demand could change
based on a number of possible factors, including dietary habits and nutritional values, concerns regarding the health effects of
ingredients and shifts in preference for various product attributes. A significant shift in consumer demand away from our products
could reduce the sales of our brands or our market share, both of which could harm our business.
dd
A significant portion of our business has exposure to continued political uncertainty in the United Kingdom and the negotiation
of its exit from the European Union, commonly referred to as “Brexit.”
In each of fiscal years 2019 and 2018, approximately 38% of our consolidated net sales were generated in the United Kingdom,
which continues to experience political, economic and market uncertainty as it negotiates the terms of Brexit. Brexit has caused
and may continue to cause disruptions to and create uncertainty surrounding our business, including affecting our relationships
with our existing and future customers, suppliers and employees, which could have an adverse effect on our business, financial
results and operations. The effects of Brexit will depend on any agreements the United Kingdom makes to retain access to European
Union markets either during a transitional period or more permanently. The measures could potentially disrupt the markets we
serve and the tax jurisdictions in which we operate, adversely change tax benefits or liabilities in these or other jurisdictions and
14
may cause us to lose customers, suppliers and employees. In addition, Brexit could lead to legal uncertainty and potentially
divergent national laws and regulations as the United Kingdom determines which European Union laws to replace or replicate.
Consolidation of customers or the loss of a significant customer could negatively impact our sales and profitability.
Our growth and continued success depend upon, among other things, our ability to maintain and increase sales volumes with
existing customers, our ability to attract new customers, the financial condition of our customers and our ability to provide products
that appeal to customers at the right price. Customers, such as supermarkets and food distributors in North America and the
European Union, continue to consolidate. This consolidation has produced larger, more sophisticated organizations with increased
negotiating and buying power that are able to resist price increases or demand increased promotional programs, as well as operate
with lower inventories, decrease the number of brands that they carry and increase their emphasis on private label products, which
could negatively impact our business. The consolidation of retail customers also increases the risk that a significant adverse impact
on their business could have a corresponding material adverse impact on our business.
Two of our customers each accounted for more than 10% of our consolidated net sales in each of the last three fiscal years,
respectively. United Natural Foods, Inc., a distributor of products to natural foods supermarkets, independent natural retailers and
other supermarkets and retailers, accounted for approximately 10%, 11% and 11% of our consolidated net sales for the fiscal years aa
ended June 30, 2019, 2018, and 2017, respectively, which were primarily related to the United States segment. Likewise, WalMart rr
Inc. and its affiliates, Sam’s Club and ASDA, together accounted for approximately 11%, 11%, and 12% of our consolidated net
sales for the fiscal years ended June 30, 2019, 2018 and 2017, respectively, which were primarily related to the United States and
United Kingdom segments.
The loss of any large customer, the reduction of purchasing levels or the cancellation of any business from a large customer for
an extended length of time could negatively impact our sales and profitability.
We rely on independent distributors for a substantial portion of our sales.
In our United States segment, we rely upon sales made by or through a group of non-affiliated distributors to customers. Distributors
purchase directly for their own account for resale. The loss of, or business disruption at, one or more of these distributors may
harm our business. If we are required to obtain additional or alternative distribution agreements or arrangements in the future,
we cannot be certain that we will be able to do so on satisfactory terms or in a timely manner. Our inability to enter into satisfactory
distribution agreements may inhibit our ability to implement our business plan or to establish markets necessary to successfully
expand the distribution of our products.
Disruptions in the worldwide economy and the financial markets may adversely impact our business and results of operations.
Adverse and uncertain economic and market conditions, particularly in the locations in which we operate, may impact customer
and consumer demand for our products and our ability to manage normal commercial relationships with our customers, suppliers
and creditors. Consumers may shift purchases to lower-priced or other perceived value offerings during economic downturns,
which may adversely affect our results of operations. Consumers may also reduce the number of organic and natural products
that they purchase where there are conventional alternatives, given that organic and natural products generally have higher retail
prices than do their conventional counterparts. In addition, consumers may choose to purchase private label products rather than
branded products, which generally have lower retail prices than do their branded counterparts. Distributors and retailers may also
become more conservative in response to these conditions and seek to reduce their inventories.
Prolonged unfavorable economic conditions may have an adverse effect on any of these factors and, therefore, could adversely
impact our sales and profitability.
We are subject to risks associated with our international sales and operations, including foreign currency, compliance and
trade risks.
Operating in international markets involves exposure to movements in currency exchange rates, which are volatile at times. The
economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real
growth, inflation, interest rates, governmental actions and other factors. Consequently, isolating the effect of changes in currency
does not incorporate these other important economic factors. These changes, if material, could cause adjustments to our financing
and operating strategies.
uu
15
We hold assets, incur liabilities, earn revenue and pay expenses in a variety of currencies other than the United States Dollar, rr
primarily the British Pound, the Euro, the Canadian Dollar and the Indian Rupee. Our consolidated financial statements are
presented in United States Dollars, and therefore we must translate our assets, liabilities, revenue and expenses into United States
Dollars for external reporting purposes. As a result, changes in the value of the United States Dollar during a period may
unpredictably and adversely impact our consolidated operating results, our asset and liability balances and our cash flows in our
consolidated financial statements, even if their value has not changed in their original currency.
During fiscal 2019, 54% of our consolidated net sales were generated outside the United States, while such sales outside the United
States were 53% of net sales in fiscal 2018 and 50% in fiscal 2017. Sales from outside our U.S. markets may continue to represent
a significant portion of our total net sales in the future. Our non-U.S. sales and operations are subject to risks inherent in conducting
business abroad, many of which are outside our control, including:
n
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
periodic economic downturns and the instability of governments, including default or deterioration in the credit worthiness
of local governments, geopolitical regional conflicts, terrorist activity, political unrest, civil strife, acts of war, public
corruption, expropriation and other economic or political uncertainties;
difficulties in managing a global enterprise, including staffing, collecting accounts receivable and managing distributors;
compliance with U.S. laws affecting operations outside of the United States, such as the U.S. Foreign Corrupt Practices
Act (“FCPA”) and the Office of Foreign Assets Control trade sanction regulations and anti-boycott regulations;
difficulties associated with operating under a wide variety of complex foreign laws, treaties and regulations, including
compliance with antitrust and competition laws, anti-modern slavery laws, anti-bribery and anti-corruption laws, data
privacy laws, including the European Union General Data Protection Regulation (“GDPR”), and a variety of other local,
national and multi-national regulations and laws;
tariffs, quotas, trade barriers or sanctions, other trade protection measures and import or export licensing requirements
imposed by governments that might negatively affect our sales, including, but not limited to, Canadian and European
Union tariffs imposed on certain U.S. food and beverages;
pandemics, such as the flu, which may adversely affect our workforce as well as our local suppliers and customers;
earthquakes, tsunamis, floods or other major disasters that may limit the supply of products that we purchase abroad;
varying regulatory, tax, judicial and administrative practices in the jurisdictions where we operate, including changes in
tax laws, interpretation of tax laws, tax audit outcomes and potentially burdensome taxation;
changes in capital controls, including price and currency exchange controls;
discriminatory or conflicting fiscal policies;
varying abilities to enforce intellectual property and contractual rights;
greater risk of uncollectible accounts and longer collection cycles;
design and implementation of effective control environment processes across our diverse operations and employee base;
foreign currency exchange and transfer restrictions;
increased costs, disruptions in shipping or reduced availability of freight transportation; and
differing labor standards.
If we do not manage our supply chain effectively, our operating results may be adversely affected.
The success of our business depends, in part, on maintaining a strong sourcing and manufacturing platform. The inability of anynn
supplier of raw materials, independent co-packer or third-party distributor to deliver or perform for us in a timely or cost-effective
manner could cause our operating costs to increase and our profit margins to decrease, especially as it relates to our products that
have a short shelf life. We must continuously monitor our inventory and product mix against forecasted demand or risk having
inadequate supplies to meet consumer demand as well as having too much inventory on hand that may reach its expiration date
and become unsaleable. If we are unable to manage our supply chain efficiently and ensure that our products are available to meet
consumer demand, our operating costs could increase, and our profit margins could decrease.
ff
Our future results of operations may be adversely affected by volatile commodity costs.
Many aspects of our business have been, and may continue to be, directly affected by volatile commodity costs, including fuel.
Agricultural commodities and ingredients, including almonds, corn, dairy, fruit and vegetables, oils, rice, soybeans and wheat, are
the principal inputs used in our products. These items are subject to price volatility which can be caused by commodity market
fluctuations, crop yields, seasonal cycles, weather conditions (including the potential effects of climate change), temperature
extremes and natural disasters (including floods, droughts, water scarcity, frosts, earthquakes and hurricanes), pest and disease
problems, changes in currency exchange rates, imbalances between supply and demand, and government programs and policies
among other factors. Volatile fuel costs translate into unpredictable costs for the products and services we receive from our third-
party providers including, but not limited to, distribution costs for our products and packaging costs. While we seek to offset the
volatility of such costs with a combination of cost savings initiatives, operating efficiencies and price increases to our customers,
16
we may be unable to manage cost volatility. If we are unable to fully offset the volatility of such costs, our financial results could
be adversely affected.
Our ability to achieve our business plans is partially dependent on our ability to implement and achieve targeted savings and
efficiencies from cost reduction initiatives.
We put in place planned productivity initiatives that are designed to control or reduce costs or that increase operating efficiencies
in order to improve our profitability and offset many of the input cost increases that are outside of our control. In addition, these
initiatives are designed to fund opportunities for investment in innovation and marketing. Our success depends on our ability to
execute these initiatives and realize cost savings and efficiencies from our operations. If we are unable to identify and fully
implement our productivity plans and achieve our anticipated efficiencies, our profitability may be adversely impacted.
Our profit margins also depend on our ability to manage our inventory efficiently. As part of our effort to manage our inventory
more efficiently, we carry out SKU rationalization programs, which may result in the discontinuation of lower-margin or low-
turnover SKUs. For example, as part of the Project Terra review, and the more recent productivity initiative in fiscal year 2019,
the Company has carried out product rationalization initiatives aimed at eliminating low margin and slow moving SKUs or brands
entirely. However, a number of factors, such as changes in customers’ inventory levels, access to shelf space and changes in
consumer preferences, may lengthen the number of days we carry certain inventories, which may impede our effort to manage
our inventory efficiently and thereby increase our costs.
Our debt may restrict our future operations, and any default under our debt agreements could have significant consequences.
We have substantial debt and have the ability to incur additional debt. As of June 30, 2019, we had approximately $626.8 million
of debt outstanding under our credit agreement, consisting of approximately $420.6 million in borrowings under a revolving credit
facility and approximately $206.3 million outstanding under a term loan. As of June 30, 2019, there was approximately $569.7
million available for additional borrowings under the revolving credit facility. Our payments of interest and principal due under
our debt could make it more difficult for us to satisfy our financial obligations and could increase our vulnerability to general
adverse economic and industry conditions.
Our credit agreement contains covenants imposing certain restrictions on our business. These restrictions may affect our abilitytt
to operate our business and may limit our ability to take advantage of potential business opportunities as they arise. The credit
agreement contains restrictive covenants including, with specified exceptions, limitations on our ability to engage in certain
business activities, incur debt and liens, make capital expenditures, pay dividends or make other distributions, enter into affiliate
transactions, consolidate, merge or acquire or dispose of assets, and make certain investments, acquisitions and loans. The credit
agreement also requires us to satisfy certain financial covenants, such as maintaining a minimum consolidated interest coverage
ratio and a maximum consolidated leverage ratio.
ff
Our ability to comply with these covenants under the credit agreement may be affected by events beyond our control, including
prevailing economic, financial and industry conditions. The breach of any of these covenants could result in a default, which would
permit the lenders to declare all outstanding debt to be due and payable, together with accrued and unpaid interest. Our obligations
under the credit agreement are guaranteed by certain existing and future domestic subsidiaries of the Company and are secured
by liens on assets of the Company and its material domestic subsidiaries, including the equity interest in each of their direct
subsidiaries and intellectual property, subject to agreed upon exceptions. Any default by us under the credit agreement could have
a material adverse effect on our financial condition and our business.
Ineffective internal controls could impact the Company’s business and financial results.
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, and for
evaluating and reporting on our system for internal control. Our management concluded in its most recent year-end assessment
that our internal control over financial reporting was effective as of June 30, 2019. However, such internal control has inherent
limitations and may not prevent or detect misstatements. Even effective internal controls can provide only reasonable assurance
with respect to the preparation and fair presentation of financial statements. If we fail to maintain adequate internal controls,
including any failure to implement required new or improved controls, or if we experience difficulties in their implementation,
we could fail to meet our financial reporting obligations and our business, financial results and reputation could be harmed.
Legal claims, government investigations or other regulatory enforcement actions could subject us to civil and criminal penalties.
We operate in a highly regulated environment with constantly evolving legal and regulatory frameworks. Consequently, we are
subject to a heightened risk of legal claims, government investigations and other regulatory enforcement actions. We are subject
17
to extensive regulations in the United States, United Kingdom, Canada, Europe, Asia, including India, and any other countries
where we manufacture, distribute and/or sell our products. Our products are subject to numerous food safety and other laws and
regulations relating to the registration and approval, sourcing, manufacturing, storing, labeling, marketing, advertising and
distribution of these products. Enforcement of existing laws and regulations, changes in legal requirements and/or evolving
interpretations of existing regulatory requirements may result in increased compliance costs and create other obligations, financial
or otherwise, that could adversely affect our business, financial condition or operating results.
aa
In addition, we could be adversely affected by violations of the FCPA and similar worldwide anti-bribery laws, which generally
prohibit companies and their intermediaries from making improper payments to non-U.S. officials or other third parties for the
purpose of obtaining or retaining business. Although we have implemented policies and procedures designed to ensure compliance
with existing laws and regulations, we cannot provide any assurance that our employees, contractors or agents will not violate our
policies and procedures.
Moreover, a failure to maintain effective control processes could lead to violations, unintentional or otherwise, of laws and
regulations. Legal claims, government investigations or regulatory enforcement actions arising out of our failure or alleged failure
to comply with applicable laws and regulations could subject us to civil and criminal penalties that could materially and adversely
affect our product sales, reputation, financial condition, and operating results. In addition, the costs and other effects of defending
potential and pending litigation and administrative actions against us may be difficult to determine and could adversely affect our
financial condition and operating results.
t
Pending and future litigation may lead us to incur significant costs.
We are, or may become, party to various lawsuits and claims arising in the normal course of business, which may include lawsuits
or claims relating to contracts, intellectual property, product recalls, product liability, the marketing and labeling of products,
employment matters, environmental matters, data protection or other aspects of our business as well as any securities class action
and stockholder derivative litigation. For example, as discussed under Item 3, “Legal Proceedings”, we are currently subject to
class actions and derivative complaints arising out of or related to the Company’s internal accounting review. Even when not
merited, the defense of these lawsuits may divert our management’s attention, and we may incur significant expenses in defending
these lawsuits. The results of litigation and other legal proceedings are inherently uncertain, and adverse judgments or settlements
in some or all of these legal disputes may result in monetary damages, penalties or injunctive relief against us, which could have
a material adverse effect on our financial position, cash flows or results of operations. Any claims or litigation, even if fully
indemnified or insured, could damage our reputation and make it more difficult to compete effectively or to obtain adequate
insurance in the future.
We may be subject to significant liability that is not covered by insurance, and our potential indemnification obligations and
limitations of our director and officer liability insurance could result in significant legal expenses or damages and cause our
business, financial condition, results of operations and cash flows to suffer.
While we believe that the extent of our insurance coverage is consistent with industry practice, any claim under our insurance
policies may be subject to certain exceptions as well as caps on amounts recoverable, may not be honored fully, in a timely manner,
or at all, and we may not have purchased sufficient insurance to cover all losses incurred. Separate from potential indemnification
obligations, if we were to incur substantial liabilities or if our business operations were interrupted for a substantial period of time,
we could incur costs and suffer losses. Such inventory and business interruption losses may not be covered by our insurance
policies. Additionally, in the future, insurance coverage may not be available to us at commercially acceptable premiums, or at
all.
n
In addition, both current and former officers and members of our Board of Directors, as individual defendants, are the subject of
lawsuits related to the Company. Under Delaware law, our bylaws and certain indemnification agreements, we may have an
obligation to indemnify both current and former officers and directors in relation to these matters, and our insurance coverage
may not be adequate to cover all of the costs associated with these claims. If the Company incurs significant uninsured indemnity
obligations, our indemnity obligations could result in significant legal expenses or damages and cause our business, financial
condition, results of operations and cash flow to suffer.
We may be subject to significant liability should the consumption of any of our products cause illness or physical harm.
The sale of products for human use and consumption involves the risk of injury or illness to consumers. Such injuries may result
from inadvertent mislabeling, tampering by unauthorized third parties or product contamination or spoilage. Under certain
circumstances, we may be required to recall or withdraw products, suspend production of our products or cease operations, which
may lead to a material adverse effect on our business. In addition, customers may cancel orders for such products as a result of
18
such events. Even if a situation does not necessitate a recall or market withdrawal, product liability claims might be asserted
against us. While we are subject to governmental inspection and regulations and believe our facilities and those of our co-packers
and suppliers comply in all material respects with all applicable laws and regulations, if the consumption of any of our products
causes, or is alleged to have caused, a health-related illness, we may become subject to claims or lawsuits relating to such matters.
Even if a product liability claim is unsuccessful or is not fully pursued, the negative publicity surrounding any assertion that our
products caused illness or physical harm, could adversely affect our reputation with existing and potential customers and consumers
and our corporate and brand image. Moreover, claims or liabilities of this type might not be covered by our insurance or by anynn
rights of indemnity or contribution that we may have against others. Although we maintain product liability and product recall
insurance in an amount that we believe to be adequate, we may incur claims or liabilities for which we are not insured or that
exceed the amount of our insurance coverage. A product liability judgment against us or a product recall could have a material
adverse effect on our business, consolidated financial condition, results of operations or liquidity.
u
An impairment in the carrying value of goodwill or other acquired intangible assets could materially and adversely affect our
consolidated results of operations and net worth.
As of June 30, 2019, we had goodwill of $1.01 billion and trademarks and other intangibles assets of $465.2 million, which in the
aggregate represented 57% of our total consolidated assets. The net carrying value of goodwill represents the fair value of acquired
businesses in excess of identifiable assets and liabilities as of the acquisition date (or subsequent impairment date, if applicable).
The net carrying value of trademarks and other intangibles represents the fair value of trademarks, customer relationships and
other acquired intangibles as of the acquisition date (or subsequent impairment date, if applicable), net of accumulated amortization.
Goodwill and other acquired intangibles expected to contribute indefinitely to our cash flows are not amortized, but must be
evaluated by management at least annually for impairment. Amortized intangible assets are evaluated for impairment whenever
events or changes in circumstances indicate that the carrying amounts of these assets may not be recoverable. Impairments to
goodwill and other intangible assets may be caused by factors outside our control, such as increasing competitive pricing pressures,
changes in discount rates based on changes in cost of capital (interest rates, etc.), lower than expected sales and profit growth
rates, changes in industry Earnings Before Interest Taxes Depreciation and Amortization (“EBITDA”) multiples, the inability to
quickly replace lost co-manufacturing business, or the bankruptcy of a significant customer. We have in the past recorded, and
may in the future be required to record, significant charges in our consolidated financial statements during the period in which
any impairment of our goodwill or intangible assets is determined. The incurrence of impairment charges could negatively affect
our results of operations and adversely impact our net worth and our consolidated earnings in the period of such charge.
We may not be able to successfully consummate divestitures as part of our strategy to become a smaller business.
As discussed under Item 1, “Business,” as part of the Company’s overall strategy, the Company may seek to dispose of businesses
and brands that are less profitable or are otherwise less of a strategic fit within our core portfolio. We may not be able to negotiate
such divestitures on terms acceptable to us. Also, our profitability may be impacted by gains or losses on the sales of such
businesses, or lost operating income or cash flows from such businesses. Additionally, we may be required to record, and have
in the past recorded, asset impairment or restructuring charges related to divested businesses. Similarly, we may be obliged to
indemnify buyers for liabilities, which may reduce our profitability and cash flows. Such potential divestitures will require
management resources and may divert management’s attention from our day-to-day operations. If we are not successful in divesting
such businesses, our business could be harmed.
Our acquisition history could expose us to risk, including our ability to continue to integrate the brands that we have acquired.
We have historically grown our business in part through the acquisition of brands, both in the United States and internationally.
The success of our more recent acquisitions will be dependent upon our ability to effectively integrate those brands, including our
ability to realize potentially available marketing opportunities and cost savings, some of which may involve operational changes.
Despite our due diligence investigation of each business that we have acquired, there may be liabilities of the acquired companies
that we failed to or were unable to discover during the diligence process and for which we, as a successor owner, may be responsible.
Our future results of operations may be adversely affected by the availability of organic ingredients.
Our ability to ensure a continuing supply of organic ingredients at competitive prices depends on many factors beyond our control,
such as the number and size of farms that grow organic crops, climate conditions, increased demand for organic ingredients by
our competitors, changes in national and world economic conditions, currency fluctuations and forecasting adequate need of
seasonal ingredients.
The organic ingredients that we use in the production of our products (including, among others, fruits, vegetables, nuts and grains)
are vulnerable to adverse weather conditions and natural disasters, such as floods, droughts, water scarcity, temperature extremes,
19
frosts, earthquakes and pestilences. Natural disasters and adverse weather conditions (including the potential effects of climate
change) can lower crop yields and reduce crop size and crop quality, which in turn could reduce our supplies of organic ingredients
or increase the prices of organic ingredients. If our supplies of organic ingredients are reduced, we may not be able to find enough
supplemental supply sources on favorable terms, if at all, which could impact our ability to supply products to our customers and
adversely affect our business, financial condition and results of operations.
a
We also compete with other manufacturers in the procurement of organic product ingredients, which may be less plentiful in the
open market than conventional product ingredients. This competition may increase in the future if consumer demand for organic
products increases. This could cause our expenses to increase or could limit the amount of products that we can manufacture and
sell.
Interruption in, disruption of or loss of operations at one or more of our manufacturing facilities could harm our business.
For the fiscal years ended June 30, 2019, 2018 and 2017, approximately 59%, 58% and 59%, respectively, of our net sales was
derived from products manufactured at our own manufacturing facilities. An interruption in, disruption of or the loss of operations
at one or more of these facilities, which may be caused by work stoppages, governmental actions, disease outbreaks or pandemics,
acts of war, terrorism, fire, earthquakes, flooding or other natural disasters at one or more of these facilities, could delay or postpone
production of our products, which could have a material adverse effect on our business, results of operations and financial condition
until such time as the interruption of operations is resolved or an alternate source of production is secured. In addition, if one or
more of our manufacturing facilities are running at full capacity and we are unable to keep up with customer demand, we may not
be able to fulfill orders on time or at all which could adversely impact our business.
aa
f
Loss of one or more of our independent co-packers could adversely affect our business.
During fiscal 2019, 2018 and 2017, approximately 41%, 42% and 41%, respectively, of our net sales were derived from products
manufactured at independent co-packers. In some cases, an individual co-packer may produce all of our requirements for a
particular brand. We believe there are a limited number of competent, high-quality co-packers in the industry, and many of our
co-packers produce products for other companies as well. Therefore, if we lose or need to change one or more co-packers,
experience disruptions or delays at a co-packer or fail to retain co-packers for newly acquired products or brands, production of
our products may be delayed or postponed and/or the availability of some of our products may be reduced or eliminated, which
could have a material adverse effect on our business, results of operations and financial condition.
Disruption of our transportation systems could harm our business.
The success of our business depends, in large part, upon dependable and cost-effective transportation systems and a strong
distribution network. A disruption in transportation services could result in an inability to supply materials to our or our co-packers’
facilities or finished products to our distribution centers or customers. We utilize distribution centers that are managed by third
parties. Activity at these distribution centers could be disrupted by a number of factors, including labor issues, failure to meet
customer standards, acts of war, terrorism, fire, earthquakes, flooding or other natural disasters or bankruptcy or other financial
issues affecting the third-party providers. Any extended disruption in the distribution of our products or an increase in the cost of
these services could have a material adverse effect on our business.
Our inability to use our trademarks could have a material adverse effect on our business.
We believe that brand awareness is a significant component in a consumer’s decision to purchase one product over another in the
highly competitive food, beverage and personal care industries. Although we endeavor to protect our trademarks and trade names,
these efforts may not be successful, and third parties may challenge our right to use one or more of our trademarks or trade names.
We believe that our trademarks and trade names are significant to the marketing and sale of our products and that the inability to
utilize certain of these names could have a material adverse effect on our business, results of operations and financial condition.
y
In addition, we market products under brands licensed under trademark license agreements, including Linda McCartney’s™, the
Sesame Street name and logo and other Sesame Workshop intellectual property on certain of our Earth’s Best® products. We
believe that these trademarks have significant value and are instrumental in our ability to market and sustain demand for those
product offerings. We cannot assure you that these trademark license agreements will remain in effect and enforceable or that any
license agreements, upon expiration, can be renewed on acceptable terms or at all. In addition, any future disputes concerning
these trademark license agreements may cause us to incur significant litigation costs or force us to suspend use of the disputed
trademarks and suspend sales of products using such trademarks.
20
We are subject to environmental laws and regulations relating to hazardous materials, substances and waste used in or resulting
from our operations. Liabilities or claims with respect to environmental matters could have a significant negative impact on
our business.
As with other companies engaged in similar businesses, the nature of our operations expose us to the risk of liabilities and claims
with respect to environmental matters, including those relating to the disposal and release of hazardous substances. Furthermore,
our operations are governed by laws and regulations relating to workplace safety and worker health, which, among other things,
regulate employee exposure to hazardous chemicals in the workplace. Any material costs incurred in connection with such liabilities
or claims could have a material adverse effect on our business, consolidated financial condition, results of operations or liquidity.
Any environmental or health and safety legislation or regulations enacted in the future, or any changes in how existing or future uu
laws or regulations will be enforced, administered or interpreted, may lead to an increase in compliance costs or expose us to
additional risk of liabilities and claims, which could have a material adverse effect on our business, consolidated financial condition,
results of operations or liquidity.
If the reputation of one or more of our leading brands erodes significantly, it could have a material impact on our results of
operations.
Our financial success is directly dependent on the consumer perception of our brands. The success of our brands may suffer if
our marketing plans or product initiatives do not have the desired impact on a brand’s image or its ability to attract consumers.
Further, our results could be negatively impacted if one of our brands suffers substantial damage to its reputation due to real or
perceived quality issues or the Company is perceived to act in an irresponsible manner. In addition, it is possible for such
information, misperceptions and opinions to be shared quickly and disseminated widely due to the use of social and digital media.
We rely on independent certification for a number of our products.
We rely on independent third-party certification, such as certifications of our products as “organic”, “Non-GMO” or “kosher,” to
differentiate our products from others. We must comply with the requirements of independent organizations or certification
authorities in order to label our products as certified organic. For example, we can lose our “organic” certification if a manufacturing
plant becomes contaminated with non-organic materials, or if it is not properly cleaned after a production run. In addition, all raw
materials must be certified organic. Similarly, we can lose our “kosher” certification if a manufacturing plant and raw materials
do not meet the requirements of the appropriate kosher supervision organization. The loss of any independent certifications could
adversely affect our market position as an organic and natural products company, which could harm our business.
n
A cybersecurity incident or other technology disruptions could negatively impact our business and our relationships with
customers.
We use computers in substantially all aspects of our business operations. We also use mobile devices, social networking and other
online activities to connect with our employees, suppliers, customers and consumers. Such uses give rise to cybersecurity risks,
including security breach, espionage, system disruption, theft and inadvertent release of information. Our business involves the
storage and transmission of numerous classes of sensitive and/or confidential information and intellectual property, including
customers’ and suppliers' information, private information about employees, and financial and strategic information about the
Company and its business partners. Further, as we pursue new initiatives that improve our operations and cost structure, we are
also expanding and improving our information technologies, resulting in a larger technological presence and increased exposure
to cybersecurity risk. If we fail to assess and identify cybersecurity risks associated with new initiatives, we may become
increasingly vulnerable to such risks. Additionally, while we have implemented measures to prevent security breaches and cyber
incidents, our preventative measures and incident response efforts may not be entirely effective. The theft, destruction, loss,
misappropriation, or release of sensitive and/or confidential information or intellectual property, or interference with our
information technology systems or the technology systems of third parties on which we rely, could result in business disruption,
negative publicity, brand damage, litigation, violation of privacy laws, loss of customers, potential liability and competitive
disadvantage any of which could have a material adverse effect on our business, financial condition or results of operations.
t
t
Our business operations could be disrupted if our information technology systems fail to perform adequately.
The efficient operation of our business depends on our information technology systems. We rely on our information technology
systems to effectively manage our business data, communications, supply chain, order entry and fulfillment, and other business
processes. The failure of our information technology systems to perform as we anticipate could disrupt our business and could
result in transaction errors, processing inefficiencies and the loss of sales and customers, causing our business and results of
operations to suffer. In addition, our information technology systems may be vulnerable to damage or interruption from
21
circumstances beyond our control, including fire, natural disasters, system failures and viruses. Any such damage or interruption
could have a material adverse effect on our business.
Compliance with data privacy laws may be costly, and non-compliance with such laws may result in significant liability.
Many jurisdictions in which the Company operates have laws and regulations relating to data privacy and protection of personal
information, including the European Union GDPR, which became effective May 25, 2018. GDPR requires companies to satisfy
requirements regarding the handling of personal data. Failure to comply with GDPR requirements could result in litigation, adverse
publicity and penalties of up to 4% of worldwide revenue. The law in this area continues to develop, and the changing nature of
privacy laws in the European Union and elsewhere could impact the Company’s processing of personal information related to the
Company’s employees, consumers, customers and vendors. The enactment of more restrictive laws, rules or regulations or future
enforcement actions or investigations could impact us through increased costs or restrictions on our business, and noncompliance
could result in regulatory penalties and significant liability.
Joint ventures that we enter into present a number of risks and challenges that could have a material adverse effect on our
business and results of operations.
As part of our business strategy, we have made minority interest investments and established joint ventures. These transactions
typically involve a number of risks and present financial and other challenges, including the existence of unknown potential
disputes, liabilities or contingencies and changes in the industry, location or political environment in which these investments are
located, that may arise after entering into such arrangements. We could experience financial or other setbacks if these transactions
encounter unanticipated problems, including problems related to execution by the management of the companies underlying these
investments. Any of these risks could adversely affect our results of operations.
Global capital and credit market issues could negatively affect our liquidity, increase our costs of borrowing and disrupt the
operations of our suppliers and customers.
We depend on stable, liquid and well-functioning capital and credit markets to fund our operations. Although we believe that our
operating cash flows, financial assets, access to capital and credit markets and revolving credit agreement will permit us to meet
our financing needs for the foreseeable future, future volatility or disruption in the capital and credit markets and the state of the
economy, including the consumer staples industry, may impair our liquidity or increase our costs of borrowing. Such disruptions
could require us to take measures to conserve cash until the markets stabilize or until alternative credit arrangements or other
funding for our business needs can be arranged. Our business could also be negatively impacted if our suppliers or customers
experience disruptions resulting from tighter capital and credit markets or a slowdown in the general economy.
Climate change may negatively affect our business and operations.
There is concern that carbon dioxide and other greenhouse gases in the atmosphere may have an adverse impact on global
temperatures, weather patterns and the frequency and severity of extreme weather and natural disasters. In the event that such
climate change has a negative effect on agricultural productivity, we may be subject to decreased availability or less favorable
pricing for certain commodities that are necessary for our products, such as corn, oats, rice, wheat and various fruits and vegetables.
As a result of climate change, we may also be subjected to decreased availability of water, deteriorated quality of water or less
favorable pricing for water, which could adversely impact our manufacturing and distribution operations.
The ownership of our common stock could be concentrated, and certain stockholders could have significant influence over
the outcome of corporate actions requiring stockholder approval.
As of August 29, 2019, based on information filed with the SEC and reported to us, Engaged Capital, LLC and certain of its
affiliates (“Engaged Capital”) beneficially owned an aggregate of approximately 20% of our outstanding common stock. Engaged
Capital and any other stockholders acquiring beneficial ownership of a significant amount of our outstanding common stock could
have significant influence over the outcome of corporate actions requiring stockholder approval, including the election of directors,
any merger, consolidation or sale of all or substantially all of our assets, and certain other significant corporate transactions.
Our ability to issue preferred stock may deter takeover attempts.
Our Board of Directors is empowered to issue, without stockholder approval, preferred stock with dividends, liquidation,
conversion, voting or other rights, which could decrease the amount of earnings and assets available for distribution to holders of
our common stock and adversely affect the relative voting power or other rights of the holders of our common stock. In the event
of issuance, the preferred stock could be used as a method of discouraging, delaying or preventing a change in control. Our amended
22
and restated certificate of incorporation authorizes the issuance of up to 5 million shares of “blank check” preferred stock with
such designations, rights and preferences as may be determined from time to time by our Board of Directors. Although we have
no present intention to issue any shares of our preferred stock, we may do so in the future under appropriate circumstances.
Item 1B.
Unresolved Staff Comments
None.
23
Item 2.
Properties
Our principal facilities, which are leased except where otherwise indicated, are as follows:
Primary Use
Location
Approximate
Square Feet
Expiration of
Lease
United States:
Headquarters office
Manufacturing and offices (Tea)
Manufacturing and distribution (Flours and grains)
Manufacturing (Snack products)
Lake Success, NY
Boulder, CO
Hereford, TX
Moonachie, NJ
Manufacturing and distribution center (Snack products)
Mountville, PA
Manufacturing (Meat-alternatives)
Manufacturing (Nut butters)
Distribution center (Grocery, snacks, and personal care
products)
Boulder, CO
Ashland, OR
Ontario, CA
Distribution (Tea)
Manufacturing and distribution (Breads, buns, and related
Boulder, CO
Boulder, CO
products)
Manufacturing and distribution (Personal Care)
Storage facility (Raw and packaging products)
Bell, CA
Ashland, OR
United Kingdom:
Manufacturing and offices (Ambient grocery products)
Manufacturing (Hot-eating desserts)
Manufacturing (Fresh fruit and salads)
Manufacturing (Chilled soups)
Manufacturing (Chilled soups)
Histon, England
Clitheroe, England
Leeds, England
Grimsby, England
North Yorkshire,
England
Manufacturing (Desserts and plant-based frozen products)
Fakenham, England
Manufacturing (Fresh prepared fruit products)
Distribution and offices (Packaging and ingredients)
Corby, England
Corby, England
Manufacturing, distribution and offices (Fresh prepared
Corby, England
fruit products and drinks)
Manufacturing and offices (Fresh prepared fruit)
Manufacturing and distribution (Crackers)
Gateshead, England
Larvik, Norway
Manufacturing and distribution (Natural sweeteners)
Newport, England
86,000
158,000
136,000
75,000
100,000
21,000
13,000
375,000
100,000
69,000
125,000
13,000
2029
Owned
Owned
Owned
2024
Owned
Owned
2023
2020
2020
2028
2020
303,000
Owned
38,000
34,000
61,000
14,000
101,000
45,000
22,500
89,500
46,000
20,000
14,500
2026
2022
2029
Owned
Owned
2024
2019
Owned
2020
2019
2023
24
Location
Approximate
Square Feet
Expiration of
Lease
Primary Use
Rest of World:
Manufacturing (Plant-based foods)
Manufacturing and offices (Personal care)
Distribution (Personal care)
Manufacturing (Plant-based foods)
Offices
Vancouver, BC,
Canada
Mississauga, ON,
Canada
Mississauga, ON,
Canada
Trenton, ON, Canada
Toronto, ON, Canada
Manufacturing, distribution and offices (Plant-based
Troisdorf, Germany
beverages)
Manufacturing and offices (Organic food products)
Distribution (Organic food products)
Andiran, France
Nerac, France
Manufacturing and offices (Plant-based foods and
Oberwart, Austria
beverages)
Manufacturing (Plant-based foods and beverages)
Manufacturing and distribution (Plant-based foods and
beverages
Schwerin, Germany
Loipersdorf, Austria
76,000
Owned
61,000
81,000
47,000
14,000
131,000
39,000
18,000
108,000
650,000
76,000
2020
2022
2028
2024
2037
Owned
Owned
Unlimited
Owned
Unlimited
We also lease space for other smaller offices and facilities in the United States, United Kingdom, Canada, Europe and other partsrr
of the world.
In addition to the foregoing distribution facilities operated by us, we also utilize bonded public warehouses from which deliveries
are made to customers.
For further information regarding our lease obligations, see Note 17, Commitments and Contingencies, in the Notes to Consolidated
Financial Statements included in Item 8 of this Form 10-K. For further information regarding the use of our properties by segments,
see Item 1, “Business - Production” of this Form 10-K.
Item 3.
Legal Proceedings
Securities Class Actions Filed in Federal Court
On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York against the Company
alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) Flora v. The
Hain Celestial Group, Inc., et al. (the “Flora Complaint”); (2) Lynn v. The Hain Celestial Group, Inc., et al. (the “Lynn Complaint”);
and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints,
the “Securities Complaints”). On June 5, 2017, the court issued an order for consolidation, appointment of Co-Lead Plaintiffs and
approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In
re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”), and Rosewood Funeral Home and
Salamon Gimpel were appointed as Co-Lead Plaintiffs. On June 21, 2017, the Company received notice that plaintiff Spadola
voluntarily dismissed his claims without prejudice to his ability to participate in the Consolidated Securities Action as an absent
class member. The Co-Lead Plaintiffs in the Consolidated Securities Action filed a Consolidated Amended Complaint on August
4, 2017 and a Corrected Consolidated Amended Complaint on September 7, 2017 on behalf of a purported class consisting of all
persons who purchased or otherwise acquired Hain Celestial securities between November 5, 2013 and February 10, 2017 (the
“Amended Complaint”). The Amended Complaint named as defendants the Company and certain of its current and former officers
(collectively, “Defendants”) and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on
allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding
the Company’s business, prospects, financial results and internal controls. Defendants filed a motion to dismiss the Amended
Complaint on October 3, 2017 which the Court granted on March 29, 2019, dismissing the case in its entirety, without prejudice
to replead. Co-Lead Plaintiffs filed a Second Amended Consolidated Class Action Complaint on May 6, 2019 (the “Second
Amended Complaint”). The Second Amended Complaint again names as defendants the Company and certain of its current and
former officers and asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegations
similar to those in the Amended Complaint, including materially false or misleading statements and omissions in public statements,
aa
25
press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. Defendants
filed a motion to dismiss the Second Amended Complaint on June 20, 2019. Co-Lead Plaintiffs filed an opposition on August 5,
2019, and Defendants have until September 3, 2019 to submit a reply.
Stockholder Derivative Complaints Filed in State Court
On September 16, 2016, a stockholder derivative complaint, Paperny v. Heyer, et al. (the “Paperny Complaint”), was filed in New
York State Supreme Court in Nassau County against the Board of Directors and certain officers of the Company alleging breach
of fiduciary duty, unjust enrichment, lack of oversight and corporate waste. On December 2, 2016 and December 29, 2016, two
additional stockholder derivative complaints were filed in New York State Supreme Court in Nassau County against the Board of
Directors and certain officers under the captions Scarola v. Simon (the “Scarola Complaint”) and Shakir v. Simon (the “Shakir
Complaint” and, together with the Paperny Complaint and the Scarola Complaint, the “Derivative Complaints”), respectively.
Both the Scarola Complaint and the Shakir Complaint alleged breach of fiduciary duty, lack of oversight and unjust enrichment.
On February 16, 2017, the parties for the Derivative Complaints entered into a stipulation consolidating the matters under the
caption In re The Hain Celestial Group (the “Consolidated Derivative Action”) in New York State Supreme Court in Nassau
County, ordering the Shakir Complaint as the operative complaint. On November 2, 2017, the parties agreed to stay the Consolidated
Derivative Action. Co-Lead Plaintiffs requested leave to file an amended consolidated complaint, and on January 14, 2019, the
Court partially lifted the stay, ordering Co-Lead Plaintiffs to file their amended complaint by March 7, 2019. Co-Lead Plaintiffs
filed a Verified Amended Shareholder Derivative Complaint on March 7, 2019. The Court continued the stay pending a decision
on Defendants’ motion to dismiss in the Consolidated Securities Action (referenced above). After the Court in the Consolidated
Securities Action dismissed the Amended Complaint, the Court in the Consolidated Derivative Action ordered Co-Lead Plaintiffs
to file a second amended complaint no later than July 8, 2019. Co-Lead Plaintiffs filed a Verified Second Amended Shareholder
Derivative Complaint on July 8, 2019 (the “Second Amended Derivative Complaint”). Defendants moved to dismiss the Second
Amended Derivative Complaint on August 7, 2019. Co-Lead Plaintiffs must file any opposition to Defendants’ motion to dismiss
by September 6, 2019, and Defendants have until September 20, 2019 to submit a reply.
ff
Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court
On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District
of New York against the Board of Directors and certain officers of the Company under the captions Silva v. Simon, et al. (the “Silva
Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint
allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment.
On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the Board of
Directors and certain officers of the Company. The complaint alleged that the Company’s directors and certain officers made
materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and
financial results. The complaint also alleged that the Company violated its by-laws and Delaware law by failing to hold its 2016
Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. On August
9, 2017, the Court granted an order to unseal this case and reveal Gary Merenstein as the plaintiff (the “Merenstein Complaint”).
On August 10, 2017, the court granted the parties stipulation to consolidate the Barnes Complaint, the Silva Complaint and the
Merenstein Complaint under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the
“Consolidated Stockholder Class and Derivative Action”) and to appoint Robbins Arroyo LLP and Scott+Scott as Co-Lead Counsel,
with the Law Offices of Thomas G. Amon as Liaison Counsel for Plaintiffs. On September 14, 2017, a related complaint was filed
under the caption Oliver v. Berke, et al. (the “Oliver Complaint”), and on October 6, 2017, the Oliver Complaint was consolidated
with the Consolidated Stockholder Class and Derivative Action. The Plaintiffs filed their consolidated amended complaint under
seal on October 26, 2017. On December 20, 2017, the parties agreed to stay Defendants’ time to answer, move, or otherwise
respond to the consolidated amended complaint through and including 30 days after a decision was rendered on the motion to
dismiss the Amended Complaint in the consolidated Consolidated Securities Action, described above.
On March 29, 2019, the Court in the Consolidated Securities Action granted Defendants’ motion, dismissing the Amended
Complaint in its entirety, without prejudice to replead. Co-Lead Plaintiffs in the Consolidated Securities Actions filed a second
amended complaint on May 6, 2019. The parties to the Consolidated Stockholder Class and Derivative Action agreed to continue
the stay of Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint. The stay is continued
through 30 days after the Court rules on the motion to dismiss the Second Amended Complaint in the Consolidated Securities
Action.
26
Other
In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal
course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably
possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company believes the probable
final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial
position, cash flows or liquidity.
aa
Item 4.
Mine Safety Disclosures
Not applicable.
27
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Outstanding shares of our common stock, par value $.01 per share, are listed on the Nasdaq Global Select Market under the ticker
symbol “HAIN”.
Holders
As of August 22, 2019, there were 251 holders of record of our common stock.
Dividends
We have not paid any cash dividends on our common stock to date. The payment of all dividends will be at the discretion of our
Board of Directors and will depend on, among other things, future earnings, operations, capital requirements, contractual
restrictions, including restrictions under our credit facility, our general financial condition and general business conditions.
Issuance of Unregistered Securities
None.
Issuer Purchases of Equity Securities
The table below sets forth information regarding repurchases by the Company of its common stock during the periods indicated.
Period
April 1, 2019 - April 30, 2019
May 1, 2019 - May 31, 2019
June 1, 2019 - June 30, 2019
Total
(1)
(2)
(a)
Total number
of shares
purchased (1)
(b)
Average
price paid
per share
8,374
$
—
13,204
21,578
$
21.99
—
20.97
21.36
(c)
Total number of
shares purchased
as part of
publicly
announced plans
(d)
Maximum
number of shares that
may yet be purchased
under the plans
(in millions) (2)
— $
—
—
—
250
250
250
Shares surrendered for payment of employee payroll taxes due on shares issued under stockholder approved stock-based
compensation plans.
On June 21, 2017, the Company’s Board of Directors authorized the repurchase of up to $250 million of the Company’s
issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-
set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The
Company did not repurchase any shares under this program in fiscal 2019, 2018 or 2017.
28
Stock Performance Graph
The following graph compares the performance of our common stock to the S&P 500 Index, the S&P Smallcap 600 Index and
the S&P Packaged Foods & Meats Index (in which we are included) for the period from June 30, 2014 through June 30, 2019.
COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among the Hain Celestial Group, Inc., the S&P 500 Index,
the S&P Smallcap 600 Index and the S&P Packaged Foods & Meats Index
$200
$150
$100
$50
$0
6/14
6/15
6/16
6/17
6/18
6/19
The Hain Celestial Group, Inc.
S&P 500
S&P Smallcap 600
S&P Packaged Foods & Meats
*$100 invested on 6/30/14 in stock or index, including reinvestment of dividends
Fiscal year ending June 30.
29
Item 6.
Selected Financial Data
The following information has been summarized from our financial statements. The information set forth below is not necessarily
indicative of results of future operations and should be read in conjunction with Item 7, “Management’s Discussion and Analysis
of Financial Condition and Results of Operations”, and the consolidated financial statements and related notes thereto included
in Item 8 of this Form 10-K to fully understand factors that may affect the comparability of the information presented below,
including the completion of several business combinations in recent years. Refer to Note 6, Acquisitions, in the Notes to
Consolidated Financial Statements in Item 8 of this Form 10-K for additional information. Amounts are presented in thousands
except per share amounts.
2019
Operating results:
Net sales
Net (loss) income from continuing operations(a)
Net (loss) income from discontinued operations,
net of tax(b)
Net (loss) income(a) (b)
))
$ 2,302,468
(49,945)
$
$ (133,369)
$ (183,314)
Basic (loss) net income per common share:
From continuing operations
From discontinued operations
Net (loss) income per common share - basic
Diluted net (loss) income per common share:
From continuing operations
From discontinued operations
Net income per common share - diluted*
$
$
$
$
(0.48)
(1.28)
(1.76)
(0.48)
(1.28)
(1.76)
Fiscal Year Ended June 30,
2017
2018
2016
2015
$ 2,457,769
$ 2,343,505
$ 2,392,864
$ 2,272,416
$
$
$
$
$
$
$
82,428
$
65,541
(72,734) $
$
9,694
1,889
67,430
0.79
(0.70)
0.09
0.79
(0.70)
0.09
$
$
$
$
0.63
0.02
0.65
0.63
0.02
0.65
$
$
$
$
$
$
$
27,571
19,858
47,429
0.27
0.19
0.46
0.26
0.19
0.46
$
$
$
$
$
$
$
147,750
17,212
164,962
1.45
0.17
1.62
1.43
0.17
1.60
Financial position:
Working capital(c)
Total assets(c)
Long-term debt, less current portion
$
318,630
$
629,142
$
534,287
$
543,206
$
537,440
$ 2,582,620
$ 2,946,674
$ 2,931,104
$ 3,008,080
$ 3,099,408
$
613,537
$
687,501
$
740,135
$
835,787
$
812,088
Stockholders’ equity
$ 1,519,319
$ 1,737,049
$ 1,712,832
$ 1,664,514
$ 1,727,667
* Net (loss)/income per common share may not add in certain periods due to rounding
(a) Loss from continuing operations and net loss for fiscal 2019 included Chief Executive Officer Succession Plan expense, net,
of $30.2 million, an impairment charge of $17.9 million related to certain of the Company’s trade names, impairments of long-
lived assets of $15.8 million associated primarily with facilities closures in the United Kingdom and write downs of the value of
certain machinery and equipment in the United States no longer in use, some of which was used to manufacture certain slow
moving SKUs that were discontinued, and $4.3 million of accounting review costs, net of insurance proceeds. Income from
continuing operations and net income for fiscal 2018 included a goodwill impairment charge of $7.7 million in our Hain Ventures
operating segment, an impairment charge of $8.4 million which related to long-lived assets associated with the closure of
manufacturing facilities in the United States and United Kingdom and discontinuation of certain slow moving SKUs in the United
States segment, an impairment charge of $5.6 million related to certain of the Company’s trade names and $9.3 million of
accounting review costs. Income from continuing operations and net income for fiscal 2017 included an impairment charge of $26.4
million related primarily to long-lived assets associated with the exit of certain portions of our own-label chilled desserts business
in the United Kingdom segment and an impairment charge of $14.1 million related to certain of the Company’s trade names.
Additionally, income from continuing operations and net income for fiscal 2017 were impacted by $29.6 million of accounting
review costs. Income from continuing operations and net income for fiscal 2016 included a goodwill impairment charge of $84.5
million and an impairment charge of $39.7 million related to certain of the Company’s trade names. See Note 9, Goodwill and
Other Intangible Assets, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.
30
(b) Loss from discontinued operations and net loss for fiscal 2019 included a loss on sale of discontinued operations of $40.9
million. Additionally, fiscal 2019 and 2018 included impairment charges of $109.3 million and $78.5 million, respectively, related
to assets held for sale. See Note 5, Discontinued Operations, in the Notes to Consolidated Financial Statements included in Item
8 of this Form 10-K.
(c) Upon adoption of Accounting Standards Update (“ASU”) 2015-17, Income Taxes (Topic 740): Balance Sheet Classification
of Deferred Taxes, deferred tax assets and liabilities for fiscal year 2016 previously classified as current are presented as non-
current. Fiscal year 2015 has not been adjusted.
31
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with
Item 1A and the Consolidated Financial Statements and the related notes thereto for the period ended June 30, 2019 included in
Item 8 of this Form 10-K. Forward-looking statements in this Form 10-K are qualified by the cautionary statement included in
this review under the sub-heading, “Cautionary Note Regarding Forward Looking Information,” at the beginning of this Form
10-K.
Overview
The Hain Celestial Group, Inc., a Delaware corporation, was founded in 1993 and is headquartered in Lake Success, New York.
The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet. The Company
continues to be a leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and
exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing
sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial
sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce
retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide.
The Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-
for-you” products, with many recognized brands in the various market categories it serves, including Almond Dream®, Arrowhead
Mills®, Bearitos®, Better Bean®, BluePrint®, Casbah®, Celestial Seasonings®, Clarks™, Coconut Dream®, Cully & Sully®, Danival®,
DeBoles®, Earth’s Best®, Ella’s Kitchen®, Europe’s Best®, Farmhouse Fare™, Frank Cooper’s®, Gale’s®, Garden of Eatin’®, GG
UniqueFiber®, Hain Pure Foods®, Hartley’s®, Health Valley®, Imagine®, Johnson’s Juice Co.™, Joya®, Lima®, Linda McCartney®
(under license), MaraNatha®, Mary Berry (under license), Natumi®, New Covent Garden Soup Co.®, Orchard House®, Rice
Dream®, Robertson’s®, Rudi’s Gluten-Free Bakery™, Rudi’s Organic Bakery®, Sensible Portions®, Spectrum® Organics, Soy
Dream®, Sun-Pat®, Sunripe®, SunSpire®, Terra®, The Greek Gods®, Walnut Acres®, Yorkshire Provender®, Yves Veggie Cuisine®
and William’s™. The Company’s personal care products are marketed under the Alba Botanica®, Avalon Organics®, Earth’s Best®,
JASON®, Live Clean® and Queen Helene® brands.
Historically, the Company divided its business into core platforms, which are defined by common consumer need, route-to-market
or internal advantage and are aligned with the Company’s strategic roadmap to continue its leadership position in the organic and
natural, “better-for-you” products industry. Those core platforms within our United States segment are:
a
• Better-for-You Baby, which includes infant foods, infant and toddler formula, toddler and kids foods and diapers that
nurture and care for babies and toddlers, under the Earth’s Best® and Ella’s Kitchen® brands.
• Better-for-You Pantry, which includes core consumer staples, such as MaraNatha®, Arrowhead Mills®, Imagine®
and Spectrum® brands.
• Better-for-You Snacking, which includes wholesome products for in-between meals, such as Terra®, Sensible
Portions® and Garden of Eatin’® brands.
• Fresh Living, which includes yogurt, plant-based proteins and other refrigerated products, such as The Greek Gods®
yogurt and Dream™ plant-based beverage brands.
• Pure Personal Care, which includes personal care products focused on providing consumers with cleaner and gentler
ingredients, such as JASON®, Live Clean®, Avalon Organics® and Alba Botanica® brands.
Tea, which includes tea products marketed under the Celestial Seasonings® brand.
•
Additionally, beginning in fiscal 2017, the Company launched Hain Ventures (formerly known as “Cultivate Ventures”), a venture
unit with a twofold purpose: (i) to strategically invest in the Company’s smaller brands in high potential categories, by giving
these brands a dedicated, creative focus for refresh and relaunch and (ii) to incubate and grow small acquisitions until they reach
the scale required to migrate to the Company’s core platforms.
During fiscal 2019, the Company refined its strategy within the United States segment, focusing on simplifying the Company’s
portfolio and reinvigorating profitable sales growth through discontinuing uneconomic investment, realigning resources to coincide
with individual brand role, reducing unproductive stock-keeping units (“SKUs”) and brands, and reassessing current pricing
architecture. As part of this initiative, the Company reviewed its product portfolio and divided it into “Get Bigger” and “Get
Better” brand categories.
32
The Company’s “Get Bigger” brands represent its strongest brands with higher margins, which compete in categories with strong
growth. In order to capitalize on the potential of these brands, the Company began reallocating resources to optimize assortment
and increase share of distribution. In addition, the Company will increase its marketing and innovation investments.
The Company’s “Get Better” brands are the brands in which the Company is primarily focused on simplification and expansion
of profit. Some of these are low margin, non-strategic brands that add complexity with minimal benefit to the Company’s operations.
Accordingly, in fiscal 2019, the Company initiated a SKU rationalization, which included the elimination of approximately 350
low velocity SKUs. The elimination of these SKUs is expected to impact sales growth in the next fiscal year, but is expected to
result in expanded profits and a remaining set of core SKUs that will maintain their shelf space in the store.
As part of the Company’s overall strategy, the Company may seek to dispose of businesses and brands that are less profitable or
are otherwise less of a strategic fit within our core portfolio. Accordingly, the Company divested of all of its operations of the
Hain Pure Protein reportable segment (discussed further below) and WestSoy® tofu, seitan and tempeh businesses in the United
States. Additionally, on August 27, 2019, the Company sold the entities comprising its Tilda operating segment and certain other
assets of the Tilda business. See Note 21, Subsequent Event in the Notes to Consolidated Financial Statements included in Item
8 of this Form 10-K for further discussion.
f
t
Productivity and Transformation
As part of the Company’s historical strategic review, it focused on a productivity initiative, which it called “Project Terra.” A key
component of this project was the identification of global cost savings, and the removal of complexity from the business. This
review has included and continues to include streamlining the Company’s manufacturing plants, co-packers and supply chain,
eliminating served categories or brands within those categories, and product rationalization initiatives which are aimed at
eliminating slow moving SKUs.
In fiscal 2019, the Company announced a new transformation initiative, of which one aspect is to identify additional areas of
productivity savings to support sustainable profitable performance.
Discontinued Operations
In March 2018, the Company’s Board of Directors approved a plan to sell all of the operations of the Hain Pure Protein Corporation
(“HPPC”) and EK Holdings, Inc. (“Empire Kosher” or “Empire”) operating segments, which were reported in the aggregate as
the Hain Pure Protein reportable segment. These dispositions were undertaken to reduce complexity in the Company’s operations
and simplify the Company’s brand portfolio, in addition to allowing additional flexibility to focus on opportunities for growth and
innovation in the Company’s more profitable and faster growing core businesses.
h
Collectively, these dispositions represented a strategic shift that had a major impact on the Company’s operations and financial
results and have been accounted for as discontinued operations.
On February 15, 2019, the Company completed the sale of substantially all of the assets used primarily for the Plainville Farms
business (a component of HPPC).
On June 28, 2019, the Company completed the sale of the remainder of HPPC and EK Holdings, Inc. which includes the FreeBird
and Empire Kosher businesses.
See Note 5, Discontinued Operations,in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K for
additional information.
Chief Executive Officer Succession Plan
On June 24, 2018, the Company entered into a Chief Executive Officer (“CEO”) succession plan, whereby the Company’s former
CEO, Irwin D. Simon, agreed to terminate his employment with the Company upon the hiring of a new CEO. On October 26,
2018, the Company’s Board of Directors appointed Mark L. Schiller as President and CEO, succeeding Mr. Simon. In connection
with the appointment, on October 26, 2018, the Company and Mr. Schiller entered into an employment agreement, which was
approved by the Board, with Mr. Schiller’s employment commencing on November 5, 2018. Accordingly, Mr. Simon’s employment
with the Company terminated on November 4, 2018. See Note 3, Chief Executive Officer Succession Plan, in the Notes to
Consolidated Financial Statements included in Item 8 of this Form 10-K for additional information.
33
Results of Operations
Comparison of Fiscal Year ended June 30, 2019 to Fiscal Year ended June 30, 2018
Consolidated Results
The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the
fiscal years ended June 30, 2019 and 2018 (amounts in thousands, other than percentages which may not add due to rounding):
Fiscal Year Ended June 30,
Change in
Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Amortization of acquired intangibles
Project Terra costs and other
Chief Executive Officer Succession Plan
expense, net
Proceeds from insurance claims
Accounting review and remediation costs, net
of insurance proceeds
Goodwill impairment
Long-lived asset and intangibles impairment
Operating (loss) income
Interest and other financing expense, net
Other expense/(income), net
(Loss) income from continuing operations
before income taxes and equity in net loss
(income) of equity-method investees
Benefit for income taxes
Equity in net loss (income) of equity-method
investees
2019
2018
Dollars
$ 2,302,468
100.0 % $ 2,457,769
1,857,255
80.7 % 1,942,321
445,213
340,949
15,294
40,107
19.3 %
14.8 %
0.7 %
1.7 %
515,448
341,634
18,202
18,026
21.0 %
100.0 % $(155,301)
(85,066)
79.0 %
(70,235)
(685)
(2,908)
22,081
13.9 %
0.7 %
0.7 %
Percentage
(6.3)%
(4.4)%
(13.6)%
(0.2)%
(16.0)%
122.5 %
30,156
(4,460)
1.3 %
(0.2)%
520
—
— %
— %
29,636
(4,460)
*
*
4,334
—
33,719
0.2 %
— %
1.5 %
(14,886)
(0.6)%
36,078
1,023
1.6 %
— %
(51,987)
(2,697)
(2.3)%
(0.1)%
655
— %
9,293
7,700
14,033
106,040
26,925
(2,087)
81,202
(887)
(339)
82,428
0.4 %
0.3 %
(4,959)
(7,700)
0.6 %
19,686
4.3 % (120,926)
9,153
1.1 %
(53.4)%
*
140.3 %
(114.0)%
34.0 %
(0.1)%
3,110
(149.0)%
3.3 % (133,189)
(1,810)
— %
(164.0)%
204.1 %
994
— %
3.4 % $(132,373)
*
(160.6)%
Net (loss) income from continuing operations
$
(49,945)
(2.2)% $
Net loss from discontinued operations, net of
tax
Net (loss) income
Adjusted EBITDA
* Percentage is not meaningful
Net Sales
(133,369)
(5.8)%
$ (183,314)
(8.0)% $
(72,734)
9,694
(60,635)
(3.0)%
0.4 % $(193,008)
83.4 %
*
$
191,420
8.3 % $
255,941
10.4 % $ (64,521)
(25.2)%
Net sales in fiscal 2019 were $2.30 billion, a decrease of $155.3 million, or 6.3%, from net sales of $2.46 billion in fiscal 2018.
Foreign currency exchange rates negatively impacted net sales by $52.6 million as compared to the prior year. On a constant
currency basis, net sales decreased approximately 4.2% from the prior year. Net sales decreased across all three of our reportable
segments. Further details of changes in net sales by segment are provided below.
a
Gross Profit
Gross profit in fiscal 2019 was $445.2 million, a decrease of $70.2 million, or 13.6%, from gross profit of $515.4 million in fiscal
2018. Gross profit margin was 19.3%, a decrease of 170 basis points from the prior year. Gross profit was unfavorably impacted
by an inventory write-down of $12.4 million in connection with the discontinuance of slow moving SKUs primarily in the United
States as part of a product rationalization initiative, higher trade and promotional investments and increased freight and commodity
costs primarily in the United States segment. These increased costs were partially offset by Project Terra cost savings.
ff
34
Selling, General and Administrative Expenses
g,
p
Selling, general and administrative expenses were $340.9 million, a decrease of $0.7 million, or 0.2%, in fiscal 2019 from $341.6
million in fiscal 2018. Selling, general and administrative expenses decreased primarily due to lower marketing investment costs
in the United States, the reversal of previously accrued amounts under the net sales portion of the 2016-2018 and 2017-2019 LTIPs
and the reversal of previously recognized stock-based compensation expense associated with the relative TSR portion of the
2017-2019 LTIP due to specified performance metrics not being attained. See Note 14, Stock-based Compensation and Incentive
Performance Plans, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K for further
discussion on the aforementioned reversals under the Company’s LTIPs. This decrease was offset in part by increased consulting
costs in the United States, as well as increased variable compensation costs. Selling, general and administrative expenses as a
percentage of net sales was 14.8% in fiscal 2019 and 13.9% in the prior year, an increase of 90 basis points, primarily attributable
to the aforementioned items.
uu
Amortization of Acquired Intangibles
g
q
Amortization of acquired intangibles was $15.3 million in fiscal 2019, a decrease of $2.9 million, or 16.0%, from $18.2 million
in fiscal 2018. The decrease was due to finite-lived intangibles from certain historical acquisitions becoming fully amortized
subsequent to June 30, 2018.
Project Terra Costs and Other
j
Project Terra costs and other was $40.1 million in fiscal 2019, an increase of $22.1 million from $18.0 million in fiscal 2018.
The increase was primarily due to increased consulting fees incurred in connection with the Company’s Project Terra strategic
review as well as increased severance costs in fiscal 2019 as compared to the prior year period.
Chief Executive Officer Succession Plan Expense, net
p
,
On June 24, 2018, the Company entered into a Chief Executive Officer succession plan, whereby the Company’s former CEO,
Irwin D. Simon, agreed to terminate his employment with the Company upon the hiring of a new CEO. Net costs and expenses
associated with the Company’s Chief Executive Officer succession plan were $30.2 million in fiscal 2019 compared to $0.5 million
in fiscal 2018. See Note 3, Chief Executive Officer Succession Plan, in the Notes to the Consolidated Financial Statements included
in Item 8 of this Form 10-K.
Proceeds from Insurance Claims
In July of 2019, the Company received $7.0 million as partial payment from an insurance claim relating to business disruption
costs associated with a co-packer. Of this amount $4.5 million was recognized in fiscal 2019 as it relates to reimbursement of
costs already incurred. The Company will record an additional $2.6 million in the first quarter of fiscal 2020.
Accounting Review and Remediation Costs, net of Insurance Proceeds
g
,
Costs and expenses associated with the internal accounting review, remediation and other related matters were $4.3 million in
fiscal 2019, compared to $9.3 million in fiscal 2018. Included in accounting review and remediation costs for fiscal 2019 and
2018 were insurance proceeds of $0.2 million and $5.7 million, respectively, related to the reimbursement of costs incurred as
part of the internal accounting review and the independent review by the Audit Committee and other related matters.
Goodwill Impairment
p
In fiscal 2018, the Company recorded a goodwill impairment charge of $7.7 million related to our Hain Ventures reporting unit
within the Rest of World segment. There were no goodwill impairment charges recorded during fiscal 2019. See Note 9, Goodwill
and Other Intangible Assets, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
35
Long-lived Asset and Intangibles Impairment
p
g
g
During fiscal 2019, the Company recorded a pre-tax impairment charge of $17.9 million ($11.3 million related to the United States
segment, $3.8 million related to the Rest of World segment and $2.8 million related to the United Kingdom segment) related to
certain tradenames of the Company. See Note 9, Goodwill and Other Intangible Assets, in the Notes to the Consolidated Financial
Statements included in Item 8 of this Form 10-K. Additionally, the Company recorded $8.7 million of non-cash impairment
charges primarily related to the Company’s decision to consolidate manufacturing of certain fruit-based products in the United
Kingdom. Moreover, the Company recorded a $9.7 million non-cash impairment charge to write down the value of certain
machinery and equipment no longer in use in the United States and United Kingdom, some of which was used to manufacture
certain slow moving SKUs that were discontinued.
During fiscal 2018, the Company determined that it was more likely than not that certain fixed assets at three of its manufacturing
facilities would be sold or otherwise disposed of before the end of their estimated useful lives due to the Company’s decision to
utilize third-party manufacturers for two facilities in the United States and to the closure of one facility to consolidate manufacturing
of certain soup products in the United Kingdom. As such, the Company recorded a $6.3 million non-cash impairment charge
primarily related to the closures of these facilities. Additionally, the Company discontinued additional slow moving SKUs in the
United States as part of a product rationalization initiative. As a result, expected future cash flows are not expected to support the
carrying value of certain machinery and equipment used to manufacture these products. As such, the Company recorded a $2.1
million non-cash impairment charge to write down the value of these assets to fair value. Also, during fiscal 2018, the Companynn
recorded a pre-tax impairment charge of $5.6 million ($5.1 million related to the Rest of World segment and $0.5 million related
to the United Kingdom segment) related to certain trade names of the Company.
uu
nn
Operating (Loss) Income
g (
p
)
Operating loss in fiscal 2019 was $14.9 million compared to operating income of $106.0 million in fiscal 2018. The decrease in
operating income resulted from the items described above.
Interest and Other Financing Expense, net
p
g
,
Interest and other financing expense, net totaled $36.1 million in fiscal 2019, an increase of $9.2 million, or 34.0%, from $26.9
million in the prior year. The increase in interest and other financing expense, net resulted primarily from higher interest expense
related to our revolving credit facility as a result of higher variable interest rates. See Note 11, Debt and Borrowings, in the Notes
to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
Other Expense/(Income), net
),
p
(
Other expense/(income), net totaled $1.0 million of expense in fiscal 2019, a decrease of $3.1 million from $2.1 million of income
in the prior year. Included in other expense/(income), net for the fiscal year ended June 30, 2019 were net unrealized foreign
currency losses, which were higher than the prior year period principally due to the effect of foreign currency movements on the
remeasurement of foreign currency denominated loans.
(
(Loss) Income from Continuing Operations Before Income Taxes and Equity in Net Loss (Income) of Equity-Method Investees
g p
y
y
q
q
)
)
(
Loss before income taxes and equity in the net loss of our equity-method investees for fiscal 2019 was $52.0 million compared
to income of $81.2 million in fiscal 2018. The decrease was due to the items discussed above.
Benefit for Income Taxes
The provision for income taxes includes federal, foreign, state and local income taxes. Our income tax benefit from continuing
operations was $2.7 million and $0.9 million for fiscal 2019 and 2018, respectively.
On December 22, 2017, the U.S. government enacted comprehensive tax legislation pursuant to the Tax Cuts and Jobs Act (the
“Tax Act”), which significantly revised the ongoing U.S. corporate income tax law by lowering the U.S. federal corporate income
tax rate from 35% to 21%, implementing a territorial tax system, imposing a one-time tax on foreign unremitted earnings and
setting limitations on deductibility of certain costs (e.g., interest expense and executive compensation), among other things.
Due to the complexities involved in accounting for the Tax Act, the U.S. Securities and Exchange Commission’s Staff Accounting
Bulletin (“SAB”) 118 required that the Company include in its financial statements a reasonable estimate of the impact of the Tax TT
Act on earnings to the extent such reasonable estimate has been determined. Pursuant to SAB 118, the Company was allowed a
36
measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts.
During fiscal year ended June 30, 2019, the Company finalized its accounting for the income tax effects of the Tax Act and recorded
an additional expense of $6.8 million related to its transition tax liability. The net increase in the transition tax was due to the
finalization of the Company’s earnings and profits study for the Company’s foreign subsidiaries. The adjustment of the Company’s
provisional tax expense was recorded as a change in estimate in accordance with SAB No. 118. Despite the completion of the
Company’s accounting for Tax Act under SAB 118, many aspects of the law remain unclear, and the Company expects ongoing
guidance to be issued at both the federal and state levels. The Company will continue to monitor and assess the impact of any new
developments.
The Tax Act also includes a provision to tax GILTI of foreign subsidiaries. The FASB Staff Q&A Topic No. 5, Accounting for
Global Intangible Low-Taxed Income, states that an entity can make an accounting policy election either to recognize deferred
taxes for temporary differences that are expected to reverse as GILTI in future years or provide for the tax expense related to GILTI
resulting from those items in the year the tax is incurred. The Company has elected to recognize the resulting tax on GILTI as a
period expense in the period the tax is incurred. The Company has computed the impact on our effective tax rate on a discrete
basis.
The effective income tax benefit rate from continuing operations was 5.2% and 1.1% of pre-tax income for the twelve months
ended June 30, 2019 and 2018, respectively. The effective income tax rate from continuing operations for the twelve months ended
June 30, 2019 was primarily impacted by the geographical mix of earnings, state taxes, provisions in the Tax Act including global
intangible low-taxed income (“GILTI”), finalization of the transition tax liability, and limitations on the deductibility of executive
compensation. The effective income tax rate was also impacted by a net increase of $9.8 million in the Company’s valuation
allowance primarily related to the Company’s state deferred tax assets and state net operating loss carryforwards.
The effective income tax rate from continuing operations for the twelve months ended June 30, 2018 was primarily impacted by
the enactment of the Tax Act on December 22, 2017. The Tax Act significantly revised the U.S. corporate income tax regime by
lowering the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018, repealing the deduction for domestic
production activities, imposing additional limitations on the deductibility of executive officers’ compensation, implementing a
territorial tax system and imposing a one-time transition tax on deemed repatriated earnings of foreign subsidiaries.
Our effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical
mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.
See Note 12, Income Taxes, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K for additional
information.
)
Equity in Net Loss (Income) of Equity-Method Investees
y
q
y
q
(
Our equity in the net loss from our equity method investments for fiscal 2019 was $0.7 million compared to equity in net income
of $0.3 million for fiscal 2018. See Note 15, Investments and Joint Ventures, in the Notes to Consolidated Financial Statements
included in Item 8 of this Form 10-K.
Net (Loss) Income from Continuing Operations
g p
(
)
Net loss from continuing operations for fiscal 2019 was $49.9 million compared to net income of $82.4 million for fiscal 2018.
Net loss per diluted share was $0.48 in fiscal 2019 compared to net income per diluted share of $0.79 in fiscal 2018.
The decrease was attributable to the factors noted above.
Net Loss from Discontinued Operations
p
Net loss from discontinued operations for fiscal 2019 and 2018 was $133.4 million and $72.7 million, respectively,
or $1.28 and $0.70 per diluted share, respectively. The increase in net loss from discontinued operations was primarily attributable
to asset impairment charges of $109.3 million and losses on sale in connection with the disposition of the Plainville Farms and
HPPC businesses of $40.2 million and $0.6 million, respectively, in each case recorded in fiscal 2019 and discussed in Note 5,
Discontinued Operations, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.
37
)
Net (Loss) Income
(
Net loss for fiscal 2019 was $183.3 million compared to net income of $9.7 million for fiscal 2018. Net loss per diluted share
was $1.76 in fiscal 2019 compared to net income per diluted share of $0.09 in 2018. The change was attributable to the factors
noted above.
Adjusted EBITDA
j
Our consolidated Adjusted EBITDA was $191.4 million and $255.9 million for fiscal 2019 and 2018, respectively, as a result of
the factors discussed above. See Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the
discussion of our results of operations for definitions and a reconciliation of our net loss to Adjusted EBITDA.
Segment Results
The following table provides a summary of net sales and operating income (loss) by reportable segment for the fiscal years ended
June 30, 2019 and 2018:
(dollars in thousands)
Fiscal 2019 net sales
Fiscal 2018 net sales
$ change
% change
United States
$ 1,009,406
$ 1,084,871
United
Kingdom
$ 885,488
$ 938,029
Rest of World
$ 407,574
$ 434,869
$
$
$
(75,465)
$
(52,541)
$
(27,295)
(7.0)%
(5.6)%
(6.3)%
Corporate
and Other
Consolidated
— $ 2,302,468
— $ 2,457,769
n/a
n/a
$ (155,301)
(6.3)%
Fiscal 2019 operating income (loss)
Fiscal 2018 operating income (loss)
$ change
% change
$
$
$
23,864
86,319
(62,455)
$
$
$
52,413
56,046
(3,633)
$
$
$
32,820
38,660
(5,840)
$ (123,983)
$
(14,886)
$
$
(74,985)
$ 106,040
(48,998)
$ (120,926)
(72.4)%
(6.5)%
(15.1)%
(65.3)%
(114.0)%
Fiscal 2019 operating income (loss) margin
Fiscal 2018 operating income margin
2.4 %
8.0 %
5.9 %
6.0 %
8.1 %
8.9 %
n/a
n/a
(0.6)%
4.3 %
United States
Our net sales in the United States in fiscal 2019 were $1.01 billion, a decrease of $75.5 million, or 7.0%, from net sales of $1.08
billion in fiscal 2018. The decrease in net sales was primarily driven by declines in our Pantry, Better-For-You-Baby, Fresh Living
and Personal Care platforms. In addition, the declines were also driven by the strategic decision to no longer support certain lower
margin SKUs in order to reduce complexity and increase gross margins. Operating income in the United States in fiscal 2019 was
$23.9 million, a decrease of $62.5 million, or 72.4%, from $86.3 million in fiscal 2018. The decrease in operating income was the
result of the aforementioned decrease in net sales, higher trade investments to drive future period growth, increased freight and
logistics costs, start-up costs incurred in connection with a new manufacturing facility, inventory write-downs of $8.3 million in
connection with the discontinuance of slow moving SKUs as part of a product rationalization initiative and a $6.5 million non-
cash impairment charge to write down the value of certain machinery and equipment no longer in use in fiscal 2019, offset in part aa
by Project Terra cost savings.
t
a
United Kingdom
Our net sales in the United Kingdom in fiscal 2019 were $885.5 million, a decrease of $52.5 million, or 5.6%, from net sales of
$938.0 million in fiscal 2018. On a constant currency basis, net sales decreased 1.8% from the prior year. The net sales decrease on
a constant currency basis was primarily due to declines from the New Covent Garden Soup Co.® and Johnson's Juice Co.™ brands
and private label sales, offset in part by growth in the Company’s Tilda and Ella’s Kitchen businesses and growth in our Hartley’s®
brand. Operating income in the United Kingdom segment for fiscal 2019 was $52.4 million, a decrease of $3.6 million, or 6.5%,
from $56.0 million in fiscal 2018. The decrease in operating income was primarily due to the aforementioned decrease in sales
and a $8.7 million non-cash impairment charge associated with the consolidation of manufacturing of certain fruit-based products
in fiscal 2019, partially offset by operating efficiencies achieved at Hain Daniels driven by Project Terra.
38
Rest of World
Our net sales in Rest of World were $407.6 million in fiscal 2019, a decrease of $27.3 million, or 6.3%, from net sales of $434.9
million in fiscal 2018. On a constant currency basis, net sales decreased 2.5% from the prior year. The decrease in net sales on a
constant currency basis was primarily due to declines in Canada from the Company’s Europe’s Best® and Dream® brands and
private label sales, partially offset by growth in our Yves Veggie Cuisine®, Sensible Portions® and Live Clean® brands. Hain
Ventures (formerly known as Cultivate Ventures) net sales decreased from the prior year, primarily driven by declines from the
Blueprint®, SunSpire® and DeBoles® brands, offset in part by growth from the GG UniqueFiber™ brand. Declines in Canada and
Hain Ventures were offset by growth in Hain Europe primarily driven by increased sales from the Joya® and Natumi® brands and
private label sales, partially offset by declines from the Danival®, Lima® and Dream® brands. Operating income in Rest of World
for fiscal 2019 was $32.8 million, a decrease of $5.8 million, or 15.1%, from $38.7 million in fiscal 2018. The decrease in operating
income was primarily due to the aforementioned decrease in sales, charges related to SKU rationalizations across all operating
segments in Rest of World, start-up costs incurred in connection with a new manufacturing facility in Canada and costs associated
with the planned closure of a manufacturing facility in the United States due to the Company’s decision to utilize a third-partytt
manufacturer.
Corporate and Other
Our Corporate and Other category consists of expenses related to the Company’s centralized administrative functions, which do
not specifically relate to an operating segment. Corporate and Other expenses are comprised mainly of the compensation and
related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to our
entire enterprise, as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a
whole. Additionally, Chief Executive Officer Succession Plan expense, net, Project Terra costs and other and accounting review
and remediation costs, net are included in Corporate and Other and were $30.2 million, $28.4 million and $4.3 million, respectively,
for the fiscal year ended June 30, 2019. Corporate and Other for the fiscal year ended June 30, 2019 also includes trade name
impairment charges of $17.9 million and a benefit of $4.5 million recorded in connection with proceeds received for an insurance
claim. Corporate and Other for the fiscal year ended June 30, 2018 included Project Terra costs and other and accounting review
and remediation costs of $10.1 million and $9.3 million (net of $5.7 million of insurance proceeds), respectively. Corporate and
Other also included impairment charges of $13.3 million for the fiscal year ended June 30, 2018.
Refer to Note 19, Segment Information, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-
K for additional details.
39
Comparison of Fiscal Year ended June 30, 2018 to Fiscal Year ended June 30, 2017
Consolidated Results
The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the
fiscal years ended June 30, 2018 and 2017 (amounts in thousands, other than percentages which may not add due to rounding):
Fiscal Year Ended June 30,
Change in
2018
2017
$ 2,457,769
100.0 % $ 2,343,505
100.0 % $
1,942,321
515,448
341,634
18,202
18,026
79.0 %
21.0 %
13.9 %
0.7 %
0.7 %
1,824,109
519,396
312,583
16,988
10,388
77.8 %
22.2 %
13.3 %
0.7 %
0.4 %
Dollars
114,264
Percentage
4.9 %
118,212
(3,948)
29,051
1,214
7,638
6.5 %
(0.8)%
9.3 %
7.1 %
73.5 %
520
— %
—
— %
520
— %
9,293
7,700
14,033
106,040
26,925
0.4 %
0.3 %
0.6 %
4.3 %
1.1 %
81,202
(887)
3.3 %
— %
(339)
— %
82,428
3.4 % $
(72,734)
(3.0)%
9,694
0.4 % $
29,562
—
40,452
109,423
21,115
430
87,878
22,466
(129)
65,541
1,889
67,430
1.3 %
— %
1.7 %
4.7 %
0.9 %
— %
3.7 %
1.0 %
(20,269)
7,700
(26,419)
(3,383)
5,810
(2,517)
(68.6)%
— %
(65.3)%
(3.1)%
27.5 %
*
(6,676)
(23,353)
(7.6)%
(103.9)%
— %
2.8 % $
(210)
16,887
162.8 %
25.8 %
0.1 %
2.9 % $
(74,623)
(57,736)
*
(85.6)%
255,941
10.4 % $
264,956
11.3 % $
(9,015)
(3.4)%
Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Amortization of acquired intangibles
Project Terra costs and other
Chief Executive Officer Succession Plan
expense, net
Accounting review and remediation costs, net
of insurance proceeds
Goodwill impairment
Long-lived asset and intangibles impairment
Operating income
Interest and other financing expense, net
Income from continuing operations before
income taxes and equity in net income of
equity-method investees
(Benefit) provision for income taxes
Equity in net income of equity-method
investees
Net income from continuing operations
Net (loss) income from discontinued
operations, net of tax
Net income
Adjusted EBITDA
* Percentage is not meaningful
Net Sales
$
$
$
Other (income)/expense, net
(2,087)
(0.1)%
Net sales in fiscal 2018 were $2.46 billion, an increase of $114.3 million, or 4.9%, from net sales of $2.34 billion in fiscal 2017.
Foreign currency exchange rates positively impacted net sales by $80.0 million as compared to the prior year. On a constant
currency basis, net sales increased approximately 1.5% from the prior year period. The increase in net sales was due to sales growth
in the United Kingdom, Europe and Canada businesses, partially offset by a decrease in net sales in the United States segment.
Further details of changes in net sales by segment are provided below.
Gross Profit
Gross profit in fiscal 2018 was $515.4 million, a decrease of $3.9 million, or 0.8%, from gross profit of $519.4 million in fiscal
2017. Foreign currency exchange rates positively impacted gross margin by $15.9 million as compared to the prior year. Gross
profit margin was 21.0%, a decrease of 120 basis points from the prior year. Gross profit was unfavorably impacted by decreased
gross profit in the United States due to increased commodity and freight and logistics costs, increased trade investment and costs
associated with the aforementioned SKU rationalization and higher commodity costs in the United Kingdom. These increased
40
costs were partially offset by Project Terra cost savings and higher profit achieved on higher net sales in the United Kingdom and
the Rest of World segments.
Selling, General and Administrative Expenses
g,
p
in
Selling, general and administrative expenses were $341.6 million, an
fiscal 2018 from $312.6 million in fiscal 2017. Selling, general and administrative expenses increased principally due to higher
marketing investment primarily in the United States and personnel costs. Selling, general and administrative expenses as a
percentage of net sales was 13.9% in fiscal 2018 and 13.3% in the prior year, an increase of 60 basis points, primarily attributable
to the aforementioned items.
increase of $29.1 million, or 9.3%,
Amortization of Acquired Intangibles
q
g
Amortization of acquired intangibles was $18.2 million in fiscal 2018, an increase of $1.2 million, or 7.1%, from $17.0 million in
fiscal 2017. The increase in amortization expense was primarily due to the intangibles acquired as a result of the Company’s recent
acquisitions and the impact of foreign exchange rates. See Note 9, Goodwill and Other Intangible Assets, in the Notes to the
Consolidated Financial Statements included in Item 8 of this Form 10-K.
n
Project Terra Costs and Other
j
We incurred Project Terra costs and other of $18.0 million in fiscal 2018, an increase of $7.6 million from $10.4 million in
fiscal 2017. The increase was primarily due to increased severance costs in the current year period as compared to the prior year
period related to the closures of two of the Company’s manufacturing facilities in the United States and one manufacturing facility
in the United Kingdom and consulting fees incurred in connection with the Company’s Project Terra strategic review.
Chief Executive Officer Succession Plan Expense, net
p
,
Net costs and expenses associated with the Company’s Chief Executive Officer Succession Plan were $0.5 million in fiscal 2018.
There were no such costs incurred in fiscal 2017. See Note 3, Chief Executive Officer Succession Plan, in the Notes to the
Consolidated Financial Statements included in Item 8 of this Form 10-K.
Accounting Review and Remediation Costs, Net of Insurance Proceeds
g
,
Costs and expenses associated with the internal accounting review, remediation and other related matters were $15.0 million in
fiscal 2018, compared to $29.6 million in fiscal 2017. Also, included in accounting review and remediation costs for
fiscal 2018 were insurance proceeds of $5.7 million related to the reimbursement of costs incurred as part of the internal accounting
review and the independent review by the Audit Committee of the Company and other related matters. The net amount of accounting
review and remediation costs for fiscal 2018 was $9.3 million.
Goodwill Impairment
p
During the fourth quarter of fiscal 2018, we recorded a goodwill impairment charge of $7.7 million related to our Hain Ventures
reporting unit within the Rest of World segment. There were no goodwill impairment charges recorded during fiscal 2017. See
Note 9, Goodwill and Other Intangible Assets, in the Notes to the Consolidated Financial Statements included in Item 8 of this
Form 10-K.
Long-lived Asset and Intangibles Impairment
g
p
g
During fiscal 2018, the Company determined that it was more likely than not that certain fixed assets at three of its manufacturing
facilities would be sold or otherwise disposed of before the end of their estimated useful lives due to the Company’s decision to
utilize third-party manufacturers for two facilities in the United States and to the closure of one facility to consolidate manufacturing
of certain soup products in the United Kingdom. As such, the Company recorded a $6.3 million non-cash impairment charge
primarily related to the closures of these facilities. Additionally, the Company discontinued additional slow moving SKUs in the
United States as part of a product rationalization initiative. As a result, expected future cash flows are not expected to support the
carrying value of certain machinery and equipment used to manufacture these products. As such, the Company recorded a $2.1
million non-cash impairment charge to write down the value of these assets to fair value. Also, during fiscal 2018, the Company
recorded a pre-tax impairment charge of $5.6 million ($5.1 million related to the Rest of World segment and $0.5 million related
to the United Kingdom segment) related to certain trade names of the Company.
uu
nn
41
During fiscal 2017, the Company recorded a pre-tax impairment charge of $14.1 million ($7.6 million related to the United
Kingdom segment and $6.5 million related to the United States segment) related to certain trade names of the Company.
Additionally, during fiscal 2017, the Company recorded long-lived asset impairment charges of $26.4 million primarily related
to the decision to exit of certain portions of our own-label chilled desserts business in the United Kingdom. See Note 9, Goodwill
and Other Intangible Assets, and Note 8, Property, Plant and Equipment in the Notes to the Consolidated Financial Statements
included in Item 8 of this Form 10-K.
t
g
Operating Income
p
Operating income in fiscal 2018 was $106.0 million, a decrease of $3.4 million, or 3.1%, from $109.4 million in fiscal 2017.
Operating income as a percentage of net sales was 4.3% in fiscal 2018 compared with 4.7% in fiscal 2017. The decrease in
operating income as a percentage of net sales resulted from the items described above.
Interest and Other Financing Expense, net
g
p
,
Interest and other financing expense, net totaled $26.9 million in fiscal 2018, an increase of $5.8 million, or 27.5%, from $21.1
million in the prior year. The increase in interest and other financing expense, net resulted primarily from higher interest expense
related to our revolving credit facility as a result of higher variable interest rates on outstanding debt. See Note 11, Debt and
Borrowings, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.
x
)
Other (Income)/Expense, net
p
(
,
Other (income)/expense, net totaled $2.1 million of income in fiscal 2018, an increase of $2.5 million from $0.4 million of expense
in the prior year. Included in other (income)/expense, net were net unrealized and realized foreign currency gains, which were
higher in the current period than the prior year period principally due to the effect of foreign currency movements on the
remeasurement of foreign currency denominated intercompany loans.
Income from Continuing Operations Before Income Taxes and Equity in Net Income of Equity-Method Investees
g p
q
q
y
y
Income before income taxes and equity in the net income of our equity-method investees for fiscal 2018 and 2017 was $81.2
million and $87.9 million, respectively. The decrease was due to the items discussed above.
Income Taxes
The provision for income taxes includes federal, foreign, state and local income taxes. Our income tax benefit from continuing
operations was $0.9 million for the fiscal 2018 compared to $22.5 million of tax expense in fiscal 2017.
Our effective income tax rate from continuing operations was (1.1)% and 25.6% of pre-tax income for the twelve months
ended June 30, 2018 and 2017, respectively. The effective income tax rate from continuing operations for the twelve months ended
June 30, 2018 was primarily impacted by the enactment of the Tax Act on December 22, 2017. The Tax Act significantly revised
the U.S. corporate income tax regime by lowering the U.S. federal corporate tax rate from 35% to 21% effective January 1, 2018,
repealing the deduction for domestic production activities, imposing additional limitations on the deductibility of executive officers’
compensation, implementing a territorial tax system and imposing a one-time transition tax on deemed repatriated earnings of
foreign subsidiaries. As the Company has a June 30 fiscal year-end, the lower corporate income tax rate will be phased in, resulting
in a U.S. federal statutory rate of approximately 28.1% for fiscal 2018 and a 21% U.S. federal statutory rate for subsequent fiscal
years.
Due to the complexities involved in accounting for the Tax Act, the U.S. Securities and Exchange Commission’s SAB 118 requires
that the Company include in its financial statements a reasonable estimate of the impact of the Tax Act on earnings to the extent
such reasonable estimate has been determined. Accordingly, the Company recorded the following reasonable estimates of the tax
impact in its earnings for the fiscal year ended June 30, 2018.
•
•
For the fiscal year ended June 30, 2018, the Company accrued a $25.0 million provisional tax benefit related to the net
change in deferred tax liabilities stemming from the Tax Act’s reduction of the U.S. federal tax rate from 35% to 21%,
and disallowance of certain incentive based compensation tax deductibility under Internal Revenue Code Section 162(m).
For the fiscal year ended June 30, 2018, the Company accrued a reasonable estimate of $7.1 million of tax expense for
the Tax Act’s one-time transition tax on the foreign subsidiaries’ accumulated, unremitted earnings going back to 1986.
42
The Company has recorded the final impact on the Company from the Tax Act’s transition tax legislation in fiscal 2019. See Note
12, Income Taxes, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K for additional information.
Pursuant to SAB 118, the Company was allowed a measurement period of up to one year after the enactment date of the Tax Act
to finalize the recording of the related tax impacts. The Company calculated the impact of the Tax Act and recorded any resulting
tax adjustments during fiscal 2019.
The Tax Act also includes a provision to tax GILTI of foreign subsidiaries. The Company will be subject to the GILTI provisions
effective beginning July 1, 2018 and is in the process of analyzing its effects, including how to account for the GILTI provision
from an accounting policy standpoint.
The effective income tax rate from continuing operations for the twelve months ended June 30, 2018 was also favorably impacted
by the geographical mix of earnings and a $4.0 million benefit relating to the release of the remainder of the Company’s domestic
uncertain tax position as a result of the expiration of the statute of limitations.
The effective income tax rate from continuing operations for the twelve months ended June 30, 2017 was favorably impacted by
the geographical mix of earnings and a reduction in the statutory tax rate in the United Kingdom enacted in the first quarter of
2017, which resulted in a $1.8 million decrease to the carrying balance of net deferred tax liabilities. The effective income tax rate
from continuing operations for the twelve months ended June 30, 2017 was also favorably impacted by a $4.6 million benefit
relating to the release of a portion of the Company’s domestic uncertain tax position as a result of the expiration of the statute of
limitations.
t
Our effective tax rate may change from period-to-period based on recurring and non-recurring factors including the geographical
mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.
See Note 12, Income Taxes, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K for additional
information.
Equity in Net Income of Equity-Method Investees
y
q
q
y
Our equity in the net income from our equity method investments for fiscal 2018 was $0.3 million compared to a $0.1 million for
fiscal 2017. See Note 15, Investments and Joint Ventures, in the Notes to the Consolidated Financial Statements included in Item
8 of this Form 10-K.
Net Income from Continuing Operations
g p
Net income from continuing operations for fiscal 2018 and 2017 was $82.4 million and $65.5 million, respectively,
or $0.79 and $0.63 per diluted share, respectively. The increase was attributable to the factors noted above.
Net (loss) Income from Discontinued Operations
p
)
(
Net (loss) income from discontinued operations for fiscal 2018 and 2017 was net loss of $72.7 million and net income of $1.9
million, respectively, or $(0.70) and $0.02 per diluted share, respectively. The net loss for fiscal 2018 was primarily attributable
to impairments of assets held for sale of $78.5 million in fiscal 2018 as discussed in Note 5, Discontinued Operations, in the Notes
to Consolidated Financial Statements included in Item 8 of this Form 10-K. In the fourth quarter of fiscal 2018, results for HPPC
(which comprises the Plainville and FreeBird brands) were below our projections. The fourth quarter results, as well as negative
market conditions in the sector, required the Company to reduce the internal projections for the business, which resulted in the
Company lowering the projected long-term growth rate and profitability levels for HPPC. Accordingly, the updated projections
indicated that the fair value of the HPPC business is below carrying value. As a result, the Company recorded asset impairments
of $78.5 million, reflected in Net (loss) income from discontinued operations, net of tax in order to reduce the carrying amount
of the net assets to their fair value less costs to sell. This impairment was partially offset by an increase in income tax benefit from
discontinued operations from $0.6 million in fiscal 2017 to $5.7 million, which includes a $20.2 million deferred tax benefit arising
from asset impairment charges and a $12.3 million deferred tax liability related to Hain Pure Protein being classified as held for
sale in fiscal 2018.
aa
43
Net Income
Net income for fiscal 2018 and 2017 was $9.7 million and $67.4 million, or $0.09 and $0.65 per diluted share, respectively. The
change was attributable to the factors noted above.
Adjusted EBITDA
j
Our consolidated Adjusted EBITDA was $255.9 million and $265.0 million for fiscal 2018 and 2017, respectively, as a result of
the factors discussed above. See Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the
discussion of our results of operations for definitions and a reconciliation from our net income to Adjusted EBITDA.
Segment Results
The following table provides a summary of net sales and operating income by reportable segment for the fiscal years ended June 30,
2018 and 2017:
(dollars in thousands)
Fiscal 2018 net sales
Fiscal 2017 net sales
$ change
% change
Fiscal 2018 operating income (loss)
Fiscal 2017 operating income (loss)
$ change
% change
United States
$
$
$
$
$
$
1,084,871
1,107,806
(22,935)
(2.1)%
86,319
145,307
(58,988)
$
$
$
$
$
$
United
Kingdom
938,029
851,757
86,272
10.1%
56,046
51,948
4,098
$
$
$
$
$
$
Rest of
World
434,869
383,942
50,927
13.3%
Corporate
and Other
Consolidated
$
$
— $ 2,457,769
— $ 2,343,505
n/a
n/a
$
114,264
4.9 %
38,660
32,010
6,650
(74,985)
$
$ (119,842)
44,857
$
$
$
$
106,040
109,423
(3,383)
(40.6)%
7.9%
20.8%
37.4%
(3.1)%
Fiscal 2018 operating income margin
Fiscal 2017 operating income margin
8.0 %
13.1 %
6.0%
6.1%
8.9%
8.3%
n/a
n/a
4.3 %
4.7 %
United States
Our net sales in the United States in fiscal 2018 were $1.08 billion, a decrease of $22.9 million, or 2.1%, from net sales of $1.11
billion in fiscal 2017. The decrease in net sales was driven by declines in our Better-for-You Snacking, Fresh Living and Better-
for-You-Pantry platforms, partially offset by growth in our Pure Personal Care, Better-for-You Baby and Tea platforms. In addition,
the declines were also driven by the strategic decision to no longer support certain lower margin SKUs in order to reduce complexity
and increase gross margins as the Company continues its focus on its top 500 SKUs and 11 brands in the United States as well as
increased trade investment. Net sales in the prior year period were negatively impacted by a realignment of customer inventories
at certain distributor customers. Operating income in the United States in fiscal 2018 was $86.3 million, a decrease of $59.0
million, or 40.6%, from operating income of $145.3 million in fiscal 2017. The decrease in operating income was the result of
lower sales, higher trade and marketing investments to drive current and future period growth, increased freight and logistics,
commodity and other input costs and costs associated with the closure of two of our manufacturing facilities in the United States.
These increased costs were partially offset by Project Terra cost savings in the current period. Additionally, operating income was
negatively impacted in both periods by charges related to the initiation of SKU rationalizations.
United Kingdom
Our net sales in the United Kingdom in fiscal 2018 were $938.0 million, an increase of $86.3 million, or 10.1%, from net sales
of $851.8 million in fiscal 2017. Foreign currency exchange rates positively impacted net sales by $54.4 million as compared to
the prior year. The net sales increase on a constant currency basis was primarily due to growth from our Tilda®, Ella’s Kitchen®,
Hartley’s®, Cully & Sully® and Linda McCartney’s® brands, partially offset by lower New Covent Garden Soup Co.® sales. Also
contributing to the increase in net sales was the impact of price realization, as well as the acquisitions of The Yorkshire Provender
Limited and Clarks. Operating income in the United Kingdom segment for fiscal 2018 was $56.0 million, an increase of $4.1
million, or 7.9%, from $51.9 million in fiscal 2017. The increase in operating income was primarily due to the aforementioned
44
increase in sales, operating efficiencies achieved at Hain Daniels, Project Terra cost savings and the impact of favorable foreign
currency. These increases were partially offset by higher commodity costs, marketing investments and costs associated with the
planned closure of a soup manufacturing facility.
Rest of World
Our net sales in Rest of World were $434.9 million in fiscal 2018, an increase of $50.9 million, or 13.3%, from net sales of $383.9
million in fiscal 2017. Foreign currency exchange rates positively impacted net sales by $25.5 million as compared to the prior
year. The increase in net sales on a constant currency basis was primarily due to increased sales volume in Europe related to both
branded and private label non-dairy products, as well as increased sales in Canada driven by growth in our Tilda®, Yves Veggie
Cuisine®,Sensible Portions® and Live Clean® brands, partially offset by Europe’s Best® lost distribution. Operating income in Rest
of World for fiscal 2018 was $38.7 million, an increase of $6.7 million, or 20.8%, from $32.0 million in fiscal 2017.
The increase in operating income was primarily due to the aforementioned increase in sales as well as operating efficiencies
achieved at our plant-based manufacturing facilities in Europe, Project Terra cost savings and the impact of favorable foreign
currency.
Corporate and Other
Our Corporate and Other category consists of expenses related to the Company’s centralized administrative functions, which do
not specifically relate to an operating segment. Corporate and Other expenses are comprised mainly of the compensation and
related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to our
entire enterprise, as well as expenses for certain professional fees, facilities, and other items which benefit the Company as a
whole. Additionally, Project Terra costs and other included in Corporate and Other totaled $10.1 million and $10.4 million for the
fiscal years ended June 30, 2018 and 2017, respectively. The Corporate and Other category also included accounting review costs
of $9.3 million (net of $5.7 million of insurance proceeds) and $29.6 million for the fiscal years ended June 30, 2018 and 2017,
respectively, and impairment charges of $13.3 million and $40.5 million for the fiscal years ended June 30, 2018 and 2017,
respectively.
Refer to Note 19, Segment Information, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-
K for additional details.
Liquidity and Capital Resources
We finance our operations and growth primarily with the cash flows we generate from our operations and from borrowings available
to us under our Credit Agreement and Amended Credit Agreement (defined below).
Our cash and cash equivalents balance decreased $67.0 million at June 30, 2019 to $39.5 million compared to $106.6 million at
June 30, 2018. Our working capital was $318.6 million at June 30, 2019, a decrease of $310.5 million from $629.1 million at the
end of fiscal 2018, which included current assets and current liabilities of discontinued operations of $191.0 million.
Liquidity is affected by many factors, some of which are based on normal ongoing operations of the Company’s business and
some of which arise from fluctuations related to global economics and markets. Our cash balances are held in the United States,
United Kingdom, Canada, Europe and India. As of June 30, 2019, approximately 77.9% ($30.8 million) of the Company’s total
cash balance was held outside of the United States. It is our current intent to indefinitely reinvest our foreign earnings outside the
United States. However, we intend to further study changes enacted by the Tax Act, costs of repatriation and the current and future
cash needs of foreign operations to determine whether there is an opportunity to repatriate foreign cash balances in the future on
a tax-efficient basis.
u
45
We maintain our cash and cash equivalents primarily in money market funds or their equivalent. As of June 30, 2019, all of our
investments were expected to mature in less than three months. Accordingly, we do not believe that our investments have significant
exposure to interest rate risk. Cash provided by (used in) operating, investing and financing activities is summarized below.
(amounts in thousands)
Cash flows provided by (used in):
Operating activities from continuing operations
Investing activities from continuing operations
Financing activities from continuing operations
(Decrease) increase in cash from continuing operations
Decrease in cash from discontinued operations
Effect of exchange rate changes on cash
Net (decrease) increase in cash and cash equivalents
Fiscal Year Ended June 30,
2019
2018
2017
$
$
$
49,519
(69,983)
(44,465)
(64,929)
(6,460)
(2,102)
(73,491) $
121,308
(82,521)
(69,482)
(30,695)
(3,477)
197
(33,975)
$
$
232,695
(60,432)
(147,089)
25,174
(2,994)
(3,114)
19,066
Cash provided by operating activities from continuing operations was $49.5 million for the fiscal year ended June 30, 2019,
compared to $121.3 million provided by in fiscal 2018 and $232.7 million in fiscal 2017. The decrease in cash provided by
operating activities in fiscal 2019 resulted primarily from a decrease of $126.9 million in net income adjusted for non-cash charges,
offset by $55.1 million of cash provided by within working capital accounts, primarily related to inventory and accounts receivable.
Cash provided by operating activities from continuing operations was $121.3 million for the fiscal year ended June 30, 2018,
compared to $232.7 million provided in fiscal 2017. The decrease in cash provided by operating activities in fiscal 2018 resulted
primarily from an additional $97.5 million of cash used within working capital accounts, primarily related to inventory and accounts
receivable and a decrease of $13.9 million in net income adjusted for non-cash charges.
Cash used in investing activities from continuing operations was $70.0 million for the fiscal year ended June 30, 2019. Capital
expenditures for fiscal 2019 were $77.1 million. We used cash in investing activities of $82.5 million during fiscal year ended
June 30, 2018, which was principally made up of $12.4 million, net of cash acquired, in connection with our Clarks UK Limited
acquisition and $70.9 million for capital expenditures for the fiscal year ended June 30, 2018. We used cash in investing activities
of $60.4 million during the fiscal year ended June 30, 2017, which was principally for the acquisitions of Better Bean and Yorkshire
Provender and capital expenditures.
Cash used in financing activities from continuing operations was $44.5 million for the fiscal year ended June 30, 2019. We had
net debt repayments of $77.0 million funded primarily through proceeds received from the sale of HPPC and EK Holdings, Inc.
Additionally, we paid $3.5 million during fiscal 2019 for stock repurchases to satisfy employee payroll tax withholdings and $36.0
million of proceeds received from operations of discontinued operations. Net cash of $69.5 million was used in financing activities
for the fiscal year ended June 30, 2018. We had net debt repayments of $40.7 million funded primarily through cash flows from
operations. Additionally, we paid $7.2 million during fiscal 2018 for stock repurchases to satisfy employee payroll tax withholdings
and $21.6 million to fund the operations of discontinued operations. Net cash of $147.1 million was used in financing activities
for the fiscal year ended June 30, 2017. We had net repayments of $110.4 million funded primarily through cash flows from
operations. Additionally, we paid $8.3 million during fiscal 2017 for stock repurchases to satisfy employee payroll tax withholdings
and $25.9 million to fund the operations of discontinued operations.
Operating Free Cash Flow
Our operating free cash flow was negative $27.6 million for the fiscal year ended June 30, 2019, a decrease of $78.0 million from
the fiscal year ended June 30, 2018. The decrease in operating free cash flow primarily resulted from an increase in our capital
expenditures of $6.2 million and a decrease in net income adjusted for non-cash items of $126.9 million, offset in part by cash
provided within working capital accounts of $55.1 million. We expect that our capital spending for fiscal 2020 will be approximately
$70-$80 million, and we may incur additional costs in connection with Project Terra. We refer the reader to the Reconciliation of
Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions
and a reconciliation from our net cash provided by operating activities from continuing operations to operating free cash flow
from continuing operations.
46
Credit Agreement
On February 6, 2018, the Company entered into the Third Amended and Restated Credit Agreement (the “Credit Agreement”).
The Credit Agreement provides for a $1.0 billion revolving credit facility through February 6, 2023 and provides for a $300.0
million term loan. Under the Credit Agreement, the revolving credit facility may be increased by an additional uncommitted $400.0
million, provided certain conditions are met. Loans under the Credit Agreement bear interest at a Base Rate or a Eurocurrency
Rate (both of which are defined in the Credit Agreement) plus an applicable margin, which is determined in accordance with a
leverage-based pricing grid, as set forth in the Credit Agreement. Borrowings may be used to provide working capital, finance
capital expenditures and permitted acquisitions, refinance certain existing indebtedness and for other general corporate purposes.
On May 8, 2019, the Company entered into the Third Amendment to the Third Amended and Restated Credit Agreement (the
“Amended Credit Agreement”), whereby, among other things, its allowable consolidated leverage ratio increased to no more
than 5.0 to 1.0 from March 31, 2019 to December 31, 2019, no more than 4.75 to 1.0 at March 31, 2020, no more than 4.25 to 1.0
at June 30, 2020 and no more than 4.0 to 1.0 on September 30, 2020 and thereafter. The allowable consolidated leverage ratio for
each period was decreased by 0.25 upon sale of the Company’s remaining Hain Pure Protein business during the fourth quarter
of fiscal 2019. Additionally, the Company’s required consolidated interest coverage ratio (as defined in the Amended Credit
Agreement) was reduced to no less than 3.0 to 1 through March 31, 2020, no less than 3.75 to 1 through March 31, 2021 and no
less than 4.0 to 1 thereafter. The Amended Credit Agreement also required that the Company and the subsidiary guarantors enter
into a Security and Pledge Agreement pursuant to which all of the obligations under Amended Credit Agreement are secured by
liens on assets of the Company and its material domestic subsidiaries, including stock of each of their direct subsidiaries and
intellectual property, subject to agreed upon exceptions. Additionally, the Company is now required to maintain a consolidated
interest coverage ratio (as defined in the Amended Credit Agreement) of no less than 3.0 to 1 through March 31, 2020, no less
than 3.75 to 1 through March 31, 2021 and no less than 4.0 to 1 thereafter. The allowable consolidated leverage ratio was decreased
by 0.25 upon sale of the Company’s remaining Hain Pure Protein business in the fourth quarter of fiscal 2019.
The Amended Credit Agreement provides that loans will bear interest at rates based on (a) the Eurocurrency Rate, as defined in
the Amended Credit Agreement, plus a rate ranging from 0.875% to 2.50% per annum; or (b) the Base Rate, as defined in the
Amended Credit Agreement, plus a rate ranging from 0.00% to 1.50% per annum, the relevant rate being the Applicable Rate.
The Applicable Rate will be determined in accordance with a leverage-based pricing grid, as set forth in the Amended Credit
Agreement. Swing line loans and Global Swing Line loans denominated in U.S. Dollars will bear interest at the Base Rate plus
the Applicable Rate, and Global Swing Line loans denominated in foreign currencies shall bear interest based on the overnight
Eurocurrency Rate for loans denominated in such currency plus the Applicable Rate. The weighted average interest rate on
outstanding borrowings under the Amended Credit Agreement at June 30, 2019 was 4.20%. Additionally, the Amended Credit
Agreement contains a Commitment Fee, as defined in the Amended Credit Agreement, on the amount unused under the Amended
Credit Agreement ranging from 0.20% to 0.45% per annum, and such Commitment Fee is determined in accordance with a
leverage-based pricing grid. As part of the Amended Credit Agreement, HPPC was released from its obligations as a borrower
and a guarantor under the Credit Agreement.
On June 28, 2019, the Company completed the sale of the Company’s remaining Hain Pure Protein business and utilized proceeds
from the sale, net of transaction related costs, to prepay a portion of the term loan. See Note 5, Discontinued Operations, in the
Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K for information on the sale of the Hain Pure
Protein business.
As of June 30, 2019 and June 30, 2018, there were $626.8 million and $698.1 million of borrowings outstanding, respectively,
under the Amended Credit Agreement.
Tilda Short-Term Borrowing Arrangements
Our former Tilda business maintained short-term borrowing arrangements primarily used to fund the purchase of rice from India
and other countries. The maximum borrowings permitted under all such arrangements were £52.0 million. Outstanding borrowings
were collateralized by the current assets of Tilda, typically had six-month terms and bore interest at variable rates typically based
on LIBOR plus a margin (weighted average interest rate of approximately 4.38% at June 30, 2019). As of June 30, 2019 and
June 30, 2018, there were $8.7 million and $9.3 million of borrowings outstanding under these arrangements, respectively. On
August 27, 2019, we sold our Tilda business as discussed in Note 21, Subsequent Event in the Notes to Consolidated Financial
Statements included in Item 8 of this Form 10-K.
y
t
Share Repurchase Program
On June 21, 2017, the Company’s Board of Directors authorized the repurchase of up to $250 million of the Company’s issued
and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans,
47
in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company
repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations.
The Company did not repurchase any shares under this program in fiscal 2019, 2018 or 2017, and accordingly, as of the end of
fiscal 2019, we had $250 million of remaining capacity under our share repurchase program.
Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures
We have included in this report measures of financial performance that are not defined by U.S. GAAP. We believe that these
measures provide useful information to investors and include these measures in other communications to investors.
For each of these non-U.S. GAAP financial measures, we are providing below a reconciliation of the differences between the non-
U.S. GAAP measure and the most directly comparable U.S. GAAP measure, an explanation of why our management and Board
of Directors believes the non-U.S. GAAP measure provides useful information to investors and any additional purposes for which
our management and Board of Directors uses the non-U.S. GAAP measure. These non-U.S. GAAP measures should be viewed
in addition to, and not in lieu of, the comparable U.S. GAAP measure.
Constant Currency Presentation
We believe that this measure provides useful information to investors because it provides transparency to underlying performance
in our consolidated net sales by excluding the effect that foreign currency exchange rate fluctuations have on year-to-year
comparability given the volatility in foreign currency exchange markets. To present this information for historical periods, current
period net sales for entities reporting in currencies other than the U.S. Dollar are translated into U.S. Dollars at the average monthly
exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange
rate in effect during the current period of the current fiscal year. As a result, the foreign currency impact is equal to the current
year results in local currencies multiplied by the change in average foreign currency exchange rate between the current fiscal
period and the corresponding period of the prior fiscal year.
uu
A reconciliation between reported and constant currency net sales decrease in fiscal 2019 is as follows:
(amounts in thousands)
Net sales - Fiscal 2019
Impact of foreign currency exchange
Net sales on a constant currency basis - Fiscal 2019
Net sales - Fiscal 2018
Net sales decrease on a constant currency basis
$
$
$
$
United Kingdom
885,488
36,122
921,610
938,029
(1.8)%
$
$
$
$
Rest of World
407,574
Hain Consolidated
$
2,302,468
16,500
424,074
434,869
(2.5)%
$
$
$
52,622
2,355,090
2,457,769
(4.2)%
A reconciliation between reported and constant currency net sales increase in fiscal 2018 is as follows:
(amounts in thousands)
Net sales - Fiscal 2018
Impact of foreign currency exchange
Net sales on a constant currency basis - Fiscal 2018
Net sales - Fiscal 2017
United Kingdom
938,029
(54,419)
883,610
$
$
$
$
851,757
$
$
$
$
Rest of World
434,869
(25,540)
409,329
Hain Consolidated
2,457,769
$
(79,959)
2,377,810
$
$
383,942
$
2,343,505
Net sales increase on a constant currency basis
3.7%
6.6%
1.5%
Adjusted EBITDA
Adjusted EBITDA is defined as net (loss) income before income taxes, net interest expense, depreciation and amortization,
impairment of long-lived and intangible assets, equity in the earnings of equity-method investees, stock-based compensation,
Project Terra costs and other, and other non-recurring items. The Company’s management believes that this presentation provides
useful information to management, analysts and investors regarding certain additional financial and business trends relating to its
results of operations and financial condition. In addition, management uses this measure for reviewing the financial results of the
f
48
Company and as a component of performance-based executive compensation. Adjusted EBITDA is a non-U.S. GAAP measure
and may not be comparable to similarly titled measures reported by other companies.
We do not consider Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with U.S.
GAAP. The principal limitation of Adjusted EBITDA is that it excludes certain expenses and income that are required by U.S.
GAAP to be recorded in our consolidated financial statements. In addition, Adjusted EBITDA is subject to inherent limitations as
this metric reflects the exercise of judgment by management about which expenses and income are excluded or included in
determining Adjusted EBITDA. In order to compensate for these limitations, management presents Adjusted EBITDA in connection
with U.S. GAAP results.
A reconciliation of net (loss) income to Adjusted EBITDA is as follows:
Fiscal Year Ended June 30,
2018
2017
(amounts in thousands)
Net (loss) income
Net (loss) income from discontinued operations
Net (loss) income from continuing operations
2019
(183,314) $
(133,369)
(49,945) $
$
$
Benefit for income taxes
Interest expense, net
Depreciation and amortization
Equity in net loss (income) of equity-method investees
Stock-based compensation, net
Stock-based compensation expense in connection with Chief Officer
Succession Agreement
Goodwill impairment
Long-lived asset and intangibles impairment
Unrealized currency (gains)/losses
EBITDA
Project Terra costs and other
Chief Executive Officer Succession Plan expense, net
Proceeds from insurance claims
Accounting review and remediation costs, net of insurance proceeds
Warehouse/manufacturing facility start-up costs
SKU rationalization
Plant closure related costs
Litigation and related expenses
Gain on sale of business
Losses on terminated chilled desserts contract
Co-packer disruption
Regulated packaging change
Toys “R” Us bad debt
Recall and other related costs
Machine break-down costs
UK deferred synergies due to CMA Board decision
(2,697)
32,970
56,914
655
9,503
429
—
33,719
(850)
80,698
39,958
29,727
(4,460)
4,334
17,636
12,381
7,457
1,517
(534)
—
—
—
—
—
—
—
Realized currency loss (gain) on repayment of international loans
2,706
9,694
(72,734)
82,428
$
$
(887)
24,339
60,809
(339)
13,380
(2,203)
7,700
14,033
(2,027)
197,233
20,749
—
—
9,293
4,179
4,913
5,513
1,015
—
6,553
3,692
1,007
897
580
317
—
—
Adjusted EBITDA
Operating Free Cash Flow
$
191,420
$
255,941
$
49
67,430
1,889
65,541
22,466
18,391
59,567
(129)
9,658
—
—
40,452
12,570
228,516
9,694
—
—
29,562
—
5,360
1,804
—
—
2,583
—
—
—
809
—
918
(14,290)
264,956
In our internal evaluations, we use the non-U.S. GAAP financial measure “operating free cash flow from continuing operations.”
The difference between operating free cash flow from continuing operations and cash flow provided by or used in operating
activities from continuing operations, which is the most comparable U.S. GAAP financial measure, is that operating free cash
flow from continuing operations reflects the impact of capital expenditures. Since capital spending is essential to maintaining our
operational capabilities, we believe that it is a recurring and necessary use of cash. As such, we believe investors should also
consider capital spending when evaluating our cash provided by or used in operating activities. We view operating free cash flow
from continuing operations as an important measure because it is one factor in evaluating the amount of cash available for
discretionary investments. We do not consider operating free cash flow from continuing operations in isolation or as an alternative
to financial measures determined in accordance with U.S. GAAP.
A reconciliation from cash flow provided by operating activities to Operating free cash flow is as follows:
(amounts in thousands)
Cash flow provided by operating activities from continuing operations
Purchase of property, plant and equipment
Operating free cash flow continuing operations
Contractual Obligations
Fiscal Year Ended June 30,
2019
2018
2017
$
$
$
49,519
(77,128)
(27,609) $
121,308
(70,891)
50,417
$
$
232,695
(47,307)
185,388
Obligations for all debt instruments, capital and operating leases and other contractual obligations as of June 30, 2019 are as
follows:
(amounts in thousands)
Long-term debt obligations (1)
Operating lease obligations
Purchase obligations (2)
Total contractual obligations
(1) Including principal and interest.
Payments Due by Period
$
Total
742,129
118,942
275,571
Less than 1
year
1-3 years
3-5 years
5+ years
$
54,534
$
88,282
$
599,202
$
19,426
259,058
30,802
16,513
24,262
—
111
44,452
—
$ 1,136,642
$
333,018
$
135,597
$
623,464
$
44,563
(2) Excludes amounts that may be payable upon termination to co-packers as we are not able to reasonably estimate such
amounts.
As of June 30, 2019, we had non-current unrecognized tax benefits of $11.9 million for which we are not able to reasonably
estimate the timing of future cash flows. As a result, this amount has not been included in the table above.
We believe that our cash on hand of $39.5 million at June 30, 2019 as well as projected cash flows from operations and availability
under our Amended Credit Agreement are sufficient to fund our working capital needs in the ordinary course of business, anticipated
fiscal 2020 capital expenditures and other expected cash requirements for at least the next 12 months.
Off Balance Sheet Arrangements
At June 30, 2019, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K that have
had or are likely to have a material current or future effect on our consolidated financial statements.
Critical Accounting Estimates
The discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements,
which are prepared in accordance with accounting principles generally accepted in the United States. Our significant accounting
policies are described in Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated
Financial Statements included in Item 8 of this Form 10-K. The policies below have been identified as the critical accounting
policies we use which require us to make estimates and assumptions and exercise judgment that affect the reported amounts of
assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods
presented. We believe in the quality and reasonableness of our critical accounting estimates; however, materially different amounts
50
might be reported under different conditions or using assumptions, estimates or making judgments different from those that we
have applied. Our critical accounting policies, including our methodology for estimates made and assumptions used, are as follows:
Revenue Recognition
The Company sells its products through specialty and natural food distributors, supermarkets, natural foods stores, mass-market
and e-commerce retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide. The
majority of our revenue contracts represent a single performance obligation related to the fulfillment of customer orders for the
purchase of our products. We recognize revenue as performance obligations are fulfilled when control passes to our customers.
Our customer contracts typically contain standard terms and conditions. In instances where formal written contracts are not in
place we consider the customer purchase orders to be contracts based on the criteria outlined in ASC 606, Revenue from Contracts
with Customers. Payment terms and conditions vary by customer and are based on the billing schedule established in our contracts
or purchase orders with customers, but we generally provide credit terms to customers ranging from 15-60 days; therefore, we
have determined that our contracts do not include a significant financing component.
t
Sales to customers generally do not include more than one performance obligation. When a contract does contain more than one
performance obligation, we allocate the contract’s transaction price to each performance obligation based on its relative standalone
selling price. The standalone selling price for each distinct good is generally determined by directly observable data.
We have determined that we satisfy our performance obligations related to our customer contracts at a point in time, as opposed
to over time, and, accordingly, revenue is recognized at a point in time. Therefore, we do not have any contract balances with our
customers recorded on our Consolidated Balance Sheets.
Sales includes shipping and handling charges billed to the customer and are reported net of discounts, trade promotions and sales
incentives, consumer coupon programs and other costs, including estimated allowances for returns, allowances and discounts
associated with aged or potentially unsalable product, and prompt pay discounts. Shipping and handling costs are accounted for
as a fulfillment activity of our promise to transfer products to our customers and are included in cost of sales line item on the
Consolidated Statements of Operations.
t
Variable Consideration
In addition to fixed contract consideration, many of our contracts include some form of variable consideration. We offer various
trade promotions and sales incentive programs to customers and consumers, such as price discounts, slotting fees, in-store display
incentives, cooperative advertising programs, new product introduction fees and coupons. The expenses associated with these
programs are accounted for as reductions to the transaction price of our products and are therefore deducted from our net sales to
determine reported net sales. Trade promotions and sales incentive accruals are subject to significant management estimates and
assumptions. The critical assumptions used in estimating the accruals for trade promotions and sales incentives include
management’s estimate of expected levels of performance and redemption rates. Management exercises judgment in developing
these assumptions. These assumptions are based upon historical performance of the retailer or distributor customers with similar a
types of promotions adjusted for current trends. The Company regularly reviews and revises, when deemed necessary, estimates
of costs to the Company for these promotions and incentives based on what has been incurred by the customers. The terms of
most of our promotion and incentive arrangements do not exceed a year and therefore do not require highly uncertain long-term
estimates. Settlement of these liabilities typically occurs in subsequent periods primarily through an authorization process for
deductions taken by a customer from amounts otherwise due to the Company. Differences between estimated expense and actual
promotion and incentive costs are normally insignificant and are recognized in earnings in the period such differences are
determined. Actual expenses may differ if the level of redemption rates and performance were to vary from estimates.
Costs to Obtain or Fulfill a Contract
As our contracts are generally shorter than one year, the Company has elected a practical expedient under ASU 2014-09 that allows
the Company to expense as incurred the incremental costs of obtaining a contract if the contract period is for one year or less.
These costs are included in the selling, general and administrative expense line item on the Consolidated Statements of Operations.
Disaggregation of Net Sales
The Company does not disaggregate revenue below the segment revenues level disclosed in Note 17, Segment Information, as all
revenues are recognized at a point in time and the Company’s segment revenues depict how the economic factors affect the nature,
amount, and timing and uncertainty of cash flows.
51
Valuation of Accounts and Chargeback Receivable
We perform routine credit evaluations on existing and new customers. We apply reserves for delinquent or uncollectible trade
receivables based on a specific identification methodology and also apply an additional reserve based on the experience we have
with our trade receivables aging categories. Credit losses have been within our expectations in recent years. While Walmart Inc.
and its affiliates, Sam’s Club and ASDA, together represented approximately 12% of accounts receivable, net at June 30, 2019,
we believe there is no significant or unusual credit exposure at this time.
Based on cash collection history and other statistical analysis, we estimate the amount of unauthorized deductions that our customers
have taken that we expect will be collectible and repaid in the near future and records a chargeback receivable. Differences between
estimated collectible receivables and actual collections are recognized in earnings in the period such differences are determined.
We may not have the same experience with our receivables during different economic conditions, or with changes in business
conditions, such as consolidation within the food industry and/or a change in the way we market and sell our products.
Accounting for Acquisitions
Our growth strategy has historically included the acquisition of numerous brands and businesses. The purchase price of these
acquisitions has been determined after due diligence of the acquired business, market research, strategic planning and the forecasting
of expected future results and synergies. Estimated future results and expected synergies are subject to judgment as we integrate
each acquisition and attempt to leverage resources.
The accounting for the acquisitions we have made requires that the assets and liabilities acquired, as well as any contingent
consideration that may be part of the agreement, be recorded at their respective fair values at the date of acquisition. This requires
management to make significant estimates in determining the fair values, especially with respect to intangible assets, including
estimates of expected cash flows, expected cost savings and the appropriate weighted average cost of capital. As a result of these
significant judgments to be made, we occasionally obtain the assistance of independent valuation firms. We complete these
assessments as soon as practical after the closing dates. Any excess of the purchase price over the estimated fair values of the
identifiable net assets acquired is recorded as goodwill. Because the fair value and the estimated useful life of an intangible asset
is a subjective estimate, it is reasonably likely that circumstances may cause the estimate to change. See Note 6, Acquisitions, in
the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.
t
t
Valuation of Long-lived Assets
Fixed assets and amortizable intangible assets are reviewed for impairment as events or changes in circumstances occur indicating
that the carrying value of the asset may not be recoverable. Undiscounted cash flow analyses are used to determine if impairment
exists. If impairment is determined to exist, the loss is calculated based on estimated fair value.
Goodwill and Intangible Assets
Goodwill and intangible assets deemed to have indefinite lives are not amortized but rather are tested at least annually for
impairment, or more often if events or changes in circumstances indicate that more likely than not the carrying amount of the asset
may not be recoverable.
Goodwill is tested for impairment at the reporting unit level. A reporting unit represents an operating segment or a component of
an operating segment. Goodwill is tested for impairment by either performing a qualitative evaluation or a two-step quantitative
test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a
reporting unit is less than its carrying amount, including goodwill. We may elect not to perform the qualitative assessment for
some or all reporting units and perform a two-step quantitative impairment test. The estimate of the fair values of our reporting
units are based on the best information available as of the date of the assessment. We generally use a blended analysis of the
present value of discounted cash flows and the market valuation approach. The discounted cash flow model uses the present
values of estimated future cash flows. Considerable management judgment is necessary to evaluate the impact of operating and
external economic factors in estimating our future cash flows. The assumptions we use in our evaluations include projections of
growth rates and profitability, our estimated working capital needs, as well as our weighted average cost of capital. The market
valuation approach indicates the fair value of a reporting unit based on a comparison to comparable publicly traded firms in similar
businesses. Estimates used in the market value approach include the identification of similar companies with comparable business
factors. Changes in economic and operating conditions impacting the assumptions we made could result in additional goodwill
impairment in future periods. If the carrying value of the reporting unit exceeds fair value, goodwill is considered impaired. The
52
amount of the impairment is the difference between the carrying value of the goodwill and the “implied” fair value, which is
calculated as if the reporting unit had just been acquired and accounted for as a business combination.
Indefinite-lived intangible assets consist primarily of acquired trade names and trademarks. We first assess qualitative factors to
determine whether it is more likely than not that an indefinite-lived intangible asset is impaired. We measure the fair value of
these assets using the relief from royalty method. This method assumes that the trade names and trademarks have value to the
extent their owner is relieved from paying royalties for the benefits received. We estimate the future revenues for the associated
brands, the appropriate royalty rate and the weighted average cost of capital.
The Company completed its annual goodwill impairment analysis in the fourth quarter of fiscal 2019, in conjunction with its
budgeting and forecasting process for fiscal year 2020, and concluded that no indicators of impairment existed at any of its reporting
units.
As of June 30, 2019, the carrying value of goodwill was $1.01 billion. As of the 2019 measurement, the estimated fair value of
each reporting unit exceeded its carrying value by at least 20%, with the exception of the Tilda and Grocery and Snacks reporting
units, whose fair values exceeded their carrying values by 13% and 8%, respectively. Holding all other assumptions used in the
2019 fair value measurement constant, a 100-basis-point increase in the weighted average cost of capital would not result in the
carrying value of any reporting unit, other than the Tilda reporting unit, to be in excess of the fair value. However, the fair values
of the Hain Daniels, Grocery and Snacks and Hain Ventures reporting units would exceed their respective carrying values by less
than 10%. The fair values were based on significant management assumptions including an estimate of future cash flow. If
assumptions are not achieved or market conditions decline, potential impairment charges could result. The Company will continue
to monitor impairment indicators and financial results in future periods.
For the fiscal year ended June 30, 2018, the Company recognized a goodwill impairment charge of $7.7 million in its Hain Ventures
reporting unit primarily as a result of lowered projected long-term revenue growth rates and profitability levels.
Indefinite-lived intangible assets are evaluated on an annual basis in conjunction with the Company’s evaluation of goodwill, or
on an interim basis if and when events or circumstances change that would more likely than not reduce the fair value of any of its
indefinite-life intangible assets below their carrying value. In assessing fair value, the Company utilizes a “relief from royalty
payments” methodology. This approach involves two steps: (i) estimating the royalty rates for each trademark and (ii) applying
these royalty rates to a projected net sales stream and discounting the resulting cash flows to determine fair value. If the carrying
value of the indefinite-lived intangible assets exceeds the fair value of the asset, the carrying value is written down to fair value
in the period identified. In the second quarter of fiscal 2019, the Company determined that an indicator of impairment existed in
certain of the Company’s indefinite-lived tradenames. The result of this interim assessment indicated that the fair value of certain
of the Company’s tradenames was below their carrying value, and therefore an impairment charge of $17.9 million was recognized
($11.3 million in the United States segment, $3.8 million in the Rest of World segment and $2.8 million in the United Kingdom
segment) during the fiscal year ended June 30, 2019. The result of the annual assessment for the year ended June 30, 2019
indicated that the fair value of the Company’s trade names exceeded their carrying values and no indicators of impairment were
present. For the fiscal year ended June 30, 2018, a trade name impairment charge of $5.6 million ($5.1 million in the Rest of
World segment and $0.5 million in the United Kingdom segment) was recorded. For the fiscal year ended June 30, 2017, a trade
name impairment charge of $14.1 million ($7.6 million in the United Kingdom segment and $6.5 million in the United States
segment) was recorded.
aa
r
See also Note 9, Goodwill and Other Intangible Assets, in the Notes to Consolidated Financial Statements included in Item 8 of
this Form 10-K, for additional information.
Stock-based Compensation
The Company records share-based payment awards exchanged for employee and non-employee directors services at fair value
on the date of grant and expenses the awards in the consolidated statements of operations over the requisite employee service
period. Stock-based compensation expense related to awards with a market or performance condition, which cliff vest, are
recognized over the vesting period on a straight line basis. Stock-based compensation awards with service conditions only are
also recognized on a straight-line basis. The fair value of restricted stock awards is equal to the market value of the Company’s
common stock on the date of grant and is recognized in expense over the vesting period using the straight-line method.
For awards that contain a market condition, expense is recognized over the defined or derived service period using a Monte Carlo
simulation model. Compensation expense is recognized for these awards on a straight-line basis over the service period, regardless
of the eventual number of shares that are earned based upon the market condition, provided that each grantee remains an employee
53
at the end of the performance period. Compensation expense is reversed if at any time during the service period a grantee is no
longer an employee.
Valuation Allowances for Deferred Tax Assets
Deferred tax assets arise when we recognize expenses in our financial statements that will be allowed as income tax deductions
in future periods. Deferred tax assets also include unused tax net operating losses and tax credits that we are allowed to carryrr
forward to future years. Accounting rules permit us to carry deferred tax assets on the balance sheet at full value as long as it is
“more likely than not” that the deductions, losses or credits will be used in the future. A valuation allowance must be recorded
against a deferred tax asset if this test cannot be met. Our determination of our valuation allowances is based upon a number of
assumptions, judgments and estimates, including forecasted earnings, future taxable income and the relative proportions of revenue
and income before taxes in the various jurisdictions in which we operate. Concluding that a valuation allowance is not required
is difficult when there is significant negative evidence that is objective and verifiable, such as cumulative losses in recent years.
We have deferred tax assets related to foreign net operating losses, primarily in the United Kingdom and to a lesser extent in
Belgium, against which we have recorded valuation allowances. The losses in the United Kingdom were recorded prior to the
acquisition of Daniels. Under current tax law in these jurisdictions, our carryforward losses have no expiration. During fiscal
2019, the Company released the valuation allowance on a majority of its U.K. net operating loss carryforwards as it is more likely
than not that the losses are realizable.
During fiscal 2019, we recorded a partial valuation allowance against our state deferred tax assets and state net operating loss
carryforwards as it is not more likely than not that the state tax attributes will be realized.
Recent Accounting Pronouncements
See Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements
included in Item 8 of this Form 10-K for information regarding recent accounting pronouncements.
Seasonality
Certain of our product lines have seasonal fluctuations. Hot tea, baking products, hot cereal, hot-eating desserts and soup sales
are stronger in colder months, while sales of snack foods, sunscreen and certain of our prepared food and personal care products
are stronger in the warmer months. As such, our results of operations and our cash flows for any particular quarter are not indicative
of the results we expect for the full year, and our historical seasonality may not be indicative of future quarterly results of operations.
In recent years, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters.
uu
f
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
Market Risk
The principal market risks (i.e., the risk of loss arising from adverse changes in market rates and prices) to which the Company
is exposed are:
•
•
•
interest rates on debt and cash equivalents;
foreign exchange rates, generating translation and transaction gains and losses; and
ingredient inputs.
Interest Rates
We centrally manage our debt and cash equivalents, considering investment opportunities and risks, tax consequences and overall
financing strategies. Our cash equivalents consist primarily of money market funds or their equivalent. As of June 30, 2019, we
had $626.8 million of variable rate debt outstanding under our Amended Credit Agreement. Assuming current cash equivalents
and variable rate borrowings, a hypothetical change in average interest rates of one percentage point would impact net interest
expense by approximately $5.9 million over the next fiscal year.
54
Foreign Currency Exchange Rates
Operating in international markets involves exposure to movements in currency exchange rates, which are volatile at times, and
the impact of such movements, if material, could cause adjustments to our financing and operating strategies.
During fiscal 2019, approximately 54% of our consolidated net sales were generated from sales outside the United States, while
such sales outside the United States were 53% of net sales in fiscal 2018 and 50% of net sales in fiscal 2017. These revenues,
along with related expenses and capital purchases, were conducted in British Pounds Sterling, Euros, Indian Rupees and Canadian
Dollars. Sales and operating income would have decreased by approximately $61.3 million and $4.5 million, respectively, if
average foreign exchange rates had been lower by 5% against the U.S. Dollar in fiscal 2019. These amounts were determined by
considering the impact of a hypothetical foreign exchange rate on the sales and operating income of the Company’s international
operations. To reduce that risk, the Company may enter into certain derivative financial instruments, when available on a cost-
effective basis, to manage such risk. We had approximately $44.1 million in notional amounts of forward contracts at June 30,
2019. See Note 16, Financial Instruments Measured at Fair Value, in the Notes to Consolidated Financial Statements included
in Item 8 of this Form 10-K.
Fluctuations in currency exchange rates may also impact the Stockholders’ Equity of the Company. Amounts invested in our non-
United States subsidiaries are translated into United States Dollars at the exchange rates as of the last day of each reporting period.
Any resulting cumulative translation adjustments are recorded in Stockholders’ Equity as Accumulated Other Comprehensive
Income. The cumulative translation adjustments component of Accumulated Other Comprehensive Loss decreased by $41.2
million during the fiscal year ended June 30, 2019.
Ingredient Inputs Price Risk
The Company purchases ingredient inputs such as almonds, coconut oil, corn, dairy, fruit and vegetables, oils, rice, soybeans, oats
and wheat, as well as packaging materials, to be used in its operations. These inputs are subject to price fluctuations that may
create price risk. We do not attempt to hedge against fluctuations in the prices of the ingredients by using future, forward, option
or other derivative instruments. As a result, the majority of our future purchases of these items are subject to changes in price.
We may enter into fixed purchase commitments in an attempt to secure an adequate supply of specific ingredients. These agreements
are tied to specific market prices. Market risk is estimated as a hypothetical 10% increase or decrease in the weighted-average
cost of our primary inputs as of June 30, 2019. Based on our cost of goods sold during the fiscal year ended June 30, 2019, such
a change would have resulted in an increase or decrease to cost of sales of approximately $136 million. We attempt to offset the
impact of input cost increases with a combination of cost savings initiatives and efficiencies and price increases.
Item 8.
Financial Statements and Supplementary Data
The following consolidated financial statements of The Hain Celestial Group, Inc. and subsidiaries are included in Item 8:
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets - June 30, 2019 and June 30, 2018
Consolidated Statements of Operations - Fiscal Years ended June 30, 2019, 2018 and 2017
Consolidated Statements of Comprehensive Income (Loss) - Fiscal Years ended June 30, 2019, 2018 and 2017
Consolidated Statements of Stockholders’ Equity - Fiscal Years ended June 30, 2019, 2018 and 2017
Consolidated Statements of Cash Flows - Fiscal Years ended June 30, 2019, 2018 and 2017
Notes to Consolidated Financial Statements
The following consolidated financial statement schedule of The Hain Celestial Group, Inc. and subsidiaries is included in Item
15(a):
Schedule II - Valuation and qualifying accounts
All other schedules for which provision is made in the applicable accounting regulation of the SEC are not required under the
related instructions or are inapplicable and therefore have been omitted.
55
Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of
The Hain Celestial Group, Inc. and Subsidiaries
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of The Hain Celestial Group, Inc. and subsidiaries (the Company)
as of June 30, 2019 and 2018, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity
and cash flows for each of the three years in the period ended June 30, 2019, and the related notes and the financial statement
schedule listed in the Index at Item 15(a) (collectively referred to as the “consolidated financial statements”). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company at June 30, 2019
and 2018, and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2019, in
conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the Company's internal control over financial reporting as of June 30, 2019, based on criteria established in Internal
Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013
framework) and our report dated August 29, 2019 expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on
the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial
statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that
were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are
material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The
communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as
a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters
or on the accounts or disclosures to which they relate.
56
Valuation of Goodwill and Trademarks and Trade names
Description of
the Matter
At June 30, 2019, the Company’s goodwill and trademarks and trade names were $1.0 billion and
$0.4 billion, respectively. As discussed in Note 9 of the 2019 audited financial statements, goodwill
and trademarks and trade names are qualitatively or quantitatively tested for impairment at least
annually, or more frequently when necessary. If the fair value of the intangible asset is less than
its carrying amount, an impairment loss is recognized.
How We
Addressed the
Matter in Our
Audit
Auditing management’s annual goodwill and trademarks and trade names impairment tests was
complex as considerable management judgment was necessary to estimate fair values of the
reporting units and trademarks and trade names. For goodwill, significant assumptions used in
management’s evaluations included projections of revenue growth rates and profitability, estimated
working capital needs and the weighted average cost of capital. For trademarks and trade names,
significant assumptions used in management’s evaluations included projections of future revenues
for the associated brands, royalty rates, and the weighted average cost of capital. The
aforementioned assumptions are affected by expectations about future market or economic
conditions that materially impact the fair value of the reporting units as well as the trademark and
trade names.
We obtained an understanding, evaluated the design, and tested the operating effectiveness of
controls over the Company’s goodwill and trademark and trade name impairment evaluation
process. For example, we tested controls over management’s review of the significant assumptions
used in the reporting unit and trademark and trade name valuations as well as management’s review
around the reasonableness of the data used in these valuations.
To test the estimated fair value of the Company’s reporting units and trademarks and trade names,
we performed audit procedures that included, among others, testing the significant assumptions
discussed above, testing the underlying data used by the Company in its analyses by comparing
to historical and other industry data, as well as validating certain assertions with data internal to
the Company and from other sources. We compared the significant assumptions used by
management to current industry and economic trends while also considering changes to the
Company’s business model, customer base and product mix. We assessed the historical accuracy
of management’s estimates and significant assumptions, such as projections of revenue growth
rates and profitability, and estimated working capital needs, by comparing management’s past
projections to actual performance. We used our valuation specialists to independently compute a
range of reasonableness for the weighted average cost of capital. We also performed sensitivity
analyses to evaluate the impact that changes in the significant assumptions would have on the fair
value of the reporting units and trademarks and trade names. In addition, we tested the reconciliation
of the fair value of the reporting units to the market capitalization of the Company. We also involved
a valuation specialist to assist in our evaluation of the Company's model, valuation methodology
and significant assumptions.
57
Description of
the Matter
Revenue Recognition
For the year ended June 30, 2019, the Company’s reported net sales from continuing operations
was $2.3 billion. As described in Note 2 of the 2019 audited financial statements, the Company
provides certain retailers and distributors with trade and promotional incentive programs, which
results in variable consideration and the Company having to estimate expected levels of promotions
that are typically settled in a period after the sale taking place. The estimated costs of these trade
promotions and sales incentives are recorded as a reduction to revenue at the time a product is
sold to the customer. The measurement of trade promotions and sales incentive programs involves
the use of judgment related to estimates of expected levels of performance and redemption rates.
Auditing the estimate of trade promotions and sales incentives is complex because the revenue
recognized is determined based on significant management estimates. In particular, estimates are
made for price discounts, slotting fees, in-store display incentives, cooperative advertising
programs, new product introduction fees and coupons. These estimates are based on historical
performance of the retailer or distributor, types of promotions, and adjustments for current trends,
among other inputs. Changes in these estimates can have a significant impact on the amount of
the revenue recognized. The completeness of the trade promotions and sales incentives estimate
could also be impacted by any undisclosed side arrangements.
How We
Addressed the
Matter in Our
Audit
We obtained an understanding, evaluated the design, and tested the operating effectiveness of
controls over the Company’s trade promotions and sales incentives estimation process. For
example, we tested controls over management’s review of the significant assumptions, such as the
historical rate and timing of deductions, management’s review of the completeness and accuracy
of the data used and other controls such as their retrospective review analysis.
Among other tests, we tested the results of the Company's retrospective review analysis of price
concessions claimed by distributors and retailers as compared to levels of performance and
redemption rates used in the estimate, evaluated the estimates used by comparing them to historical
trends, and performed sensitivity analyses over the Company's significant assumptions. We also
performed detailed transactional testing of customer deduction data underlying the estimate to
validate the nature, timing and amount of deductions taken. Additionally, we obtained
confirmations from sales representatives and distributor customers in order to assess the
completeness of incentive programs.
Measurement of SKU Rationalization Reserve
Description of
the Matter
At June 30, 2019, the Company’s Stock Keeping Unit (“SKU”) rationalization inventory reserve
was $12.4 million. As discussed in Note 7 of the 2019 audited financial statements, the Company
recorded inventory write-downs in connection with the discontinuance of slow-moving SKUs as
part of a product rationalization initiative. Inputs to the calculation of the reserve at year end related
to those items in the SKU rationalization program that are subjective and judgmental, specifically
the estimated selling price and the quantities to be sold.
How We
Addressed the
Matter in Our
Audit
Auditing management’s SKU rationalization reserves was complex as considerable management
judgment was necessary in determining the amounts that would be reserved. The significant
estimates used in the calculation of the reserve include the estimated selling price and the quantities
to be sold.
We obtained an understanding, evaluated the design, and tested the operating effectiveness of
controls over the SKU rationalization process. For example, we tested controls over management’s
review of the estimated selling prices and sales quantity data used in the inventory reserve
calculation.
Our audit procedures to test the adequacy of the Company's SKU rationalization reserve included,
among others, testing the accuracy and completeness of the underlying data, including the estimated
selling price and quantities. This testing included a retrospective review analysis of sales
subsequent to the implementation of the SKU rationalization. We also assessed the historical
accuracy of management’s estimates related to previous SKU rationalization reserves and
performed sensitivity analyses of significant assumptions (such as selling prices and sales quantity)
to evaluate the impact that changes in these assumptions would have on the SKU rationalization
inventory reserve.
58
Assessment of Realizability of Deferred Tax Assets
Description of
the Matter
As more fully described in Note 12 to the consolidated financial statements, at June 30, 2019, the
Company had deferred tax assets related to deductible temporary differences and carryforwards
of $77.0 million, net of a $34.9 million valuation allowance. Deferred tax assets are reduced by a
valuation allowance if, based on the weight of all available evidence, in management’s judgment
it is more likely than not that some portion, or all, of the federal, state and foreign deferred tax
assets will not be realized.
Auditing management’s assessment of the realizability of its deferred tax assets involved complex
auditor judgment because management’s estimate of future taxable income is highly judgmental
and based on significant assumptions that may be affected by future market conditions and the
Company’s performance.
How we
addressed the
matter in our
audit
We obtained an understanding, evaluated the design, and tested the operating effectiveness of
controls that address the risks of material misstatement relating to the realizability of deferred tax
assets. This included controls over management’s scheduling of the future reversal of existing
taxable temporary differences and estimate of future taxable income.
Among other audit procedures performed, we tested the Company’s scheduling of the reversal of
existing temporary taxable differences. We also evaluated the assumptions used by the Company
to develop estimates of future taxable income by jurisdiction and tested the completeness and
accuracy of the underlying data used in its projections. For example, we compared the estimates
of future taxable income with the actual results of prior periods, as well as management’s
consideration of other future market conditions. We also assessed the accuracy of management’s
historical projections and compared the estimate of future taxable income with other forecasted
financial information prepared by the Company.
/s/ ERNST & YOUNG LLP
We have served as the Company’s auditor since 1994.
Jericho, New York
August 29, 2019
59
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
JUNE 30, 2019 AND JUNE 30, 2018
(In thousands, except par values)
Current assets:
Cash and cash equivalents
ASSETS
f $588 and $1,828,
Accounts receivable, less allowance for doubtful accounts of $588 and $1,828,
respectively
Inventories
Prepaid expenses and other current assets
Current assets of discontinued operations
Total current assets
Property, plant and equipment, net
Goodwill
Trademarks and other intangible assets, net
Investments and joint ventures
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Current portion of long-term debt
Current liabilities of discontinued operations
Total current liabilities
Long-term debt, less current portion
Deferred income taxes
Other noncurrent liabilities
Total liabilities
Commitments and contingencies (Note 17)
Stockholders’ equity:
June 30,
2019
2018
$
39,526
$
106,557
236,945
364,887
60,429
—
701,787
328,362
1,008,979
465,211
18,890
59,391
252,708
391,525
59,946
240,851
1,051,587
310,172
1,024,136
510,387
20,725
29,667
$
2,582,620
$
2,946,674
$
238,298
$
118,940
25,919
—
383,157
613,537
51,910
14,697
229,993
116,001
26,605
49,846
422,445
687,501
86,909
12,770
1,063,301
1,209,625
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none
—
—
Common stock - $.01 par value, authorized 150,000 shares; issued: 108,833 and
108,422 shares, respectively; outstanding: 104,219 and 103,952 shares, respectively
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Less: Treasury stock, at cost, 4,614 and 4,470 shares, respectively
Total stockholders’ equity
Total liabilities and stockholders’ equity
See notes to consolidated financial statements.
1,088
1,158,257
695,017
(225,004)
1,629,358
(110,039)
1,519,319
1,084
1,148,196
878,516
(184,240)
1,843,556
(106,507)
1,737,049
$
2,582,620
$
2,946,674
60
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FISCAL YEARS ENDED JUNE 30, 2019, 2018 AND 2017
(In thousands, except per share amounts)
Net sales
Cost of sales
Gross profit
Selling, general and administrative expenses
Amortization of acquired intangibles
Project Terra costs and other
Chief Executive Officer Succession Plan expense, net
Proceeds from insurance claim
Accounting review and remediation costs, net of insurance proceeds
Goodwill impairment
Long-lived asset and intangibles impairment
Operating (loss) income
Interest and other financing expense, net
Other expense/(income), net
(Loss) income from continuing operations before income taxes and equity
in net loss (income) of equity-method investees
(Benefit) provision for income taxes
Equity in net loss (income) of equity-method investees
Net (loss) income from continuing operations
Net (loss) income from discontinued operations, net of tax
Net (loss) income
Net (loss) income per common share:
Basic net (loss) income per common share from continuing operations
Basic net (loss) income per common share from discontinued operations
Basic net (loss) income per common share
Diluted net (loss) income per common share from continuing operations
Diluted net (loss) income per common share from discontinued operations
Diluted net (loss) income per common share
$
$
$
$
$
$
Shares used in the calculation of net (loss) income per common share:
Fiscal Year Ended June 30,
$
2018
2,457,769
1,942,321
$
2017
2,343,505
1,824,109
$
2019
2,302,468
1,857,255
445,213
340,949
515,448
341,634
18,202
18,026
520
—
9,293
7,700
14,033
106,040
26,925
(2,087)
81,202
(887)
(339)
82,428
(72,734)
9,694
0.79
(0.70)
0.09
0.79
(0.70)
0.09
$
$
$
$
$
$
519,396
312,583
16,988
10,388
—
—
29,562
—
40,452
109,423
21,115
430
87,878
22,466
(129)
65,541
1,889
67,430
0.63
0.02
0.65
0.63
0.02
0.65
15,294
40,107
30,156
(4,460)
4,334
—
33,719
(14,886)
36,078
1,023
(51,987)
(2,697)
655
(49,945) $
(133,369)
(183,314) $
(0.48) $
(1.28)
(1.76) $
(0.48) $
(1.28)
(1.76) $
Basic
Diluted
104,076
104,076
103,848
104,477
103,611
104,248
See notes to consolidated financial statements.
61
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
FISCAL YEARS ENDED JUNE 30, 2019, 2018 AND 2017
(In thousands)
Fiscal Year Ended June 30, 2019
Fiscal Year Ended June 30, 2018
Fiscal Year Ended June 30, 2017
Pre-tax
amount
Tax
(expense)
benefit
After-tax
amount
Pre-tax
amount
Tax
(expense)
benefit
After-tax
amount
Pre-tax
amount
Tax
(expense)
benefit
Net (loss) income
$ (183,314)
$
9,694
After-tax
amount
$
67,430
Other comprehensive (loss)
income:
Foreign currency
translation adjustments
Change in deferred gains
(losses) on cash flow
hedging instruments
Change in unrealized
(losses) gains on equity
investment
Total other comprehensive
(loss) income
Total comprehensive (l
income
(loss)
)
$ (41,180) $
—
(41,180) $
11,497
$
—
11,497
$ (22,951) $
—
(22,951)
83
—
(15)
—
68
—
(82)
15
(67)
(411)
(190)
(1)
(191)
(53)
32
15
(379)
(38)
$ (41,097) $
(15) $ (41,112) $
11,225
$
14
$
11,239
$ (23,415) $
47
$ (23,368)
$ (224,426)
$
20,933
$
44,062
See notes to consolidated financial statements.
62
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
FISCAL YEARS ENDED JUNE 30 2019, 2018 AND 2017
(In thousands, except par values)
Balance at June 30, 2016
Net income
Other comprehensive loss
Issuance of common stock pursuant
to stock-based compensation
plans
Stock-based compensation income
tax effects
Shares withheld for payment of
employee payroll taxes due on
shares issued under stock-based
compensation plans
Stock-based compensation
expense
Balance at June 30, 2017
Net income
Other comprehensive income
Issuance of common stock pursuant
to stock-based compensation
plans
Shares withheld for payment of
employee payroll taxes due on
shares issued under stock-based
compensation plans
Stock-based compensation
expense
Common Stock
Additional
Accumulated
Other
Shares
Amount
at $.01
Paid-in
Capital
Retained
Earnings
Treasury Stock
Comprehensive
Shares
Amount
Income (Loss)
Total
107,479
$
1,075
$ 1,123,206
$ 801,392
4,018
$ (89,048) $
(172,111) $ 1,664,514
67,430
67,430
(23,368)
(23,368)
510
5
1,995
2,865
9,658
52
(1,999)
217
(8,268)
1
2,865
(8,268)
9,658
107,989
$
1,080
$ 1,137,724
$ 868,822
4,287
$ (99,315) $
(195,479) $ 1,712,832
9,694
11,239
433
4
(4)
—
—
183
(7,192)
10,476
9,694
11,239
—
(7,192)
10,476
Balance at June 30, 2018
108,422
$
1,084
$ 1,148,196
$ 878,516
4,470
$ (106,507) $
(184,240) $ 1,737,049
Continued on next page
63
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
FISCAL YEARS ENDED JUNE 30 2019, 2018 AND 2017
(In thousands, except par values)
Continued from previous page
Balance at June 30, 2018
Net loss
Cumulative effect of adoption of
ASU 2016-01
Cumulative effect of adoption of
ASU 2014-09
Other comprehensive l loss
Issuance of common stock pursuant
to stock-based compensation
plans
Shares withheld for payment of
employee payroll taxes due on
shares issued under stock-based
compensation plans
Stock-based compensation
expense
Common Stock
Additional
Accumulated
Other
Shares
Amount
at $.01
Paid-in
Capital
Retained
Earnings
Treasury Stock
Comprehensive
Shares
Amount
Income (Loss)
Total
108,422
$
1,084
$ 1,148,196
$ 878,516
4,470
$ (106,507) $
(184,240) $ 1,737,049
(183,314)
(348)
163
348
(183,314)
—
163
(41,112)
(41,112)
411
4
(4)
—
—
—
10,065
144
(3,532)
(3,532)
10,065
Balance at June 30, 2019
108,833
$
1,088
$ 1,158,257
$ 695,017
4,614
$ (110,039) $
(225,004) $ 1,519,319
See notes to consolidated financial statements.
64
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FISCAL YEARS ENDED JUNE 30, 2019, 2018 AND 2017
(In thousands)
Fiscal Year Ended June 30,
2019
2018
2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) income
Net (loss) income from discontinued operations
Net (loss) income from continuing operations
Adjustments to reconcile net (loss) income from continuing operations to net cash
provided by operating activities from continuing operations:
$
$
(183,314) $
(133,369)
(49,945) $
9,694
(72,734)
82,428
$
$
Depreciation and amortization
Deferred income taxes
Equity in net loss (income) of equity-method investees
Stock-based compensation, net
Impairment charges
Other non-cash items, net
Increase (decrease) in cash attributable to changes in operating assets and liabilities, net of
amounts applicable to acquisitions:
Accounts receivable
Inventories
Other current assets
Other assets and liabilities
Accounts payable and accrued expenses
Net cash provided by operating activities from continuing operations
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment
Proceeds from sale of assets and other
Acquisitions of businesses, net of cash acquired
Net cash used in investing activities from continuing operations
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings under bank revolving credit facility
Repayments under bank revolving credit facility
Borrowings under term loan
Repayments under term loan
Repayments of other debt, net
Proceeds from (funding of) discontinued operations entities
Acquisition related contingent consideration
Shares withheld for payment of employee payroll taxes
Net cash used in financing activities from continuing operations
Effect of exchange rate changes on cash
CASH FLOWS FROM DISCONTINUED OPERATIONS
Cash used in operating activities
Cash provided by (used in) investing activities
Cash (used in) provided by financing activities
Net cash used in discontinued operations
Net (decrease)/increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Less: cash and cash equivalents of discontinued operations
Cash and cash equivalents of continuing operations at end of year
56,914
(25,790)
655
9,932
33,719
1,225
21,194
20,648
(5,758)
3,697
(16,972)
49,519
(77,128)
7,145
—
(69,983)
285,000
(268,791)
—
(90,000)
(3,171)
36,029
—
(3,532)
(44,465)
(2,102)
(8,250)
37,941
(36,151)
(6,460)
(73,491)
113,017
60,809
(21,503)
(339)
11,177
21,733
(741)
(24,841)
(45,036)
(9,269)
(2,396)
49,286
121,308
(70,891)
738
(12,368)
(82,521)
65,000
(400,220)
299,245
(3,750)
(996)
(21,568)
—
(7,193)
(69,482)
197
(14,086)
(10,752)
21,361
(3,477)
(33,975)
146,992
$
$
$
39,526
$
113,017
$
— $
(6,460) $
39,526
$
106,557
$
67,430
1,889
65,541
59,568
(10,456)
(129)
9,658
40,452
2,813
33,494
209
33,109
(4,521)
2,957
232,695
(47,307)
6,419
(19,544)
(60,432)
90,000
(181,203)
—
—
(19,199)
(25,921)
(2,498)
(8,268)
(147,089)
(3,114)
(12,772)
(15,813)
25,591
(2,994)
19,066
127,926
146,992
(9,937)
137,055
See notes to consolidated financial statements.
65
THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands, except par values and per share data)
1.
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
Description of Business
The Hain Celestial Group, Inc., a Delaware corporation, was founded in 1993 and is headquartered in Lake Success, New York.
The Company’s mission has continued to evolve since its founding, with health and wellness being the core tenet. The Company
continues to be a leading marketer, manufacturer and seller of organic and natural, “better-for-you” products by anticipating and
exceeding consumer expectations in providing quality, innovation, value and convenience. The Company is committed to growing
sustainably while continuing to implement environmentally sound business practices and manufacturing processes. Hain Celestial
sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce
retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide.
The Company manufactures, markets, distributes and sells organic and natural products under brand names that are sold as “better-
for-you” products, with many recognized brands in the various market categories it serves, including Almond Dream®, Arrowhead
Mills®, Bearitos®, Better Bean®, BluePrint®, Casbah®, Celestial Seasonings®, Clarks™, Coconut Dream®, Cully & Sully®, Danival®,
DeBoles®, Earth’s Best®, Ella’s Kitchen®, Europe’s Best®, Farmhouse Fare™, Frank Cooper’s®, Gale’s®, Garden of Eatin’®, GG
UniqueFiber®, Hain Pure Foods®, Hartley’s®, Health Valley®, Imagine®, Johnson’s Juice Co.™, Joya®, Lima®, Linda McCartney®
(under license), MaraNatha®, Mary Berry (under license), Natumi®, New Covent Garden Soup Co.®, Orchard House®, Rice
Dream®, Robertson’s®, Rudi’s Gluten-Free Bakery™, Rudi’s Organic Bakery®, Sensible Portions®, Spectrum® Organics, Soy
Dream®, Sun-Pat®, Sunripe®, SunSpire®, Terra®, The Greek Gods®, Walnut Acres®, Yorkshire Provender®, Yves Veggie Cuisine®
and William’s™. The Company’s personal care products are marketed under the Alba Botanica®, Avalon Organics®, Earth’s Best®,
JASON®, Live Clean® and Queen Helene® brands.
Historically, the Company divided its business into core platforms, which are defined by common consumer need, route-to-market
or internal advantage and are aligned with the Company’s strategic roadmap to continue its leadership position in the organic and
natural, “better-for-you” products industry. Those core platforms within our United States segment are:
a
• Better-for-You Baby, which includes infant foods, infant and toddler formula, toddler and kids foods and diapers that
nurture and care for babies and toddlers, under the Earth’s Best® and Ella’s Kitchen® brands.
• Better-for-You Pantry, which includes core consumer staples, such as MaraNatha®, Arrowhead Mills®, Imagine®
and Spectrum® brands.
• Better-for-You Snacking, which includes wholesome products for in-between meals, such as Terra®, Sensible
Portions® and Garden of Eatin’® brands.
• Fresh Living, which includes yogurt, plant-based proteins and other refrigerated products, such as The Greek Gods®
yogurt and Dream™ plant-based beverage brands.
• Pure Personal Care, which includes personal care products focused on providing consumers with cleaner and gentler
ingredients, such as JASON®, Live Clean®, Avalon Organics® and Alba Botanica® brands.
Tea, which includes tea products marketed under the Celestial Seasonings® brand.
•
Additionally, beginning in fiscal 2017, the Company launched Hain Ventures (formerly known as “Cultivate Ventures”), a venture
unit with a twofold purpose: (i) to strategically invest in the Company’s smaller brands in high potential categories, by giving
these brands a dedicated, creative focus for refresh and relaunch and; (ii) to incubate and grow small acquisitions until they reach
the scale required to migrate to the Company’s core platforms.
During fiscal 2019, the Company refined its strategy within the United States segment, focusing on simplifying the Company’s
portfolio and reinvigorating profitable sales growth through removing uneconomic investment, realigning resources to coincide
with individual brand role, reducing unproductive stock-keeping units (“SKUs”) and brands, and reassessing current pricing
architecture. As part of this initiative, the Company reviewed its product portfolio and divided it into “Get Bigger” and “Get
Better” brand categories.
The Company’s “Get Bigger” brands represent its strongest brands with higher margins, which compete in categories with strong
growth. In order to capitalize on the potential of these brands, the Company began reallocating resources to optimize assortment
and increase share of distribution. In addition, the Company will increase its marketing and innovation investments.
66
The Company’s “Get Better” brands are the brands in which the Company is primarily focused on simplification and expansion
of profit. Some of these are low margin, non-strategic brands that add complexity with minimal benefit to the Company’s operations.
Accordingly, in fiscal 2019, the Company initiated a SKU rationalization, which included the elimination of approximately 350
low velocity SKUs. The elimination of these SKUs is expected to impact sales growth in the next fiscal year, but is expected to
result in expanded profits and a remaining set of core SKUs that will maintain their shelf space in the store.
As part of the Company’s overall strategy, the Company may seek to dispose of businesses and brands that are less profitable or
are otherwise less of a strategic fit within our core portfolio. Accordingly, the Company divested of all of its operations of the
Hain Pure Protein reportable segment (discussed further below) and WestSoy® tofu, seitan and tempeh businesses in the United
States. Additionally, on August 27, 2019, the Company sold the entities comprising its Tilda operating segment and certain other
assets of the Tilda business. See Note 21, Subsequent Event, for additional information.
f
t
Productivity and Transformation
As part of the Company’s historical strategic review, it focused on a productivity initiative, which it called “Project Terra.” A key
component of this project was the identification of global cost savings, and the removal of complexity from the business. This
review has included and continues to include streamlining the Company’s manufacturing plants, co-packers and supply chain,
eliminating served categories or brands within those categories, and product rationalization initiatives which are aimed at
eliminating slow moving SKUs.
In fiscal 2019, the Company announced a new transformation initiative, of which one aspect is to identify additional areas of
productivity savings to support sustainable profitable performance.
Discontinued Operations
In March 2018, the Company’s Board of Directors approved a plan to sell all of the operations of the Hain Pure Protein Corporation
(“HPPC”) operating segment, which includes the Plainville Farms and FreeBird businesses, and the EK Holdings, Inc. (“Empire
Kosher” or “Empire”) operating segment, which were reported in the aggregate as the Hain Pure Protein reportable segment. These
dispositions were being undertaken to reduce complexity in the Company’s operations and simplify the Company’s brand portfolio,
in addition to allowing additional flexibility to focus on opportunities for growth and innovation in the Company’s more profitable
and faster growing core businesses.
Collectively, these dispositions represent a strategic shift that will have a major impact on the Company’s operations and financial
results and have been accounted for as discontinued operations.
a
On February 15, 2019, the Company completed the sale of substantially all of the assets used primarily for the Plainville Farms
business (a component of HPPC).
On June 28, 2019, the Company completed the sale of the remainder of HPPC and Empire Kosher which includes the FreeBird
and Empire Kosher businesses. See Note 5, Discontinued Operations, for additional information.
Basis of Presentation
The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned
subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies
in which the Company exercises significant influence, but which it does not control, are accounted for under the equity method
of accounting. As such, consolidated net (loss) income includes the Company’s equity in the current earnings or losses of such
companies.
Unless otherwise indicated, references in these consolidated financial statements to 2019, 2018 and 2017 or “fiscal” 2019, 2018
and 2017 or other years refer to our fiscal year ended June 30 of that respective year and references to 2020 or “fiscal” 2020 refer
to our fiscal year ending June 30, 2020.
Reclassifications
Certain prior year amounts have been reclassified to conform with current year presentation.
67
Discontinued Operations
The financial statements separately report discontinued operations and the results of continuing operations (See Note 5). All
footnotes exclude discontinued operations unless otherwise noted.
Use of Estimates
The financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S.
GAAP”). The accounting principles we use require us to make estimates and assumptions that affect the reported amounts of
assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods
presented. These estimates include, among others, revenue recognition, trade promotions and sales incentives, valuation of accounts
and chargeback receivables, accounting for acquisitions, valuation of long-lived assets, goodwill and intangible assets, stock-
based compensation, and valuation allowances for deferred tax assets. We believe in the quality and reasonableness of our critical
accounting estimates; however, materially different amounts may be reported under different conditions or using assumptions
different from those that we have consistently applied.
2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND PRACTICES
Cash and Cash Equivalents
The Company considers cash and cash equivalents to include cash in banks, commercial paper and deposits with financial
institutions that can be liquidated without prior notice or penalty. The Company considers all highly liquid investments with an
original maturity of three months or less to be cash equivalents.
Revenue Recognition
The Company sells its products through specialty and natural food distributors, supermarkets, natural foods stores, mass-market
and e-commerce retailers, food service channels and club, drug and convenience stores in over 80 countries worldwide. The
majority of our revenue contracts represent a single performance obligation related to the fulfillment of customer orders for the
purchase of our products. We recognize revenue as performance obligations are fulfilled when control passes to our customers.
Our customer contracts typically contain standard terms and conditions. In instances where formal written contracts are not in
place we consider the customer purchase orders to be contracts based on the criteria outlined in ASC 606, Revenue from Contracts
with Customers. Payment terms and conditions vary by customer and are based on the billing schedule established in our contracts
or purchase orders with customers, but we generally provide credit terms to customers ranging from 15-60 days; therefore, we
have determined that our contracts do not include a significant financing component.
t
Sales includes shipping and handling charges billed to the customer and are reported net of discounts, trade promotions and sales
incentives, consumer coupon programs and other costs, including estimated allowances for returns, allowances and discounts
associated with aged or potentially unsalable product, and prompt pay discounts. Shipping and handling costs are accounted for
as a fulfillment activity of our promise to transfer products to our customers and are included in cost of sales line item on the
Consolidated Statements of Operations.
t
During the fourth quarter of fiscal 2016, the Company identified the practice of granting additional concessions to certain distributors
in the United States and commenced an internal accounting review in order to (i) determine whether the revenue associated with
those concessions was accounted for in the correct period and (ii) evaluate its internal control over financial reporting. The Audit
Committee of the Company’s Board of Directors separately conducted an independent review of these matters and retained
independent counsel to assist in their review. On November 16, 2016, the Company announced that the independent review of the
Audit Committee was completed and that the review found no evidence of intentional wrongdoing in connection with the preparation
of the Company’s financial statements.
Management’s internal accounting review included consideration of certain side agreements and concessions provided to
distributors in the United States in fiscal 2016, including payment terms beyond the customer’s standard terms, rights of returnrr
of product and post-sale concessions, most of which were associated with sales that occurred at the end of the quarter. It had been
the Company’s policy to record revenue related to these distributors when title of the product transfers to the distributor. The
Company concluded that its historical accounting policy for these distributors is appropriate as the sales price is fixed or determinable
at the time ownership transfers to these distributors, based on the Company’s ability to make a reasonable estimate of future returns
and certain concessions at the time of shipment.
68
Variable Consideration
In addition to fixed contract consideration, many of our contracts include some form of variable consideration. We offer various
trade promotions and sales incentive programs to customers and consumers, such as price discounts, slotting fees, in-store display
incentives, cooperative advertising programs, new product introduction fees and coupons. The expenses associated with these
programs are accounted for as reductions to the transaction price of our products and are therefore deducted from our net sales to
determine reported net sales. Trade promotions and sales incentive accruals are subject to significant management estimates and
assumptions. The critical assumptions used in estimating the accruals for trade promotions and sales incentives include
management’s estimate of expected levels of performance and redemption rates. Management exercises judgment in developing
these assumptions. These assumptions are based upon historical performance of the retailer or distributor customers with similar a
types of promotions adjusted for current trends. The Company regularly reviews and revises, when deemed necessary, estimates
of costs to the Company for these promotions and incentives based on what has been incurred by the customers. The terms of
most of our promotion and incentive arrangements do not exceed a year and therefore do not require highly uncertain long-term
estimates. Settlement of these liabilities typically occurs in subsequent periods primarily through an authorization process for
deductions taken by a customer from amounts otherwise due to the Company. Differences between estimated expense and actual
promotion and incentive costs are normally insignificant and are recognized in earnings in the period such differences are
determined. Actual expenses may differ if the level of redemption rates and performance were to vary from estimates.
Costs to Obtain or Fulfill a Contract
As our contracts are generally shorter than one year, the Company has elected a practical expedient under ASC 606 that allows
the Company to expense as incurred the incremental costs of obtaining a contract if the contract period is for one year or less.
These costs are included in the selling, general and administrative expense line item on the Consolidated Statements of Operations.
Disaggregation of Net Sales
The Company does not disaggregate revenue below the segment revenues level disclosed in Note 19, Segment Information, as all
revenues are recognized at a point in time and the Company’s segment revenues depict how the economic factors affect the nature,
amount, and timing and uncertainty of cash flows.
Valuation of Accounts and Chargebacks Receivable and Concentration of Credit Risk
The Company routinely performs credit evaluations on existing and new customers. The Company applies reserves for delinquent
or uncollectible trade receivables based on a specific identification methodology and also applies an additional reserve based on
the experience the Company has with its trade receivables aging categories. Credit losses have been within the Company’s
expectations in recent years. While one of the Company’s customers represented approximately 12% and 11% of trade receivables
balances as of June 30, 2019 and 2018, respectively, the Company believes that there is no significant or unusual credit exposure
at this time.
Based on cash collection history and other statistical analysis, the Company estimates the amount of unauthorized deductions
customers have taken that we expect will be collected and repaid in the near future and records a chargeback receivable. Differences
between estimated collectible receivables and actual collections are recognized in earnings in the period such differences are
determined.
Sales to one customer and its affiliates approximated 11%, 11% and 12% of net sales during the fiscal years ended June 30,
2019, 2018 and 2017, respectively. Sales to a second customer and its affiliates approximated 10%, 11% and 11% of net sales
during the fiscal years ended June 30, 2019, 2018 and 2017, respectively.
In addition, cash and cash equivalents are maintained with several financial institutions. Deposits held with banks may exceed the
amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand.
Inventory
Inventory is valued at the lower of cost or net realizable value, utilizing the first-in, first-out method. The Company provides
write-downs for finished goods expected to become non-saleable due to age and specifically identifies and provides for slow
moving or obsolete raw ingredients and packaging.
69
Property, Plant and Equipment
Property, plant and equipment is carried at cost and depreciated or amortized on a straight-line basis over the estimated useful
lives or lease term (for leasehold improvements), whichever is shorter. The Company believes the useful lives assigned to our
property, plant and equipment are within ranges generally used in consumer products manufacturing and distribution businesses.
The Company’s manufacturing plants and distribution centers, and their related assets, are reviewed when impairment indicators
are present by analyzing underlying cash flow projections. The Company believes no impairment of the carrying value of such
assets exists other than as disclosed under Note 8, Property, Plant and Equipment, Net, and Note 5, Discontinued Operations.
Ordinary repairs and maintenance costs are expensed as incurred. The Company utilizes the following ranges of asset lives:
Buildings and improvements
Machinery and equipment
Furniture and fixtures
10 - 40 years
3 - 20 years
3 - 15 years
Leasehold improvements are amortized over the shorter of the respective initial lease term or the estimated useful life of the assets,
and generally range from 3 to 15 years.
Goodwill and Other Indefinite-Lived Intangible Assets
Goodwill and other intangible assets with indefinite useful lives are not amortized but rather are tested at least annually for
impairment, or when circumstances indicate that the carrying amount of the asset may not be recoverable. The Company performs
its annual test for impairment at the beginning of the fourth quarter of its fiscal year.
Goodwill is tested for impairment at the reporting unit level. A reporting unit is an operating segment or a component of an operating
segment. Goodwill is tested for impairment by either performing a qualitative evaluation or a two-step quantitative test. The
qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting
unit is less than its carrying amount, including goodwill. We may elect not to perform the qualitative assessment for some or all
reporting units and perform a two-step quantitative impairment test. The impairment test for goodwill requires the Company to
compare the fair value of a reporting unit to its carrying value, including goodwill. The Company uses a blended analysis of a
discounted cash flow model and a market valuation approach to determine the fair values of its reporting units. If the carrying
value of a reporting unit exceeds its fair value, the Company would then compare the carrying value of the goodwill to its implied
fair value in order to determine the amount of the impairment, if any.
Indefinite-lived intangible assets are tested for impairment by comparing the fair value of the asset to the carrying value. Fair
value is determined based on a relief from royalty method that include significant management assumptions such as revenue
growth rates, weighted average cost of capital, and assumed royalty rates. If the fair value is less than the carrying value, the asset
is reduced to fair value.
t
See Note 9, Goodwill and Other Intangible Assets, for information on goodwill and intangibles impairment charges.
Cost of Sales
Included in cost of sales are the cost of products sold, including the costs of raw materials and labor and overhead required to
produce the products, warehousing, distribution, supply chain costs, as well as costs associated with shipping and handling of our
inventory.
Foreign Currency Translation and Remeasurement
The assets and liabilities of international operations are translated at the exchange rates in effect at the balance sheet date. Revenue
and expense accounts are translated at the monthly average exchange rates. Adjustments arising from the translation of the foreign
currency financial statements of the Company’s international operations are reported as a component of accumulated other
comprehensive (loss)/income in the Company’s Consolidated Balance Sheets. Gains and losses arising from intercompany foreign
currency transactions that are of a long-term nature are reported in the same manner as translation adjustments.
Gains and losses arising from intercompany foreign currency transactions that are not of a long-term nature and certain transactions
of the Company’s subsidiaries which are denominated in currencies other than the subsidiaries’ functional currency are recognized
as incurred in other (income)/expense, net in the Consolidated Statements of Operations.
70
Selling, General and Administrative Expenses
Included in selling, general and administrative expenses are advertising costs, promotion costs not paid directly to the Company’snn
customers, salary and related benefit costs of the Company’s employees in the finance, human resources, information technology,
legal, sales and marketing functions, facility related costs of the Company’s administrative functions, research and development nn
costs, and costs paid to consultants and third party providers for related services.
Research and Development Costs
Research and development costs are expensed as incurred and are included in selling, general and administrative expenses in the
accompanying consolidated financial statements. Research and development costs amounted to $11,120 in fiscal 2019, $9,696
in fiscal 2018 and $10,130 in fiscal 2017, consisting primarily of personnel related costs. The Company’s research and development
expenditures do not include the expenditures on such activities undertaken by co-packers and suppliers who develop numerous
products on behalf of the Company and on their own initiative with the expectation that the Company will accept their new product
ideas and market them under the Company’s brands.
Advertising Costs
Advertising costs, which are included in selling, general and administrative expenses, amounted to $28,164 in fiscal 2019, $35,138
in fiscal 2018 and $30,333 in fiscal 2017. Such costs are expensed as incurred.
Proceeds from Insurance Claims
In July of 2019, the Company received $7,027 as partial payment from an insurance claim relating to business disruption costs
associated with a co-packer, $4,460 of which was recognized in fiscal 2019 as it relates to reimbursement of costs already incurred.
The Company will record an additional $2,567 in the first quarter of fiscal 2020.
u
Income Taxes
The Company follows the liability method of accounting for income taxes. Under the liability method, deferred taxes are determined
based on the differences between the financial statement and tax bases of assets and liabilities at enacted rates in effect in the years
in which the differences are expected to reverse. Valuation allowances are provided for deferred tax assets to the extent it is more
likely than not that the deferred tax assets will not be recoverable against future taxable income.
The Company recognizes liabilities for uncertain tax positions based on a two-step process prescribed by the authoritative guidance.
The first step requires the Company to determine if the weight of available evidence indicates that the tax position has met the
threshold for recognition; therefore, the Company must evaluate whether it is more likely than not that the position will be sustained
on audit, including resolution of any related appeals or litigation processes. The second step requires the Company to measure
the tax benefit of the tax position taken, or expected to be taken, in an income tax return as the largest amount that is more than
50% likely of being realized upon ultimate settlement. The Company reevaluates the uncertain tax positions each period based
on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit,
and new audit activity. Depending on the jurisdiction, such a change in recognition or measurement may result in the recognition
of a tax benefit or an additional charge to the tax provision in the period. The Company records interest and penalties in the
provision for income taxes.
Fair Value of Financial Instruments
The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between
willing parties. At June 30, 2019 and 2018, the Company had $44 and $99, respectively, invested in money market funds, which
are classified as cash equivalents. At June 30, 2019 and 2018, the carrying values of financial instruments such as accounts
receivable, accounts payable, accrued expenses and other current liabilities, as well as borrowings under our credit facility and
other borrowings, approximated fair value based upon either the short-term maturities or market interest rates of these instruments.
a
Derivative Instruments
The Company utilizes derivative instruments, principally foreign exchange forward contracts, to manage certain exposures to
changes in foreign exchange rates. The Company’s contracts are hedges for transactions with notional balances and periods
consistent with the related exposures and do not constitute investments independent of these exposures. These contracts, which
are designated and documented as cash flow hedges, qualify for hedge accounting treatment in accordance with ASC 815,
71
Derivatives and Hedging. Exposure to counterparty credit risk is considered low because these agreements have been entered
into with high quality financial institutions.
All derivative instruments are recognized on the Consolidated Balance Sheets at fair value. The effective portion of changes in
the fair value of derivative instruments that qualify for cash flow hedge accounting treatment are recognized in stockholders’
equity as a component of accumulated other comprehensive (loss)/income until the hedged item is recognized in earnings. Changes
in the fair value of fair value hedges, derivatives that do not qualify for hedge accounting treatment, as well as the ineffective
portion of any cash flow hedges, are recognized currently in earnings as a component of other (income)/expense, net in the
accompanying financial statements.
Stock-Based Compensation
The Company has employee and director stock-based compensation plans.
The fair value of stock-based compensation awards is recognized as an expense over the vesting period using the straight-line
method. For awards that contain a market condition, expense is recognized over the defined or derived service period using a
Monte Carlo simulation model. Compensation expense is recognized for these awards on a straight-line basis over the service
period, regardless of the eventual number of shares that are earned based upon the market condition, provided that each grantee
remains an employee at the end of the performance period. Compensation expense on awards that contain a market condition is
reversed if at any time during the service period a grantee is no longer an employee.
For restricted stock awards which include performance criteria, compensation expense is recorded when the achievement of the
performance criteria is probable and is recognized over the performance and vesting service periods. Compensation expense is
recognized for only that portion of stock-based awards that are expected to vest. Therefore, estimated forfeiture rates that are
derived from historical employee termination activity are applied to reduce the amount of compensation expense recognized. If
the actual forfeitures differ from the estimate, additional adjustments to compensation expense may be required in future periods.
The Company receives an income tax deduction in certain tax jurisdictions for restricted stock grants when they vest and for stock
options exercised by employees equal to the excess of the market value of our common stock on the date of exercise over the
option price. Excess tax benefits (tax benefits resulting from tax deductions in excess of compensation cost recognized) are
classified as a cash flow provided by operating activities in the accompanying Consolidated Statements of Cash Flows.
Valuation of Long-Lived Assets
The Company periodically evaluates the carrying value of long-lived assets, other than goodwill and intangible assets with indefinite
lives, held and used in the business when events and circumstances occur indicating that the carrying amount of the asset may not
be recoverable. An impairment test is performed when the estimated undiscounted cash flows associated with the asset or group
of assets is less than their carrying value. Once such impairment test is performed, a loss is recognized based on the amount, if
any, by which the carrying value exceeds the estimated fair value for assets to be held and used.
See Note 8, Property, Plant and Equipment, Net, and Note 5, Discontinued Operations, for information on long-lived asset
impairment charges.
Net (Loss) Income Per Share
Basic net (loss) income per share is computed by dividing net (loss) income by the weighted-average number of common shares
outstanding for the period. Diluted net (loss) income per share reflects the potential dilution that would occur if securities or other
contracts to issue common stock were exercised or converted into common stock.
72
Newly Adopted Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09,
Revenue from Contracts with Customers (Topic 606). This guidance outlines a single, comprehensive model for accounting for
revenue from contracts with customers, providing a single five-step model to be applied to all revenue transactions. The guidance
also requires improved disclosures to assist users of the financial statements to better understand the nature, amount, timing and
uncertainty of revenue that is recognized. Subsequent to the issuance of ASU 2014-09, the FASB issued various additional ASUs
clarifying and amending this new revenue guidance. The Company adopted the new revenue standard on July 1, 2018 using the
modified retrospective transition method. The adoption did not materially impact our results of operations or financial position,
and, as a result, comparisons of revenues and operating profit between periods were not materially affected by the adoption of
ASU 2014-09. The Company recorded a net increase to beginning retained earnings of $163 on July 1, 2018 due to the cumulative
impact of adopting ASU 2014-09.
In January 2016, the FASB issued ASU 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities. ASU 2016-01 requires that most equity investments be measured at fair value, with
subsequent changes in fair value recognized in net income. The pronouncement also impacts financial liabilities under the fair
value option and the presentation and disclosure requirements for financial instruments. The Company adopted ASU 2016-01 in
the three months ended September 30, 2018, which resulted in a net decrease to beginning retained earnings of $348 on July 1,
2018, representing the accumulated unrealized losses (net of tax) reported in accumulated other comprehensive income (loss) for
available-for-sale equity securities on June 30, 2018. We no longer classify equity investments as trading or available-for-sale and
no longer recognize unrealized holding gains and losses on equity securities previously classified as available-for-sale in other
comprehensive income (loss) as a result of adoption of ASU 2016-01.
In May 2017, the FASB issued ASU 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting,
which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to
apply modification accounting in Topic 718. The guidance is effective for annual periods beginning after December 15, 2017. The
Company adopted the provisions of ASU 2016-15 as of July 1, 2018. There was no impact on the Company's consolidated financial
statements resulting from the adoption of this guidance.
Recently Issued Accounting Pronouncements Not Yet Effective
In February 2016, the FASB issued ASU 2016-02, Leases (ASC 842). The amendments in this ASU replace most of the existing
U.S. GAAP lease accounting guidance in order to increase transparency and comparability among organizations by recognizing
lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The ASU is
effective for annual periods beginning after December 15, 2018, and interim periods within those years, with early adoption
permitted. The ASU requires lessees and lessors to recognize and measure leases at the beginning of the earliest period presented
using a modified retrospective approach. In July 2018, the FASB approved amendments to create an optional transition method
that will provide an option to use the effective date of ASC 842 as the date of initial application of the transition. Under the new
transition method, a reporting entity would initially apply the new lease requirements at the effective date and recognize a
cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption, continue to report comparative
periods presented in the financial statements in the period of adoption in accordance with current U.S. GAAP (i.e., ASC 840,
Leases) and provide the required disclosures under ASC 840 for all periods presented under current U.S. GAAP.
As part of the Company’s assessment work to-date, the Company has formed an implementation work team to perform a
comprehensive evaluation of the impact of the adoption of this guidance, which includes assessing the Company’s lease portfolio,
the impact to business processes and internal controls over financial reporting and the related disclosure requirements. Additionally,
the Company has implemented lease accounting software to assist in the quantification of the expected impact on the Company’s
Consolidated Balance Sheet and to facilitate the calculations of the related accounting entries and disclosures, as well as to facilitate
accounting, presentation and disclosure for all leases after the initial date of application under the new standard.
The Company will adopt ASC 842 during the first quarter of fiscal 2020 using the modified retrospective method. The new guidance
will be applied to leases that exist or are entered into on or after July 1, 2019 without adjusting comparative periods in the financial
statements. The Company will utilize the package of practical expedients under ASC 842, which allows entities to (1) not reassess
whether any expired or existing contracts are or contain leases, (2) retain the classification of leases (e.g., operating or finance
lease) existing as of the date of adoption and (3) not reassess initial direct costs for any existing leases. Based on the most recent
assessment of existing leases, the Company expects to record lease liabilities in the range of $85,000 to $95,000, with a
corresponding amount for the right-of-use assets, which will also be adjusted by reclassifications of existing assets and liabilities
primarily related to deferred rent. The Company does not expect the adoption of ASC 842 to have a material impact on the
Company’s results of operations or cash flows.
t
In January 2017, the FASB, issued ASU 2017-04, Simplifying the Test for Goodwill Impairment, which removes the second step
of the goodwill impairment test that requires a hypothetical purchase price allocation. A goodwill impairment will now be the
73
amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. This
guidance is effective for interim and annual reporting periods beginning after December 15, 2019. Early adoption is permitted for
annual or any interim impairment tests with a measurement date on or after January 1, 2017. The adoption of this standard is not
expected to have a material impact to the Company’s consolidated financial statements.
ff
3.
CHIEF EXECUTIVE OFFICER SUCCESSION PLAN
On June 24, 2018, the Company entered into a CEO succession plan, whereby the Company’s former CEO, Irwin D. Simon,
agreed to terminate his employment with the Company upon the hiring of a new CEO (the “Succession Agreement”).
On October 26, 2018, the Company’s Board of Directors appointed Mark L. Schiller as President and CEO, succeeding Mr. Simon.
In connection with the appointment, on October 26, 2018, the Company and Mr. Schiller entered into an employment agreement,
which was approved by the Board, with Mr. Schiller’s employment commencing on November 5, 2018. Accordingly, Mr. Simon’s
employment with the Company terminated on November 4, 2018.
Cash Separation Payments
The Succession Agreement provided Mr. Simon with a cash separation payment of $34,295 payable in a single lump sum and
cash benefits continuation costs of $208. These costs were recognized from June 24, 2018 through November 4, 2018. Expense
recognized in connection with these payments was $33,051 and $1,452 in the twelve months ended June 30, 2019 and 2018. The
cash separation payment was paid on May 6, 2019.
Consulting Agreement
On October 26, 2018, the Company and Mr. Simon entered into a Consulting Agreement (the “Consulting Agreement”) in order
to, among other things, assist Mr. Schiller with his transition as the Company’s incoming CEO. The term of the Consulting
Agreement commenced on November 5, 2018 and continued until February 5, 2019. Mr. Simon was entitled to receive an aggregate
consulting fee of $975 as compensation for his services during the consulting term, which was fully recognized in the Consolidated
Statement of Operations as a component of “Chief Executive Officer Succession Plan expense, net” in the twelve months ended
June 30, 2019.
aa
Long Term Incentive Award
Mr. Simon was granted 164 total shareholder return (“TSR”) performance based awards on September 26, 2017. The performance
period was set to end on June 30, 2019. Under the Succession Agreement, he was entitled to compensation if the TSR components
were met. The Succession Agreement modified Mr. Simon’s award such that his award went from improbable of being earned to
probable since the Succession Agreement allowed him to be eligible for the award while he is no longer an employee. Accordingly,
the Company determined that a Type III modification pursuant to ASC 718 occurred. Therefore, in accordance with ASC 718,
the Company determined the fair value of the replacement award as of the modification date, utilizing the Monte Carlo valuation
model. As a result, the fair value of the TSR performance based awards granted on September 26, 2017 was reduced from $31.60
per share to $3.19 per share based on the lower likelihood of attainment, resulting in revised expense of $524, which was amortized
on a straight-line basis from June 24, 2018 through November 4, 2018. In the fiscal year ended June 30, 2018, the Company
reversed the previously recognized stock-based compensation expense of $2,244 and recognized $22 of stock-based compensation
expense associated with the modified grant, resulting in a net reduction to stock-based compensation expense of $2,222 in the
twelve months ended June 30, 2018 associated with the modification of this grant recognized in the Consolidated Statement of
Operations. Additionally, the Succession Agreement allowed for acceleration of vesting of all service-based awards outstanding
at the Succession Date. In connection with these accelerations, the Company recognized $19 in the twelve months ended June 30,
2018. In connection with the aforementioned items, the Company recorded a net benefit of $2,203 as a component of “Chief
Executive Officer Succession Plan expense, net” in the twelve months ended June 30, 2018.
74
4.
EARNINGS (LOSS) PER SHARE
The following table sets forth the computation of basic and diluted net (loss) income per share:
Numerator:
Net (loss) income from continuing operations
Net (loss) income from discontinued operations, net of tax
Net (loss) income
Denominator:
Basic weighted average shares outstanding
Effect of dilutive stock options, unvested restricted stock and
unvested restricted share units
Diluted weighted average shares outstanding
Basic net (loss) income per common share:
Continuing operations
Discontinued operations
Basic net (loss) income per common share
Diluted net (loss) income per common share:
Continuing operations
Discontinued operations
Diluted net (loss) income per common share
Fiscal Year Ended June 30,
2019
2018
2017
(49,945) $
(133,369) $
(183,314) $
$
82,428
(72,734) $
$
9,694
65,541
1,889
67,430
104,076
103,848
103,611
—
104,076
629
104,477
637
104,248
(0.48) $
(1.28)
(1.76) $
(0.48) $
(1.28)
(1.76) $
0.79
(0.70)
0.09
0.79
(0.70)
0.09
$
$
$
$
0.63
0.02
0.65
0.63
0.02
0.65
$
$
$
$
$
$
$
Basic net (loss) income per share excludes the dilutive effects of stock options, unvested restricted stock and unvested restricted
share units.
Due to our net loss in the twelve months ended June 30, 2019, all common stock equivalents such as stock options and unvested
restricted stock awards have been excluded from the computation of diluted net loss per share because the effect would have been
anti-dilutive to the computations. Diluted earnings per share for the fiscal years ended June 30, 2018 and 2017 includes the dilutive
effects of common stock equivalents such as stock options and unvested restricted stock awards.
There were 3,625, 560 and 271 stock-based awards excluded from our diluted net (loss) income per share calculations for the
fiscal years ended June 30, 2019, 2018 and 2017, respectively, as such awards were contingently issuable based on market or
performance conditions, and such conditions had not been achieved during the respective periods. Additionally, 659, 4 and 12
restricted stock awards were excluded from our diluted net (loss) income per share calculation for the fiscal years ended June 30,
2019, 2018 and 2017, respectively, as such awards were anti-dilutive.
There were 110 potential shares of common stock issuable upon exercise of stock options excluded from our diluted net loss per
share calculation for the fiscal year ended June 30, 2019, as they were anti-dilutive due to the net loss recorded in the period. No
such awards were excluded for the fiscal years ended June 30, 2018 and 2017.
Share Repurchase Program
On June 21, 2017, the Company's Board of Directors authorized the repurchase of up to $250,000 of the Company’s issued and
outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans,
in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Companynn
repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations.
The Company did not repurchase any shares under this program in fiscal 2019, 2018 or 2017, and accordingly, as of the end of
fiscal 2019, we had $250,000 of remaining capacity under our share repurchase program.
75
5. DISCONTINUED OPERATIONS
In March 2018, the Company’s Board of Directors approved a plan to sell all of the operations of the Hain Pure Protein Corporation
(“HPPC”) operating segment, which includes the Plainville Farms and FreeBird businesses, and the EK Holdings, Inc. (“Empire
Kosher” or “Empire”) operating segment, which were reported in the aggregate as the Hain Pure Protein reportable segment.
Collectively, these dispositions represented a strategic shift that will have a major impact on the Company’s operations and financial
results and have been accounted for as discontinued operations.
The Company is presenting the operating results and cash flows of Hain Pure Protein within discontinued operations in the current
and prior periods. The assets and liabilities of Hain Pure Protein are presented as assets and liabilities of discontinued operations
in the Consolidated Balance Sheets for all periods presented.
The Company recorded reserves of $109,252 and $78,464 in fiscal years ended June 30, 2019 and 2018, respectively, to adjust
the carrying value of Hain Pure Protein and Empire Kosher to its fair value, less its cost to sell, which is reflected in net (loss)
income from discontinued operations, net of taxes in each respective period. The reserves were recorded due to negative market
conditions in the sector, resulting in the Company lowering the projected long-term growth rate and profitability levels of HPPC
and to adjust the carrying value of Hain Pure Protein to its estimated selling price.
Sale of Plainville Farms Business
On February 15, 2019, the Company completed the sale of substantially all of the assets used primarily for the Plainville Farms
business (a component of HPPC), which included $25,000 in cash to the purchaser, for a nominal purchase price. In addition, the
purchaser assumed the current liabilities of the Plainville Farms business as of the closing date. As a condition to consummating
the sale, the Company entered into a Contingent Funding and Earnout Agreement, which provides for the issuance by the Company
of an irrevocable stand-by letter of credit of $10,000 which expires nineteen months after issuance. The Company is entitled to
receive an earnout not to exceed, in the aggregate, 120% of the maximum amount that the purchaser draws on the letter of credit
at any point from the date of issuance through the expiration of the letter of credit. Earnout payments are based on a specified
percentage of annual free cash flow achieved for all fiscal years ending on or prior to June 30, 2026. If a change in control of the
purchaser occurs prior to June 30, 2026, the purchaser will pay the Company 120% of the difference between the amount drawn
on the letter of credit less the sum of all earnout payments made prior to such time up to the net proceeds received by the purchaser.
At June 30, 2019, the Company had not recorded an asset associated with the earnout. As a result of the disposition, the Companynn
recognized a pre-tax loss on sale of $40,223, or $29,685 net of tax, in the twelve months ended June 30, 2019 to write down the
assets and liabilities to the final sales price less costs to sell, inclusive of the $10,000 stand-by letter of credit.
Sale of HPPC and Empire Kosher
On June 28, 2019, the Company completed the sale of the remainder of HPPC and EK Holdings, which includes the FreeBird and
Empire Kosher businesses. The purchase price, net of customary adjustments based on the closing balance sheet of HPPC, was
$77,714. The Company used the proceeds from the sale to pay down outstanding borrowings under its term loan. As a result of
the disposition, the Company recognized a pre-tax loss of $636 in the twelve months ended June 30, 2019 to write down the assets
and liabilities to the final sales price less costs to sell.
The following table presents the major classes of Hain Pure Protein’s line items constituting the “Net (loss) income from
discontinued operations, net of tax” in our Consolidated Statements of Operations:
76
Net sales
Cost of sales
Gross (loss) profit
s (loss) pro
Asset impairments
Selling, general and administrative expense
Other expense
Loss on sale of discontinued operations before income taxes
Net (loss) income from discontinued operations before income
taxes
Benefit for income taxes
Net (loss) income from discontinued operations, net of tax
$
Fiscal Year Ended June 30,
2019
2018
2017
$
408,109
$
509,475
$
409,433
(1,324)
109,252
16,384
9,088
40,859
486,023
23,452
78,464
18,743
4,699
—
(176,907)
(43,538)
(133,369) $
(78,454)
(5,720)
(72,734) $
509,606
487,631
21,975
—
19,180
1,530
—
1,265
(624)
1,889
Assets and liabilities of discontinued operations presented in the Consolidated Balance Sheets as of June 30, 2018 are included
in the following table:
Cash and cash equivalents
Accounts receivable, less allowance for doubtful accounts
ASSETS
Inventories
Prepaid expenses and other current assets
Property, plant and equipment, net
Goodwill
Trademarks and other intangible assets, net
Other assets
Impairments of long-lived assets held for sale
Current assets of discontinued operations
LIABILITIES
Accounts payable
Accrued expenses and other current liabilities
Deferred tax liabilities
Other noncurrent liabilities
Current liabilities of discontinued operations
June 30,
2018
6,460
21,616
105,359
5,604
83,776
41,089
51,029
4,382
(78,464)
240,851
31,762
6,880
11,111
93
49,846
$
$
$
$
77
6.
ACQUISITIONS
The Company accounts for acquisitions in accordance with ASC 805, Business Combinations. The results of operations of the
acquisitions have been included in the consolidated results from their respective dates of acquisition. The purchase price of each
acquisition is allocated to the tangible assets, liabilities and identifiable intangible assets acquired based on their estimated fair
values. Acquisitions may include contingent consideration, the fair value of which is estimated on the acquisition date as the
present value of the expected contingent payments, determined using weighted probabilities of possible payments. The fair values
assigned to identifiable intangible assets acquired were determined primarily by using an income approach which was based on
assumptions and estimates made by management. Significant assumptions utilized in the income approach were based on Company
specific information and projections which are not observable in the market and are thus considered Level 3 measurements as
defined by authoritative guidance. The excess of the purchase price over the fair value of the identified assets and liabilities has
been recorded as goodwill.
The costs related to all acquisitions have been expensed as incurred and are included in “Project Terra costs and other” in the
Consolidated Statements of Operations. Acquisition-related costs of $409 and $2,035 were expensed in the fiscal years ended
June 30, 2018 and 2017, respectively. Acquisition-related costs for the fiscal year ended June 30, 2019 were de minimis. The
expenses incurred primarily related to professional fees and other transaction related costs associated with our recent acquisitions.
Fiscal 2019
There were no acquisitions completed in the fiscal year ended June 30, 2019.
Fiscal 2018
On December 1, 2017, the Company acquired Clarks UK Limited (“Clarks”), a leading maple syrup and natural sweetener brand
in the United Kingdom. Clarks produces natural sweeteners under the ClarksTM brand, including maple syrup, honey and carob,
date and agave syrups, which are sold in leading retailers and used by food service and industrial customers in the United Kingdom.
Consideration for the transaction, inclusive of a subsequent working capital adjustment, consisted of cash, net of cash acquired,
totaling £9,179 (approximately $12,368 at the transaction date exchange rate). Additionally, contingent consideration of up to a
maximum of £1,500 is payable based on the achievement of specified operating results over the 18-month period following
completion of the acquisition. Clarks is included in our United Kingdom operating segment. Net sales and income before income
taxes attributable to the Clarks acquisition included in our consolidated results for the fiscal year ended June 30, 2018 represented
less than 1% of our consolidated results.
Fiscal 2017
On June 19, 2017, the Company acquired Sonmundo, Inc. d/b/a The Better Bean Company (“Better Bean”), which offers prepared
beans and bean-based dips sold in refrigerated tubs under the Better BeanTM brand. Consideration for the transaction consisted
of cash, net of cash acquired, totaling $3,434. Additionally, contingent consideration of up to a maximum of $4,000 is payable
based on the achievement of specified operating results over the three-year period following the closing date. Better Bean is
included in our Hain Ventures operating segment, which is part of the Rest of World segment. Net sales and income before income
taxes attributable to the Better Bean acquisition and included in our consolidated results for the fiscal year ended June 30, 2017
were less than 1% of consolidated results.
On April 28, 2017, the Company acquired The Yorkshire Provender Limited (“Yorkshire Provender”), a producer of premium
branded soups based in North Yorkshire in the United Kingdom. Yorkshire Provender supplies leading retailers, on-the-go food
outlets and food service providers in the United Kingdom. Consideration for the transaction consisted of cash, net of cash acquired,
totaling £12,465 (approximately $16,110 at the transaction date exchange rate). Additionally, contingent consideration of up to
a maximum of £1,500 is payable based on the achievement of specified operating results at the end of the three-year period
following the closing date. Yorkshire Provender is included in our United Kingdom operating and reportable segment. Net sales
and income before income taxes attributable to Yorkshire Provender and included in our consolidated results for the fiscal year
ended June 30, 2017 were less than 1% of consolidated results.
qq
78
7.
INVENTORIES
Inventories consisted of the following:
Finished goods
Raw materials, work-in-progress and packaging
June 30,
2019
220,600
144,287
364,887
$
$
June 30,
2018
231,926
159,599
391,525
$
$
At each period end, inventory is reviewed to ensure that it is recorded at the lower of cost or net realizable value. In the twelve
months ended June 30, 2019, the Company recorded inventory write-downs of $12,381 in connection with the discontinuance of
slow moving SKUs as part of a product rationalization initiative, $10,346 of which was recorded in the three months ended June
30, 2019.
In the twelve months ended June 30, 2018, the Company recorded an inventory write-down of $4,913 in connection with the
discontinuance of slow moving SKUs as part of a product rationalization initiative.
8.
PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment, net consisted of the following:
Land
Buildings and improvements
Machinery and equipment
Computer hardware and software
Furniture and fixtures
Leasehold improvements
Construction in progress
Less: Accumulated depreciation
June 30,
2019
June 30,
2018
$
26,892
$
89,534
306,670
52,655
18,501
32,264
35,786
562,302
233,940
$
328,362
$
28,378
83,289
323,348
54,092
17,894
31,519
17,280
555,800
245,628
310,172
Depreciation expense for the fiscal years ended June 30, 2019, 2018, and 2017 was $32,872, $33,973 and $33,558, respectively.
During fiscal 2019, the Company determined that it was more likely than not that certain fixed assets of two of its manufacturing
facilities would be sold or otherwise disposed of before the end of their estimated useful lives due to the Company’s decision to
consolidate manufacturing of certain fruit-based and soup products in the United Kingdom. As such, the Company recorded a
$6,166 non-cash impairment charge related to the closures of these facilities.
During fiscal 2019, the Company recorded non-cash impairment charges of $9,653 to write down the value of certain machinery
and equipment no longer in use in the United States and United Kingdom, some of which was used to manufacture certain slow
moving SKUs that were discontinued.
In fiscal 2018, the Company determined that it was more likely than not that certain fixed assets at three of its manufacturing
facilities would be sold or otherwise disposed of before the end of their estimated useful lives due to the Company’s decision to
utilize third-party manufacturers for two facilities in the United States and to consolidate manufacturing of certain soup products
in the United Kingdom. As such, the Company recorded a $6,344 non-cash impairment charge primarily related to the closures
of these facilities and included $3,767 as assets held for sale within “Prepaid expenses and other current assets” in its June 30,
2018 Consolidated Balance Sheet.
dd
Additionally, the Company recorded a $2,057 non-cash impairment charge to write down the value of certain machinery and
equipment used to manufacture certain slow moving SKUs in the United States that were discontinued and included $686 as assets
held for sale within “Prepaid expenses and other current assets” in its June 30, 2018 Consolidated Balance Sheet.
79
In fiscal 2017, the Company determined that it was more likely than not that certain fixed assets at one of its manufacturing
facilities in the United Kingdom would be sold or otherwise disposed of before the end of their estimated useful lives due to the
Company’s decision to exit its own-label chilled desserts business over the next twelve months. As such, the Company recorded
a $23,712 non-cash impairment charge related to the long-lived assets associated with the own-label chilled desserts business to
their estimated fair values, which was equal to its salvage value. Additionally, the Company recorded a $2,661 non-cash impairment
charge related to fixed assets in the United States.
tt
9.
GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
The following table shows the changes in the carrying amount of goodwill by business segment:
Balance as of June 30, 2017(1)
Acquisition activity
Reallocation of goodwill between reporting units(2)
Impairment charge
Translation and other adjustments, net
Balance as of June 30, 2018(3)
Translation and other adjustments, net
Balance as of June 30, 2019(3)
United States
United Kingdom
Rest of World
Total
$
588,333
$
329,135
$
101,424
$
1,018,892
—
(35,519)
—
—
552,814
—
$
552,814
$
7,062
35,519
—
5,447
377,163
(14,344)
362,819
$
—
—
(7,700)
435
94,159
(813)
93,346
7,062
—
(7,700)
5,882
1,024,136
(15,157)
1,008,979
$
(1) The total carrying value of goodwill is reflected net of $126,577 of accumulated impairment charges, of which $97,358 related
to the Company’s United Kingdom operating segment and $29,219 related to the Company’s Europe operating segment.
(2) Effective July 1, 2017, due to changes to the Company’s internal management and reporting structure, the United Kingdom
operations of the Ella’s Kitchen® brand, which was previously included within the United States reportable segment, was moved
to the United Kingdom reportable segment. Goodwill totaling $35,519 was reallocated to the United Kingdom reportable segment
in connection with this change. See Note 1, Business, and Note 19, Segment Information, for additional information on the
Company’s operating and reportable segments.
(3) The total carrying value of goodwill is reflected net of $134,277 of accumulated impairment charges, of which $97,358 related
to the Company’s United Kingdom operating segment, $29,219 related to the Company’s Europe operating segment and $7,700
related to the Company’s Hain Ventures operating segment.
Additions during the fiscal year ended June 30, 2018 were due to the acquisition of Clarks on December 1, 2017.
The Company completed its annual goodwill impairment analysis in the fourth quarter of fiscal 2019, in conjunction with its
budgeting and forecasting process for fiscal year 2020, and concluded that no indicators of impairment existed at any of its reporting
units.
Other Intangible Assets
The following table sets forth balance sheet information for intangible assets, excluding goodwill, subject to amortization and
intangible assets not subject to amortization:
Non-amortized intangible assets:
Trademarks and trade names(1)
Amortized intangible assets:
Other intangibles
Less: accumulated amortization
Net carrying amount
80
June 30,
2019
June 30,
2018
$
359,727
$
385,609
232,450
(126,966)
465,211
$
239,323
(114,545)
510,387
$
(1) The gross carrying value of trademarks and trade names is reflected net of $83,734 and $65,834 of accumulated impairment
charges as of June 30, 2019 and 2018, respectively.
Indefinite-lived intangible assets, which are not amortized, consist primarily of acquired trade names and trademarks. Indefinite-
lived intangible assets are evaluated on an annual basis in conjunction with the Company’s evaluation of goodwill, or on an interim
basis if and when events or circumstances change that would more likely than not reduce the fair value of any of its indefinite-
life intangible assets below their carrying value. In assessing fair value, the Company utilizes a “relief from royalty” methodology.
This approach involves two steps: (i) estimating the royalty rates for each trademark and (ii) applying these royalty rates to a
projected net sales stream and discounting the resulting cash flows to determine fair value. If the carrying value of the indefinite-
lived intangible assets exceeds the fair value of the asset, the carrying value is written down to fair value in the period identified.
In the second quarter of fiscal 2019, the Company determined that an indicator of impairment existed in certain of the Company’s
indefinite-lived tradenames. The result of this interim assessment indicated that the fair value of certain of the Company’s
tradenames was below their carrying value, and therefore an impairment charge of $17,900 was recognized ($11,300 in the United
States segment, $3,813 in the Rest of World segment and $2,787 in the United Kingdom segment) during the fiscal year ended
June 30, 2019. The result of the annual assessment for the year ended June 30, 2019 indicated that the fair value of the Company’s
trade names exceeded their carrying values and no indicators of impairment were present.
nn
ff
During the fiscal year ended June 30, 2018, an impairment charge of $5,632 ($5,100 in the Rest of World segment and $532 in
the United Kingdom segment) related to certain of the Company’s trade names was recognized.
Amortizable intangible assets, which are deemed to have a finite life, primarily consist of customer relationships and are being
amortized over their estimated useful lives of 3 to 25 years. Amortization expense included in continuing operations was as
follows:
Amortization of intangible assets
Expected amortization expense over the next five fiscal years is as follows:
Fiscal Year Ended June 30,
2019
2018
2017
$
15,294
$
18,202
$
16,988
Estimated amortization expense
$
13,916
$
13,473
$
12,770
$
12,197
$
9,646
2020
2021
2022
2023
2024
Fiscal Year Ending June 30,
The weighted average remaining amortization period of amortized intangible assets is 9.4 years.
10.
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current liabilities consisted of the following:
Payroll, employee benefits and other administrative accruals
Facility, freight and warehousing accruals
Selling and marketing related accruals
Other accruals
June 30,
2019
June 30,
2018
$
80,338
$
21,402
7,399
9,801
75,918
20,970
15,546
3,567
$
118,940
$
116,001
81
11.
DEBT AND BORROWINGS
Debt and borrowings consisted of the following:
Revolving credit facility
Term loan
Less: Unamortized issuance costs
Tilda short-term borrowing arrangements
Other borrowings
Short-term borrowings and current portion of long-term debt
Long-term debt, less current portion
Credit Agreement
June 30,
2019
420,575
$
June 30,
2018
401,852
$
206,250
(1,022)
8,687
4,966
639,456
25,919
296,250
(692)
9,338
7,358
714,106
26,605
$
613,537
$
687,501
On February 6, 2018, the Company entered into the Third Amended and Restated Credit Agreement (the “Credit Agreement”).
The Credit Agreement provides for a $1,000,000 revolving credit facility through February 6, 2023 and provides for
a $300,000 term loan. Under the Credit Agreement, the revolving credit facility may be increased by an additional
uncommitted $400,000, provided certain conditions are met.
Borrowings under the Credit Agreement may be used to provide working capital, finance capital expenditures and permitted
acquisitions, refinance certain existing indebtedness and for other lawful corporate purposes. The Credit Agreement provides for
multicurrency borrowings in Euros, Pounds Sterling and Canadian Dollars as well as other currencies which may be designated.
In addition, certain wholly-owned foreign subsidiaries of the Company may be designated as co-borrowers. The Credit Agreement
contains restrictive covenants, which are usual and customary for facilities of its type, and include, with specified exceptions,
limitations on the Company’s ability to engage in certain business activities, incur debt, have liens, make capital expenditures,
pay dividends or make other distributions, enter into affiliate transactions, consolidate, merge or acquire or dispose of assets, and
make certain investments, acquisitions and loans. The Credit Agreement also requires the Company to satisfy certain financial
covenants. On the date the Credit Agreement was consummated, these covenants included maintaining a consolidated interest
coverage ratio (as defined in the Credit Agreement) of no less than 4.0 to 1.0 and a consolidated leverage ratio (as defined in the
Credit Agreement) of no more than 3.5 to 1.0. The consolidated leverage ratio is subject to a step-up to 4.0 to 1.0 for the four full
fiscal quarters following an acquisition. Obligations under the Credit Agreement are guaranteed by certain existing and future
domestic subsidiaries of the Company. As of June 30, 2019, there were $420,575 and $206,250 of borrowings outstanding under
the revolving credit facility and term loan, respectively, and $9,698 letters of credit outstanding under the Amended Credit
Agreement.
uu
On November 7, 2018, the Company amended the Credit Agreement to modify the calculation of the consolidated leverage ratio
related to costs associated with CEO succession as well as the Project Terra cost reduction programs.
On February 6, 2019, the Company entered into an amendment to the Credit Agreement, whereby its allowable consolidated
leverage ratio increased to no more than 4.0 to 1.0 as of December 31, 2018 and no more than 3.75 to 1.0 as of March 31, 2019
and June 30, 2019. Under the terms of the February 6, 2019 amendment, the consolidated leverage ratio would return to 3.5 to
1.0 beginning in the period ending September 30, 2019.
On May 8, 2019, the Company entered into the Third Amendment to the Third Amended and Restated Credit Agreement (the
“Amended Credit Agreement”), whereby, among other things, its allowable consolidated leverage ratio increased to no more than
5.0 to 1.0 from March 31, 2019 to December 31, 2019, no more than 4.75 to 1.0 at March 31, 2020, no more than 4.25 to 1.0 at
June 30, 2020 and no more than 4.0 to 1.0 on September 30, 2020 and thereafter. The allowable consolidated leverage ratio for
each period was decreased by 0.25 upon sale of the Company’s remaining Hain Pure Protein business. Additionally, the Company’s
required consolidated interest coverage ratio (as defined in the Credit Agreement) was reduced to no less than 3.0 to 1 through
March 31, 2020, no less than 3.75 to 1 through March 31, 2021 and no less than 4.0 to 1 thereafter. As part of the Amended Credit
Agreement, HPPC was released from its obligations as a borrower and a guarantor under the Credit Agreement.
The Amended Credit Agreement also required that the Company and the subsidiary guarantors enter into a Security and Pledge
Agreement pursuant to which all of the obligations under the Amended Credit Agreement are secured by liens on assets of the
82
Company and its material domestic subsidiaries, including stock of each of their direct subsidiaries and intellectual property,
subject to agreed upon exceptions.
As of June 30, 2019, $569,727 was available under the Amended Credit Agreement, and the Company was in compliance with
all associated covenants, as amended by the Amended Credit Agreement.
The Amended Credit Agreement provides that loans will bear interest at rates based on (a) the Eurocurrency Rate, as defined in
the Credit Agreement, plus a rate ranging from 0.875% to 2.50% per annum; or (b) the Base Rate, as defined in the Credit
Agreement, plus a rate ranging from 0.00% to 1.50% per annum, the relevant rate being the Applicable Rate. The Applicable Rate
will be determined in accordance with a leverage-based pricing grid, as set forth in the Amended Credit Agreement. Swing line
loans and Global Swing Line loans denominated in U.S. dollars will bear interest at the Base Rate plus the Applicable Rate, and
Global Swing Line loans denominated in foreign currencies shall bear interest based on the overnight Eurocurrency Rate for loans
denominated in such currency plus the Applicable Rate. The weighted average interest rate on outstanding borrowings under the
Amended Credit Agreement at June 30, 2019 was 4.20%. Additionally, the Amended Credit Agreement contains a Commitment
Fee, as defined in the Amended Credit Agreement, on the amount unused under the Amended Credit Agreement ranging
from 0.20% to 0.45% per annum, and such Commitment Fee is determined in accordance with a leverage-based pricing grid.
The term loan has required installment payments due on the last day of each fiscal quarter commencing June 30, 2018 in an amount
equal to $3,750 and can be prepaid in whole or in part without premium or penalty.
On June 28, 2019, the Company completed the sale of the Company’s remaining Hain Pure Protein business and utilized the
proceeds from the sale, net of transaction related costs, to prepay a portion of the term loan. See Note 5, Discontinued Operations,
for information on the sale of the Hain Pure Protein business. In connection with the prepayment of debt, the Company wrote-
off unamortized issuance costs of $372.
Tilda Short-Term Borrowing Arrangements
Tilda, formerly a component of the Company’s United Kingdom reportable segment, maintained short-term borrowing
arrangements primarily used to fund the purchase of rice from India and other countries. The maximum borrowings permitted
under all such arrangements were £52,000. Outstanding borrowings were collateralized by the current assets of Tilda, typically
had six-month terms and bore interest at variable rates typically based on LIBOR plus a margin (weighted average interest rate
of approximately 4.38% at June 30, 2019). As of June 30, 2019 and 2018, there were $8,687 and $9,338 of borrowings under these
arrangements, respectively. See Note 21, Subsequent Event, for information on the sale of the Tilda business.
Maturities of all debt instruments at June 30, 2019, are as follows:
Due in Fiscal Year
Amount
2020
2021
2022
2023
2024
Thereafter
$
25,919
16,400
15,204
581,775
47
111
$
639,456
Interest paid during the fiscal years ended June 30, 2019, 2018 and 2017 amounted to $33,751, $24,168 and $18,819, respectively.
83
12.
INCOME TAXES
The components of (loss) income from continuing operations before income taxes and equity in net loss (income) of equity-method
investees were as follows:
Domestic
Foreign
Total
The (benefit) provision for income taxes consisted of the following:
Current:
Federal
State and local
Foreign
Deferred:
Federal
State and local
Foreign
Total
Fiscal Year Ended June 30,
2019
(134,096)
82,109
(51,987)
$
$
$
$
2018
2017
(13,936)
95,138
81,202
$
$
47,781
40,097
87,878
Fiscal Year Ended June 30,
2019
2018
2017
$
3,639
$
760
18,694
23,093
(24,045)
1,188
(2,933)
(25,790)
(2,697)
$
$
(1,309)
1,383
20,542
20,616
(22,612)
1,973
(864)
(21,503)
(887)
$
$
18,331
(293)
14,884
32,922
(3,198)
960
(8,218)
(10,456)
22,466
For the fiscal year ended June 30, 2019, the Company paid cash for income taxes, net of refunds, of $22,535. Cash paid for income
taxes, net of (refunds), during the fiscal years ended June 30, 2018 and 2017 amounted to $24,284 and $(2,900), respectively.
The reconciliation of the U.S. federal statutory rate to our effective rate on income before provision (benefit) for income taxes
was as follows:
84
2019
%
2018
2018
%
2017
2017
%
Fiscal Year Ended June 30,
$
(10,917)
21.0 % $
22,818
28.1 % $
30,757
35.0 %
Expected United States federal income tax at
statutory rate
State income taxes, net of federal (benefit)
provision
Domestic manufacturing deduction
Foreign income at different rates
Impairment of goodwill and intangibles
Change in valuation allowance
Unrealized foreign exchange losses
Change in reserves for uncertain tax positions
Tax Act’s transition tax (a)
Tax Act’s impact of deferred taxes (b)
(9,793)
18.8 %
—
205
—
— %
(0.4)%
— %
9,810
(18.9)%
—
841
— %
(1.6)%
6,834
(13.1)%
—
— %
Global Intangible Low Taxed Income
3,872
(7.4)%
Reduction of deferred tax liabilities resulting
from change in United Kingdom tax rate
Other
(Benefit) provision for income taxes
$
—
(3,549)
(2,697)
— %
6.8 %
5.2 % $
2,774
—
(7,174)
1,816
119
—
(3,859)
7,054
(25,006)
—
—
571
(887)
3.4 %
— %
(8.8)%
2.2 %
0.1 %
— %
(4.8)%
8.7 %
(30.8)%
— %
— %
0.8 %
2,757
(846)
(6,539)
—
(60)
807
(4,417)
—
—
—
(1,841)
1,848
(1.1)% $
22,466
3.1 %
(1.0)%
(7.4)%
— %
(0.1)%
0.9 %
(5.0)%
— %
— %
— %
(2.1)%
2.2 %
25.6 %
(a) For the year ended June 30, 2018, the Company accrued a provisional estimate of $7,054 of tax expense for the Tax Act’s one-
time transition tax on the foreign subsidiaries’ accumulated, unremitted earnings in accordance with U.S. Securities and Exchange
Commission’s Staff Accounting Bulletin (“SAB 118”). Additionally, during fiscal year June 30, 2019, the Company recorded
$6,834 of tax expense upon finalizing its analysis of the impact from the Tax Act.
(b) For the year ended June 30, 2018, the Company accrued $25,006 in provisional tax benefit related to the net change in deferred
tax liabilities stemming from the Tax Cuts and Jobs Act’s (the “Tax Act”) reduction of the U.S. federal tax rate from 35% to 21%
and disallowance of certain incentive based compensation tax deductibility under Internal Revenue Code 162(m). There was an
immaterial tax benefit recorded for the period ended June 30, 2019 related to return to provision adjustments.
rr
With the effective date of January 1, 2018, the Tax Act also introduced a provision to tax global intangible low-taxed income
(“GILTI”) of foreign subsidiaries and a measure to tax certain intercompany payments under the base erosion anti-abuse tax
“BEAT” regime. For the fiscal year ended June 30, 2019, the Company did not generate intercompany transactions that met the
BEAT threshold but did generate GILTI tax. The Company elected to account for GILTI tax as a current period cost and recorded
an expense of $3,872 during the fiscal year ended June 30, 2019.
85
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for
financial reporting purposes and the amounts for income tax purposes. Deferred tax assets and liabilities consisted of the following:
June 30,
2019
June 30,
2018
Noncurrent deferred tax assets/(liabilities):
Basis difference on inventory
Reserves not currently deductible
Basis difference on intangible assets
Basis difference on property and equipment
Other comprehensive income
Net operating loss and tax credit carryforwards
Stock-based compensation
Other
Valuation allowances
$
9,128
$
23,518
(92,923)
(6,060)
502
73,976
827
3,985
(34,912)
(21,959) $
9,139
11,060
(97,365)
(8,444)
(133)
18,276
1,348
41
(20,831)
(86,909)
Noncurrent deferred tax liabilities, net(1)
$
(1) Includes $29,951 of non-current deferred tax assets included within Other Assets on the June 30, 2019 consolidated balance
sheet.
At June 30, 2019 and 2018, the Company had U.S. federal net operating loss (“NOL”) carryforwards of approximately $201,242
and $23,057, respectively, the majority of which will not expire until 2036. Certain of these federal loss carryforwards are subject
to Internal Revenue Code Section 382 which imposes limitations on utilization following certain changes in ownership of the
entity generating the loss carryforward. The Company had foreign NOL carryforwards of approximately $23,761 and $30,065 at
June 30, 2019 and 2018, respectively, the majority of which are indefinite lived.
At June 30, 2019, the Company utilized the U.S. federal foreign tax credit carryforward of approximately $877.
The company historically considered the undistributed earnings of its foreign subsidiaries to be indefinitely reinvested and as a
result has not provided for taxes on such earnings. The company has not changed previous indefinite reinvestment assertion
following the enactment of the Tax Act, which required a one-time transition tax for deemed repatriation of accumulated
undistributed earnings of certain foreign subsidiaries. At June 30, 2019, cumulative undistributed earnings of foreign subsidiaries
were approximately $289,076 which partially have been already subjected to U.S. transition tax as part of the Tax Act. If the
company determines that all or a portion of its foreign earnings are no longer indefinitely reinvested, then the company may be
subject to additional foreign withholding taxes and U.S. state income taxes, beyond the Tax Act’s one-time transition tax.
aa
As required by the authoritative guidance on accounting for income taxes, the Company evaluates the realizability of deferred tax
assets on a jurisdictional basis at each reporting date. Accounting for income taxes requires that a valuation allowance be established
when it is more likely than not that all or a portion of the deferred tax assets will not be realized. In circumstances where there is
sufficient negative evidence indicating that the deferred tax assets are not more likely than not realizable, we establish a valuation
allowance. We have recorded valuation allowances in the amounts of $34,912 and $20,831 at June 30, 2019 and 2018, respectively.
During fiscal 2019, we recorded a partial valuation allowance against our state deferred tax assets and state net operating loss
carryforwards as it is not more likely than not that the state tax attributes will be realized.
t
The changes in valuation allowances against deferred income tax assets were as follows:
Balance at beginning of year
Additions charged to income tax expense
Reductions credited to income tax expense
Currency translation adjustments
Balance at end of year
86
Fiscal Year Ended June 30,
2019
2018
$
$
20,831
$
17,773
(3,231)
(461)
34,912
$
20,712
1,251
(1,345)
213
20,831
Unrecognized tax benefits activity, including interest and penalties, is summarized below:
Balance at beginning of year
Additions based on tax positions related to the current year
Additions based on tax positions related to prior years
Reductions due to lapse in statute of limitations and settlements
Balance at end of year
Fiscal Year Ended June 30,
2019
2018
2017
6,730
$
11,602
$
16,019
248
5,446
(555)
11,869
$
118
—
(4,990)
6,730
$
217
—
(4,634)
11,602
$
$
As of June 30, 2019, the Company had $11,869 of unrecognized tax benefits, of which $8,057 represents the amount that, if
recognized, would impact the effective tax rate in future periods. As of June 30, 2018 and 2017, the Company had $6,730 and
$11,602, respectively, of unrecognized tax benefits of which $2,917 and $6,409, respectively, would impact the effective income
tax rate in future periods. Accrued liabilities for interest and penalties were $275 and $82 at June 30, 2019 and 2018, respectively.
Interest and penalties (expense and/or benefit) are recorded as a component of the provision (benefit) for income taxes in the
consolidated financial statements.
The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and several
foreign jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income
tax examinations by tax authorities for years prior to fiscal 2016. However, to the extent we generated NOLs or tax credits in
closed tax years, future use of the NOL or tax credit carryforward balance would be subject to examination within the relevant
statute of limitations for the year in which utilized. The Company is no longer subject to tax examinations in the United Kingdom
for years prior to fiscal 2016. Given the uncertainty regarding when tax authorities will complete their examinations and the
possible outcomes of their examinations, a current estimate of the range of reasonably possible significant increases or decreases
of income tax that may occur within the next twelve months cannot be made. Although there are various tax audits currently
ongoing, the Company does not believe the ultimate outcome of such audits will have a material impact on the Company’s
consolidated financial statements.
d
87
13. STOCKHOLDERS’ EQUITY
Preferred Stock
The Company is authorized to issue “blank check” preferred stock of up to 5,000 shares with such designations, rights and
preferences as may be determined from time to time by the Board of Directors. Accordingly, the Board of Directors is empowered
to issue, without stockholder approval, preferred stock with dividends, liquidation, conversion, voting or other rights which could
decrease the amount of earnings and assets available for distribution to holders of the Company’s Common Stock. At June 30,
2019 and 2018, no preferred stock was issued or outstanding.
Accumulated Other Comprehensive Income (Loss)
The following table presents the changes in accumulated other comprehensive income (loss):
Foreign currency translation adjustments:
Other comprehensive (loss) income before reclassifications (1)
$
(41,180) $
11,497
Fiscal Year Ended June 30,
2019
2018
Deferred gains/(losses) on cash flow hedging instruments:
Other comprehensive income before reclassifications
Amounts reclassified into income (2)
Unrealized gain on equity investment:
Other comprehensive loss before reclassifications
Other comprehensive (loss) income
94
(26)
39
(106)
—
(41,112) $
$
(191)
11,239
(1) Foreign currency translation adjustments included intra-entity foreign currency transactions that were of a long-term
investment nature and were a loss of $619 and a gain of $493 for the fiscal years ended June 30, 2019 and 2018,
respectively.
(2) Amounts reclassified into income for deferred gains/(losses) on cash flow hedging instruments are recorded in “Cost of
sales” in the Consolidated Statements of Operations and, before taxes, were $32 and $132 for the fiscal years ended
June 30, 2019 and 2018, respectively.
88
14.
STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS
The Company has one shareholder-approved plan, the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan,
under which the Company’s officers, senior management, other key employees, consultants and directors may be granted options
to purchase the Company’s common stock or other forms of equity-based awards. The Company also grants shares under its 2019
Equity Inducement Award Program to induce selected individuals to become employees of the Company.
2002 Long-Term Incentive and Stock Award Plan, as amended
g
,
In November 2002, our stockholders approved the 2002 Long-Term Incentive and Stock Award Plan. An aggregate of 3,200 shares
of common stock were originally reserved for issuance under this plan. At various Annual Meetings of Stockholders, including
the 2014 Annual Meeting, the plan was amended to increase the number of shares issuable to 31,500 shares. The plan provides
for the granting of stock options, stock appreciation rights, restricted stock, restricted share units, performance shares, performance
share units and other equity awards to employees, directors and consultants. Awards denominated in shares of common stock
other than options and stock appreciation rights will be counted against the available share limit as two and seven hundredths
shares for every one share covered by such award. All of the options granted to date under the plan have been incentive or non-
qualified stock options providing for the exercise price equal to the fair market price at the date of grant. Stock option awards
granted under the plan expire seven years after the date of grant. Options and other stock-based awards vest in accordance withtt
provisions set forth in the applicable award agreements. No awards shall be granted under this plan after November 20, 2024.
As of June 30, 2019, no options are outstanding under the plan.
a
There were no options granted under this plan in fiscal years 2019, 2018 or 2017.
There were 1,626, 685 and 195 shares of restricted stock and restricted share units granted under this plan during fiscal years 2019,
2018 and 2017, respectively, of which 1,130, 307 and 0, respectively, are subject to the achievement of minimum performance
goals established under those programs or market conditions.
At June 30, 2019, 1,898 unvested restricted stock and restricted share units were outstanding under this plan, and there were 3,774
shares available for grant under this plan. At June 30, 2019, there were no options outstanding under this plan.
Other Plans
At June 30, 2019, there were 122 options outstanding that were granted under a prior Celestial Seasonings plan. Although no
further awards can be granted under the prior Celestial Seasonings plan, the options outstanding continue in accordance with the
terms of the plan and grants.
Compensation cost and related income tax benefits recognized in the Consolidated Statements of Operations for stock-based
compensation plans were as follows:
Selling, general and administrative expense
Chief Executive Officer Succession Plan expense, net
Discontinued operations
Total compensation cost recognized for stock-based compensation plans
Related income tax benefit
Fiscal Year Ended June 30,
2019
2018
2017
$
$
$
9,503
$
429
133
10,065
1,189
$
$
13,380
(2,203)
—
11,177
2,165
$
$
$
9,658
—
—
9,658
3,622
In the fiscal year ended June 30, 2019, the Company recorded a benefit of $1,867 related to the reversal of expense associated
with the total share return (“TSR”) Grant under the 2017-2019 LTIP, as defined and discussed further below.
In the fiscal year ended June 30, 2018, the Company recorded a net benefit of $2,203 primarily in connection with the modification
of Irwin D. Simon’s TSR performance based awards granted on September 26, 2017. Refer to Note 3, Chief Executive Officer
Succession Plan, for further discussion.
89
Restricted Stock
Awards of restricted stock may be either grants of restricted stock or restricted share units that are issued at no cost to the recipient.
For restricted stock grants, at the date of grant the recipient has all rights of a stockholder, subject to certain restrictions on
transferability and a risk of forfeiture. For restricted share units, legal ownership of the shares is not transferred to the employee
until the unit vests. Restricted stock and restricted share unit grants vest in accordance with provisions set forth in the applicable
award agreements, which may include performance criteria for certain grants. The compensation cost of these awards is determined
using the fair market value of the Company’s common stock on the date of the grant. Compensation expense for restricted stock
awards with a service condition is recognized on a straight-line basis over the vesting term. Compensation expense for restricted
stock awards with a performance condition is recorded when the achievement of the performance criteria is probable and is
recognized over the performance and vesting service periods.
A summary of the restricted stock and restricted share units activity for the three fiscal years ended June 30 is as follows:
Non-vested restricted stock and
restricted share units - beginning of year
Granted
Vested
Forfeited
Weighted
Average
Grant
Date Fair
Value
(per share)
$22.29
$7.11
$27.36
$18.33
2019
1,057
4,088
(411)
(374)
Weighted
Average
Grant
Date Fair
Value
(per share)
2018
992
685
(433)
(187)
$27.59
$26.13
$36.68
$31.15
Weighted
Average
Grant
Date Fair
Value
(per share)
$28.24
$33.68
$33.89
$29.88
2017
1,121
195
(290)
(34)
Non-vested restricted stock and restricted
share units - end of year
4,360
$7.92
1,057
$22.29
992
$27.59
Fair value of restricted stock and restricted share units granted
Fair value of shares vested
Tax benefit recognized from restricted shares vesting
Fiscal Year Ended June 30,
2019
29,067
11,232
3,241
$
$
$
2018
17,898
15,736
5,235
$
$
$
2017
6,567
9,866
3,768
$
$
$
At June 30, 2019, $23,942 of unrecognized stock-based compensation expense, net of estimated forfeitures, related to non-vested
restricted stock awards was expected to be recognized over a weighted-average period of approximately 2.1 years.
Stock Options
A summary of the stock option activity for the three fiscal years ended June 30 is as follows:
Outstanding at beginning of year
Exercised
Outstanding at end of year
Options exercisable at end of year
Weighted
Average
Exercise
Price
Weighted
Average
Exercise
Price
2017
Weighted
Average
Exercise
Price
2018
2019
122
$
— $
122
122
$
$
2.26
—
2.26
2.26
122
$
— $
122
122
$
$
2.26
—
2.26
2.26
342
(220)
122
122
$
$
$
$
6.66
9.10
2.26
2.26
90
Intrinsic value of options exercised
Cash received from stock option exercises
Tax benefit recognized from stock option exercises
Fiscal Year Ended June 30,
2019
2018
2017
$
$
$
— $
— $
— $
— $
— $
— $
6,507
—
2,538
For options outstanding and exercisable at June 30, 2019, the aggregate intrinsic value (the difference between the closing stock
price on the last day of trading in the year and the exercise price) was $2,394, and the weighted average remaining contractual
life was 12.0 years. At June 30, 2019, there was no unrecognized compensation expense related to stock option awards.
Long-Term Incentive Plan
The Company maintains a long-term incentive program (the “LTI Plan”). The LTI Plan currently consists of four performance-
based long-term incentive plans (the “2016-2018 LTIP”, “2017-2019 LTIP”, “2018-2020 LTIP” and “2019-2021 LTIP”) that
provide for performance equity awards that can be earned over defined performance periods. Participants in the LTI Plan include
certain of the Company’s executive officers and other key executives.
The Compensation Committee administers the LTI Plan and is responsible for, among other items, selecting the specific performance
measures for awards and setting the target performance required to receive an award after the completion of the performance
period. The Compensation Committee determines the specific payout to the participants. Any such stock-based awards shall be
issued pursuant to and be subject to the terms and conditions of the Amended and Restated 2002 Long-Term Incentive and Stock
Award Plan, as in effect and as amended from time-to-time, and the 2019 Equity Inducement Award Program, as applicable.
Grants Made Pursuant to the Amended and Restated 2002 Long-Term Incentive and Stock Award Plan
2019-2021 LTIP
On January 24, 2019, upon adoption of the 2019-2021 LTIP, the Compensation Committee granted 912 performance share units
(“PSUs”), the achievement of which is dependent upon a defined calculation of relative TSR over the period from November 6,
2018 to November 6, 2021. The PSUs granted represent 100% of the targeted award and will vest pursuant to the achievement
of pre-established three-year compound annual TSR levels that are aligned with the CEO inducement grant (as further discussed
below). The number of shares actually issued will range from zero to 300% of the shares granted. No PSUs will vest if the three-
year compound annual TSR is below 15%. Of the 912 PSUs issued, 451 are subject to a holding period of one year after the
vesting date. As such, an illiquidity discount was applied to the grant date fair value for those shares subject to the one year holding
period. The total grant date fair value with and without the illiquidity discount was estimated to be $5.99 and $5.26 per share,
respectively. The total grant date fair value of this award was $5,132. Total compensation cost related to this PSU award was $872
in the twelve months ended June 30, 2019.
a
The Company also issued 156 three-year time-based restricted share units under the 2019-2021 LTIP.
2018-2020 LTIP
Upon adoption of the 2018-2020 LTIP, the Compensation Committee granted 45 PSUs, the achievement of which is dependent
upon a defined calculation of relative TSR over the period from January 24, 2019 to June 30, 2020. The total grant date fair value
of this award was estimated to be $18.32 per share, or $819.
2016-2018 and 2017-2019 LTIP
Upon adoption of the 2016-2018 LTIP and 2017-2019 LTIP, the Compensation Committee granted PSUs to each participant, the
achievement of which is dependent upon a defined calculation of relative TSR over the period from July 1, 2015 to June 30, 2018
and from July 1, 2017 to June 30, 2019 (the “TSR Grant”), respectively. The grant date fair value for these awards was separately
estimated based on a Monte Carlo simulation that calculated the likelihood of goal attainment. Each performance unit translates
into one unit of common stock. The TSR Grant represents half of each participant’s target award. The other half of the 2016-2018
LTIP and 2017-2019 LTIP is based on the Company’s achievement of specified net sales growth targets over the respective three-
year period. If the targets are achieved, the award in connection with the 2017-2019 LTIP may be paid only in unrestricted shares
of the Company’s common stock.
a
91
In the first quarter of fiscal 2019, in connection with the 2016-2018 LTIP, for the three-year performance period of July 1, 2015
through June 30, 2018, the Compensation Committee determined that the adjusted operating income goal required to be met for
Section 162(m) funding was not achieved and determined that no awards would be paid or vested pursuant to the 2016-2018 LTIP.
Accordingly, the 223 unvested performance stock unit awards previously granted in connection with the relative TSR portion of
the award were forfeited, and amounts accrued relating to the net sales portion of the award were reversed. As such, in the first
quarter of fiscal 2019, the Company recorded a benefit of $6,482 associated with the reversal of previously accrued amounts under
the net sales portion of the 2016-2018 LTIP, of which $5,065 was recorded in Chief Executive Officer Succession Plan expense,
net on the Consolidated Statements of Operations.
In connection with the 2017-2019 LTIP, in the first quarter of fiscal 2019, the Company determined that the achievement of the
adjusted operating income goal required to be met for Section 162(m) funding was not probable. Accordingly, in the first quarter
of fiscal 2019, the Company recorded benefits of $1,129 and $1,867 associated with the reversal of previously accrued amounts
under the portions of the 2017-2019 LTIP that were dependent on the achievement of pre-determined performance measures of
net sales and relative TSR, respectively.
Other Grants
In the twelve months ended June 30, 2019, the Company granted 262 time-based restricted share units to certain key employees
and members of the Company’s Board of Directors that vest primarily over three years. Additionally, the Company issued 173
PSUs to certain key executives vesting over a period of one to two years based upon the achievement of certain market and/or
performance based metrics being met.
Grants Made Pursuant to the 2019 Equity Inducement Award Program
The primary purpose of the 2019 Equity Inducement Award Program is to further the long term stability and success of the Companynn
by providing a program to reward selected individuals newly hired as employees of the Company with grants of inducement
awards. Shares issued under this program are granted outside of the Amended and Restated 2002 Long-Term Incentive and Stock
Award Plan. At June 30, 2019, 1,412 unvested restricted stock and restricted share units were outstanding under this plan, and
there were 1,588 shares available for grant under this plan.
In the twelve months ended June 30, 2019, the Compensation Committee granted 1,398 PSUs to selected individuals hired as
employees of the Company, the achievement of which is dependent upon a defined calculation of relative TSR over the period
from November 6, 2018 to November 6, 2021. The PSUs granted represent 300% of the targeted award and will vest pursuant to
the achievement of pre-established three-year compound annual TSR levels, which are aligned with the CEO Inducement Grant
(defined and discussed further below). Additionally, 14 time-based restricted share units were granted under the 2019 Equity
Inducement Award Program in fiscal 2019.
The number of PSUs expected to be earned, based upon the achievement of the TSR market condition, is factored into the grant
date Monte Carlo valuation. Compensation expense is recognized on a straight-line basis over the service period, regardless of
the eventual number of PSUs that are earned based upon the market condition, provided that each grantee remains an employee
at the end of the performance period. Compensation expense is reversed if at any time during the service period a grantee is no
longer an employee. With the exception of the April 25, 2019 grant, these PSUs are subject to a holding period of one year after
the vesting date. As such, an illiquidity discount was applied to the grant date fair value.
Grant Date
Shares Issued Fair Value Per Share Grant Date Fair Value
February 19, 2019
March 29, 2019
April 15, 2019
April 25, 2019
May 15, 2019
739 $
187 $
136 $
123 $
213 $
Total
1,398
1.79 $
3.01
2.83 $
2.64
3.55 $
$
1,324
563
385
325
755
3,352
The fair value per share amounts reflect the number of shares granted at 300% of the target award. The total number of shares
actually issued will range from zero to 1,398. No PSUs will vest if the three-year compound annual TSR is below 15%.
Total compensation cost related to these awards recognized in the fiscal year ended June 30, 2019 was $289.
92
CEO Inducement Grant
On November 6, 2018, Mr. Schiller received an award of 1,050 PSUs intended to represent the total three-year long-term incentive
opportunity that would have been made in fiscal years 2019 – 2021. The PSUs will vest pursuant to the achievement of pre-
established three-year compound annual TSR levels. The number of shares actually issued will range from zero to 1,050. No
PSUs will vest if the three-year compound annual TSR is below 15%. This award was granted outside of Amended and Restated
2002 Long-Term Incentive and Stock Award Plan and the 2019 Equity Inducement Award Program.
The number of PSUs expected to be earned, based upon the achievement of the TSR market condition, is factored into the grant
date Monte Carlo valuation. Compensation expense is recognized on a straight-line basis over the three-year service period,
regardless of the eventual number of PSUs that are earned based upon the market condition, provided Mr. Schiller remains an
employee at the end of the three-year period. Compensation expense is reversed if at any time during the three-year service period
Mr. Schiller is no longer an employee, subject to certain termination and change in control eligibility provisions. These PSUs are
subject to a holding period of one year after the vesting date. As such, an illiquidity discount was applied to the grant date fair
value. The total grant date fair value of the award was estimated to be $7,571, or $7.21 per share.
Total compensation cost related to this award recognized in the fiscal year ended June 30, 2019 was $1,636.
The Company also issued 79 three-year time-based restricted share units to Mr. Schiller.
93
15.
INVESTMENTS AND JOINT VENTURES
Equity method investment
On October 27, 2015, the Company acquired a 14.9% interest in Chop’t Creative Salad Company LLC (“Chop’t”). Chop’t develops
and operates fast-casual, fresh salad restaurants in the Northeast and Mid-Atlantic United States. Chop’t markets and sells certain
of the Company’s branded products and provides consumer insight and feedback. The investment is being accounted for as an
equity method investment due to the Company’s representation on the Board of Directors. During fiscal 2018, the Company’s
ownership interest was reduced to 13.4% due to the distribution of additional ownership interests. Further ownership interest
distributions could potentially dilute the Company’s ownership interest to as low as 11.9%. At June 30, 2019 and June 30, 2018,
the carrying value of the Company’s investment in Chop’t was $14,632 and $15,524, respectively, and is included in the
Consolidated Balance Sheets as a component of “Investments and joint ventures.”
16.
FINANCIAL INSTRUMENTS MEASURED AT FAIR VALUE
The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels
prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:
• Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted
assets or liabilities;
• Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for
substantially the full term of the asset or liability; and
• Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and
unobservable (i.e., supported by little or no market activity).
The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring
basis as of June 30, 2019:
Assets:
Cash equivalents
Forward foreign currency contracts
Equity investment
Liabilities:
Forward foreign currency contracts
Total
Quoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Total
$
$
$
44
$
626
621
1,291
$
103
103
$
44
—
621
665
$
$
—
— $
— $
626
—
626
$
103
103
$
—
—
—
—
—
—
94
The following table presents by level within the fair value hierarchy assets and liabilities measured at fair value on a recurring
basis as of June 30, 2018:
Assets:
Cash equivalents
Forward foreign currency contracts
Equity investment
Liabilities:
Forward foreign currency contracts
Contingent consideration, non-current
Total
Quoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Total
$
$
$
99
$
365
692
1,156
$
27
1,909
$
$
99
—
692
791
—
—
1,936
$
— $
— $
365
—
365
$
27
—
27
$
—
—
—
—
—
1,909
1,909
The equity investment consists of the Company’s less than 1% investment in Yeo Hiap Seng Limited, a food and beverage
manufacturer and distributor based in Singapore. Fair value is measured using the market approach based on quoted prices. The
Company utilizes the income approach to measure fair value for its foreign currency forward contracts. The income approach
uses pricing models that rely on market observable inputs such as yield curves, currency exchange rates and forward prices.
The Company estimates the original fair value of the contingent consideration as the present value of the expected contingent
payments, determined using the weighted probabilities of the possible payments. The Company reassesses the fair value of
contingent payments on a periodic basis. Although the Company believes its estimates and assumptions are reasonable, different
assumptions, including those regarding the operating results of the respective businesses, or changes in the future may result in
different estimated amounts.
In connection with the acquisitions of Better Bean and Yorkshire Provender during fiscal 2017, payments of a portion of the
respective purchase prices were contingent upon the achievement of certain operating results. Contingent consideration of up to
a maximum of $4,000 related to the Better Bean acquisition is payable based on the achievement of specified operating results
over the three years following the closing date. Contingent consideration of up to a maximum of £1,500 related to the Yorkshire
Provender acquisition is payable based on the achievement of specified operating results at the end of the three-year period
following the closing date.
In connection with the acquisition of Clarks during fiscal 2018, payment of a portion of the purchase price is contingent upon the
achievement of certain operating results. Contingent consideration of up to a maximum of £1,500 is payable based on the
achievement of specified operating results over the 18-month period following completion of the acquisition.
The following table summarizes the Level 3 activity:
Balance at beginning of year
Fair value of initial contingent consideration
Contingent consideration adjustment(1)
Translation adjustment
Balance at end of year
Fiscal Year Ended June 30,
2019
2018
$
$
1,909
$
—
(1,870)
(39)
— $
2,656
1,547
(2,281)
(13)
1,909
(1) The change in the fair value of contingent consideration is included in “Project Terra costs and other” in the Company’s
Consolidated Statements of Operations.
In the fiscal years ended June 30, 2019 and 2018, the Company recorded net benefits of $1,870 and $2,281, respectively. The net
benefit in the fiscal year ended June 30, 2019 was due to a decrease in the fair value of contingent consideration related to Clarks.
The net benefit in the fiscal year ended June 30, 2018 was due to a decrease in the fair value of contingent consideration related
95
to Better Bean and Yorkshire Provender. The decreases in each period were due to lower probability of achievement of specified
operating results.
There were no transfers of financial instruments between the three levels of fair value hierarchy during the fiscal years ended
June 30, 2019 or 2018.
The carrying amount of cash and cash equivalents, accounts receivable, net, accounts payable and certain accrued expenses and
other current liabilities approximate fair value due to the short-term maturities of these financial instruments. The Company’s
debt approximates fair value due to the debt bearing fluctuating market interest rates (See Note 11, Debt and Borrowings).
Derivative Instruments
The Company primarily has exposure to changes in foreign currency exchange rates relating to certain anticipated cash flows and
firm commitments from its international operations. The Company may enter into certain derivative financial instruments, when
available on a cost-effective basis, to manage such risk. Derivative financial instruments are not used for speculative purposes.
The fair value of these derivatives is included in prepaid expenses and other current assets and accrued expenses and other current
liabilities in the Consolidated Balance Sheets. For derivative instruments that qualify as hedges of probable forecasted cash flows,
the effective portion of changes in fair value is temporarily reported in accumulated other comprehensive income and recognized
in earnings when the hedged item affects earnings. Fair value hedges and derivative instruments not designated as hedges are
marked-to-market each reporting period with any unrealized gains or losses recognized in earnings.
rr
ff
Derivative instruments designated at inception as hedges are measured for effectiveness at the inception of the hedge and on a
quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective
in off-setting changes in the cash flows of hedged items. Any ineffective portion of change in fair value is not deferred in accumulated
other comprehensive income and is included in current period results. The Company will discontinue cash flow hedge accounting
when the forecasted transaction is no longer probable of occurring on the originally forecasted date or when the hedge is no longer
effective. There were no discontinued foreign exchange hedges for the fiscal years ended June 30, 2019 and June 30, 2018.
The notional and fair value amounts of cash flow hedges at June 30, 2019 were $2,275 and $83 of net assets, respectively. There
were no cash flow hedges or fair value hedges outstanding as of June 30, 2018.
The notional amounts of foreign currency exchange contracts not designated as hedges at June 30, 2019 and June 30, 2018 were
$41,845 and $20,986, respectively. The fair values of foreign currency exchange contracts not designated as hedges at June 30,
2019 and June 30, 2018 were $440 and $338 of net assets, respectively.
Gains and losses related to both designated and non-designated foreign currency exchange contracts are recorded in the Company’s
Consolidated Statements of Operations based upon the nature of the underlying hedged transaction and were not material in the
fiscal years ended June 30, 2019 and 2018.
96
17.
COMMITMENTS AND CONTINGENCIES
Lease commitments and rent expense
The Company leases office, manufacturing and warehouse space. These leases provide for additional payments of real estate taxes
and other operating expenses over a base period amount.
The aggregate minimum future lease payments for these operating leases at June 30, 2019 are as follows:
Fiscal Year
2020
2021
2022
2023
2024
Thereafter
$
$
19,426
16,584
14,218
13,221
11,041
44,452
118,942
Rent expense charged to operations for the fiscal years ended June 30, 2019, 2018 and 2017 was $37,091, $36,054 and $35,153,
respectively.
Off Balance Sheet Arrangements
At June 30, 2019, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K that have
had, or are likely to have, a material current or future effect on our consolidated financial statements.
Legal Proceedings
Securities Class Actions Filed in Federal Court
aa
n
On August 17, 2016, three securities class action complaints were filed in the Eastern District of New York against the Company
alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The three complaints are: (1) Flora v. The
Hain Celestial Group, Inc., et al. (the “Flora Complaint”); (2) Lynn v. The Hain Celestial Group, Inc., et al. (the “Lynn Complaint”);
and (3) Spadola v. The Hain Celestial Group, Inc., et al. (the “Spadola Complaint” and, together with the Flora and Lynn Complaints,
the “Securities Complaints”). On June 5, 2017, the court issued an order for consolidation, appointment of Co-Lead Plaintiffs and
approval of selection of co-lead counsel. Pursuant to this order, the Securities Complaints were consolidated under the caption In
re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”), and Rosewood Funeral Home and
Salamon Gimpel were appointed as Co-Lead Plaintiffs. On June 21, 2017, the Company received notice that plaintiff Spadola
voluntarily dismissed his claims without prejudice to his ability to participate in the Consolidated Securities Action as an absent
class member. The Co-Lead Plaintiffs in the Consolidated Securities Action filed a Consolidated Amended Complaint on August
4, 2017 and a Corrected Consolidated Amended Complaint on September 7, 2017 on behalf of a purported class consisting of all
persons who purchased or otherwise acquired Hain Celestial securities between November 5, 2013 and February 10, 2017 (the
“Amended Complaint”). The Amended Complaint named as defendants the Company and certain of its current and former officers
(collectively, “Defendants”) and asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on
allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding
the Company’s business, prospects, financial results and internal controls. Defendants filed a motion to dismiss the Amended
Complaint on October 3, 2017 which the Court granted on March 29, 2019, dismissing the case in its entirety, without prejudice
to replead. Co-Lead Plaintiffs filed a Second Amended Consolidated Class Action Complaint on May 6, 2019 (the “Second
Amended Complaint”). The Second Amended Complaint again names as defendants the Company and certain of its current and
former officers and asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegations
similar to those in the Amended Complaint, including materially false or misleading statements and omissions in public statements,
press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls. Defendants
filed a motion to dismiss the Second Amended Complaint on June 20, 2019. Co-Lead Plaintiffs filed an opposition on August 5,
2019, and Defendants have until September 3, 2019 to submit a reply.
Stockholder Derivative Complaints Filed in State Court
97
On September 16, 2016, a stockholder derivative complaint, Paperny v. Heyer, et al. (the “Paperny Complaint”), was filed in New
York State Supreme Court in Nassau County against the Board of Directors and certain officers of the Company alleging breach
of fiduciary duty, unjust enrichment, lack of oversight and corporate waste. On December 2, 2016 and December 29, 2016, two
additional stockholder derivative complaints were filed in New York State Supreme Court in Nassau County against the Board of
Directors and certain officers under the captions Scarola v. Simon (the “Scarola Complaint”) and Shakir v. Simon (the “Shakir
Complaint” and, together with the Paperny Complaint and the Scarola Complaint, the “Derivative Complaints”), respectively.
Both the Scarola Complaint and the Shakir Complaint alleged breach of fiduciary duty, lack of oversight and unjust enrichment.
On February 16, 2017, the parties for the Derivative Complaints entered into a stipulation consolidating the matters under the
caption In re The Hain Celestial Group (the “Consolidated Derivative Action”) in New York State Supreme Court in Nassau
County, ordering the Shakir Complaint as the operative complaint. On November 2, 2017, the parties agreed to stay the Consolidated
Derivative Action. Co-Lead Plaintiffs requested leave to file an amended consolidated complaint, and on January 14, 2019, the
Court partially lifted the stay, ordering Co-Lead Plaintiffs to file their amended complaint by March 7, 2019. Co-Lead Plaintiffs
filed a Verified Amended Shareholder Derivative Complaint on March 7, 2019. The Court continued the stay pending a decision
on Defendants’ motion to dismiss in the Consolidated Securities Action (referenced above). After the Court in the Consolidated
Securities Action dismissed the Amended Complaint, the Court in the Consolidated Derivative Action ordered Co-Lead Plaintiffs
to file a second amended complaint no later than July 8, 2019. Co-Lead Plaintiffs filed a Verified Second Amended Shareholder
Derivative Complaint on July 8, 2019 (the “Second Amended Derivative Complaint”). Defendants moved to dismiss the Second
Amended Derivative Complaint on August 7, 2019. Co-Lead Plaintiffs must file any opposition to Defendants’ motion to dismiss
by September 6, 2019, and Defendants have until September 20, 2019 to submit a reply.
ff
Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court
On April 19, 2017 and April 26, 2017, two class action and stockholder derivative complaints were filed in the Eastern District
of New York against the Board of Directors and certain officers of the Company under the captions Silva v. Simon, et al. (the “Silva
Complaint”) and Barnes v. Simon, et al. (the “Barnes Complaint”), respectively. Both the Silva Complaint and the Barnes Complaint
allege violation of securities law, breach of fiduciary duty, waste of corporate assets and unjust enrichment.
On May 23, 2017, an additional stockholder filed a complaint under seal in the Eastern District of New York against the Board of
Directors and certain officers of the Company. The complaint alleged that the Company’s directors and certain officers made
materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and
financial results. The complaint also alleged that the Company violated its by-laws and Delaware law by failing to hold its 2016
Annual Stockholders Meeting and includes claims for breach of fiduciary duty, unjust enrichment and corporate waste. On August
9, 2017, the Court granted an order to unseal this case and reveal Gary Merenstein as the plaintiff (the “Merenstein Complaint”).
On August 10, 2017, the court granted the parties stipulation to consolidate the Barnes Complaint, the Silva Complaint and the
Merenstein Complaint under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the
“Consolidated Stockholder Class and Derivative Action”) and to appoint Robbins Arroyo LLP and Scott+Scott as Co-Lead Counsel,
with the Law Offices of Thomas G. Amon as Liaison Counsel for Plaintiffs. On September 14, 2017, a related complaint was filed
under the caption Oliver v. Berke, et al. (the “Oliver Complaint”), and on October 6, 2017, the Oliver Complaint was consolidated
with the Consolidated Stockholder Class and Derivative Action. The Plaintiffs filed their consolidated amended complaint under
seal on October 26, 2017. On December 20, 2017, the parties agreed to stay Defendants’ time to answer, move, or otherwise
respond to the consolidated amended complaint through and including 30 days after a decision was rendered on the motion to
dismiss the Amended Complaint in the consolidated Consolidated Securities Action, described above.
On March 29, 2019, the Court in the Consolidated Securities Action granted Defendants’ motion, dismissing the Amended
Complaint in its entirety, without prejudice to replead. Co-Lead Plaintiffs in the Consolidated Securities Action filed a second
amended complaint on May 6, 2019. The parties to the Consolidated Stockholder Class and Derivative Action agreed to continue
the stay of Defendants’ time to answer, move, or otherwise respond to the consolidated amended complaint. The stay is continued
through 30 days after the Court rules on the motion to dismiss the Second Amended Complaint in the Consolidated Securities
Action.
Other
In addition to the litigation described above, the Company is and may be a defendant in lawsuits from time to time in the normal
course of business. While the results of litigation and claims cannot be predicted with certainty, the Company believes the reasonably
possible losses of such matters, individually and in the aggregate, are not material. Additionally, the Company believes the probable
final outcome of such matters will not have a material adverse effect on the Company’s consolidated results of operations, financial
position, cash flows or liquidity.
aa
98
18.
DEFINED CONTRIBUTION PLANS
We have a 401(k) Employee Retirement Plan (the “Plan”) to provide retirement benefits for eligible employees. All full-time
employees of the Company and its wholly-owned domestic subsidiaries are eligible to participate upon completion of 30 days of
service. On an annual basis, we may, in our sole discretion, make certain matching contributions. For the fiscal years ended
June 30, 2018 and 2017, we made contributions to the Plan of $1,371 and $1,367, respectively, including with respect to employees
of Hain Pure Protein. There were no contributions made in fiscal 2019.
In addition, while certain of our international subsidiaries maintain separate defined contribution plans for their employees, the
amounts are not significant to the Company’s consolidated financial statements.
99
19.
SEGMENT INFORMATION
The Company is managed in seven operating segments: the United States, United Kingdom, Tilda, Ella’s Kitchen UK, Europe,
Canada and Hain Ventures (formerly known as Cultivate Ventures). Beginning in the third quarter ended March 31, 2018, the
Hain Pure Protein operations were classified as discontinued operations as discussed in “Note 5, Discontinued Operations.”
Therefore, segment information presented excludes the results of Hain Pure Protein. On August 27, 2019, the Company sold its
Tilda business as discussed in “Note 21, Subsequent Event.”
Net sales and operating income are the primary measures used by the Company’s Chief Operating Decision Maker (“CODM”) to
evaluate segment operating performance and to decide how to allocate resources to segments. The CODM is the Company’s Chief
Executive Officer. Expenses related to certain centralized administration functions that are not specifically related to an operating
segment are included in “Corporate and Other.” Corporate and Other expenses are comprised mainly of the compensation and
related expenses of certain of the Company’s senior executive officers and other selected employees who perform duties related
to the entire enterprise, as well as expenses for certain professional fees, facilities and other items which benefit the Company as
a whole. Additionally, Project Terra costs and other, along with accounting review and remediation costs, are included in “Corporate
and Other.” Expenses that are managed centrally, but can be attributed to a segment, such as employee benefits and certain facility
costs, are allocated based on reasonable allocation methods. Assets are reviewed by the CODM on a consolidated basis and therefore
are not reported by operating segment.
aa
ff
The following tables set forth financial information about each of the Company’s reportable segments. Transactions between
reportable segments were insignificant for all periods presented.
Net Sales: (1)
United States
United Kingdom
Rest of World
Operating (Loss) Income:
g (
p
)
United States
United Kingdom
Rest of World
Corporate and Other (2)
Fiscal Years Ended June 30,
2019
2018
2017
$ 1,009,406
$ 1,084,871
$ 1,107,806
885,488
407,574
938,029
434,869
851,757
383,942
$ 2,302,468
$ 2,457,769
$ 2,343,505
$
$
23,864
52,413
32,820
109,097
(123,983)
(14,886)
$
$
86,319
56,046
38,660
181,025
(74,985)
106,040
$
145,307
51,948
32,010
229,265
(119,842)
109,423
$
(1) One of our customers accounted for approximately 11%, 11%, and 12% of our consolidated net sales for the fiscal years
ended June 30, 2019, 2018 and 2017, respectively, which were primarily related to the United States and United Kingdom
segments. A second customer accounted for approximately, 10%, 11% and 11% of our consolidated net sales for the fiscal
years ended June 30, 2019, 2018 and 2017, respectively, which were primarily related to the United States segment.
(2) For the fiscal year ended June 30, 2019, Corporate and Other included $30,156 of Chief Executive Officer Succession Plan
expense, net, $28,443 of Project Terra costs and other and $4,334 of accounting review and remediation costs. Corporate
and Other for the fiscal year ended June 30, 2019 also included impairment charges of $17,900 ($11,300 related to the United
States segment, $2,787 related to the United Kingdom segment and $3,813 in the Rest of World segment) related to certain
of the Company’s tradenames and a $4,460 benefit for proceeds received in connection with an insurance recovery.
For the fiscal year ended June 30, 2018, Corporate and Other included $10,118 of Project Terra costs and other and $9,293
of accounting review and remediation costs, net of insurance proceeds. Corporate and Other for the fiscal year ended June 30,
2018 also included impairment charges of $5,632 ($5,100 related to the Rest of World segment and $532 related to the United
Kingdom segment) related to certain of the Company’s trade names.
100
For the fiscal year ended June 30, 2017, Corporate and Other included $29,562 of accounting review and remediation costs
and $10,388 of Project Terra costs and other. Corporate and Other for the fiscal year ended June 30, 2017 also included
impairment charges of $14,079 ($7,579 related to the United Kingdom segment and $6,500 related to the United States
segment) related to certain of the Company’s trade names and a $26,373 impairment charge primarily related to long-lived
assets associated with the exit of certain portions of our own-label chilled desserts business in the United Kingdom segment.
The Company’s net sales by product category are as follows:
Grocery
Snacks
Personal Care
Tea
Total
Fiscal Year Ended June 30,
2019
$ 1,709,695
2018
$ 1,842,535
2017
$ 1,743,860
298,333
178,966
115,474
302,795
196,245
116,194
312,784
176,408
110,453
$ 2,302,468
$ 2,457,769
$ 2,343,505
The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as
follows:
United States
United Kingdom
All Other
Total
Fiscal Year Ended June 30,
2019
$ 1,057,625
2018
$ 1,144,832
2017
$ 1,167,688
885,488
359,355
938,029
374,908
851,757
324,060
$ 2,302,468
$ 2,457,769
$ 2,343,505
The Company’s long-lived assets, which primarily represent net property, plant and equipment, by geographic region are as follows:
United States
United Kingdom
All Other
Total
$
Fiscal Year Ended June 30,
2019
115,866
173,544
87,277
2018
$
99,650
174,214
86,700
$
376,687
$
360,564
101
20.
QUARTERLY FINANCIAL DATA (UNAUDITED)
A summary of the Company’s consolidated quarterly results of operations is as follows. The sum of the net income per share from
continuing operations for each of the four quarters may not equal the net income per share for the full year, as presented, due to
rounding.
Net sales
Gross profit
Operating income (loss)
(Loss) income before income taxes and equity in earnings of
equity-method investees
Net (loss) income from continuing operations
Net loss from discontinued operations, net of tax
Net loss
Net (loss) income per common share:
Basic net (loss) income per common share from continuing
operations
$
$
$
$
$
$
$
$
Basic net loss per common share from discontinued operations $
Basic net loss per common share
Diluted net (loss) income per common share from continuing
operations
Diluted net loss per common share from discontinued
operations
Diluted net loss per common share
$
$
$
$
June 30,
2019
557,682
106,077
740
$
$
$
(8,408) $
(7,654) $
(5,897) $
(13,551) $
Three Months Ended
March 31,
2019
599,797
December 31,
2018
584,156
$
September
30, 2018
$
560,833
125,269
23,865
13,407
$
$
$
10,088
$
(75,925) $
(65,837) $
114,273
$
(15,387) $
99,594
(24,104)
(24,577) $
(29,278) $
(37,223) $
(66,501) $
(32,409)
(23,101)
(14,324)
(37,425)
(0.07) $
(0.06) $
(0.13) $
$
0.10
(0.73) $
(0.63) $
(0.28) $
(0.36) $
(0.64) $
(0.22)
(0.14)
(0.36)
(0.07) $
0.10
$
(0.28) $
(0.22)
(0.06) $
(0.13) $
(0.73) $
(0.63) $
(0.36) $
(0.64) $
(0.14)
(0.36)
Net loss from continuing operations in the quarter ended June 30, 2019 was impacted by $4,393 ($3,558 net of tax) and $5,617
($4,143 net of tax) non-cash impairment charges in the United Kingdom and United States, respectively, primarily associated witht
a write down of the value of certain machinery and equipment no longer in use, some of which was used to manufacture certain
slow moving SKUs that were discontinued. Additionally, the Company recorded an inventory write-down of $10,346 ($7,606 net
of tax) related to the discontinuation of additional slow moving SKUs in the United States as part of an ongoing product
rationalization initiative.
Net loss from discontinued operations in the quarter ended March 31, 2019 included a pre-tax loss on sale on the disposition of
the Plainville Farms business of $40,223 ($29,511 net of tax), to write down the assets and liabilities to the final sales price less
costs to sell and asset impairments of $51,348 ($37,532 net of tax), each as a component of net loss on discontinued operations,
net of tax.
The quarter ended December 31, 2018 was impacted by $10,148 ($7,484 net of tax) of Chief Executive Officer Succession Plan
expense, net, $920 ($678 net of tax) related to professional fees associated with our internal accounting review and the independent
review by the Audit Committee and other related matters, impairment charges of $17,900 ($13,374 net of tax) related to indefinite-
lived intangible assets (trade names) and asset impairment charges in discontinued operations of $54,946 ($40,314 net of tax).
The quarter ended September 30, 2018 was impacted by $19,553 ($14,420 net of tax) of Chief Executive Officer Succession Plan
expense, net, $3,414 ($2,518 net of tax) related to professional fees associated with our internal accounting review and the
independent review by the Audit Committee and other related matters, $4,243 ($3,436 net of tax) primarily related to the closure
of a manufacturing facility of fruit-based products in the United Kingdom and asset impairment charges in discontinued operations
of $2,958 ($2,170 net of tax).
102
Net sales
Gross profit
Operating income
Income before income taxes and equity in earnings of
equity-method investees
Net (loss) income from continuing operations
Net (loss) income from discontinued operations, net of
tax
Net (loss) income
Net (loss) income per common share:
Basic net (loss) income per common share from
continuing operations
Basic net (loss) income per common share from
discontinued operations
Basic net (loss) income per common share
Diluted net (loss) income per common share from
continuing operations
Diluted net (loss) income per common share from
discontinued operations
Diluted net (loss) income per common share
June 30,
2018
619,598
125,097
16,580
5,838
(4,556)
(65,385)
(69,941)
(0.04)
(0.63)
(0.67)
(0.04)
(0.63)
(0.67)
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
Three Months Ended
March 31,
2018
632,720
December 31,
2017
616,232
$
September 30,
2017
589,219
$
133,013
29,254
24,032
25,241
(12,555)
12,686
0.24
(0.12)
0.12
0.24
(0.12)
0.12
$
$
$
$
$
$
$
$
$
$
$
$
133,950
30,965
25,246
43,130
3,973
47,103
0.42
0.04
0.45
0.41
0.04
0.45
$
$
$
$
$
$
$
$
$
$
$
$
123,388
29,241
26,086
18,613
1,233
19,846
0.18
0.01
0.19
0.18
0.01
0.19
The quarter ended June 30, 2018 was impacted by goodwill impairment charges of $7,700 ($5,553 net of tax) in the Hain Ventures
(formerly known as Cultivate Ventures) operating segment, impairment charges of $5,632 ($5,192 net of tax) related to indefinite-
lived intangible assets (trade names), as well as a $113 ($104 net of tax) impairment charge primarily related to the closure of
manufacturing facilities in the United States. Additionally, the quarter ended June 30, 2018 was impacted by $2,887 ($1,941 net
of tax) related to professional fees associated with our internal accounting review and remediation costs, net of insurance proceeds.
Net loss from discontinued operations in the quarter ended June 30, 2018 was impacted by asset impairment charges of $78,464
($52,699 net of tax) to adjust the carrying value of Hain Pure Protein to its fair value, less its cost to sell.
The quarter ended March 31, 2018 was impacted by impairment charges of $2,557 ($2,050 net of tax) primarily related to the
closure of a manufacturing facility of certain soup products in the United Kingdom, as well as an impairment charge of $2,057
($1,648 net of tax) related to the discontinuation of additional slow moving SKUs in the United States as part of an ongoing product
rationalization initiative. Additionally, the quarter ended March 30, 2018 was impacted by $3,313 ($2,654 net of tax) related to
professional fees associated with our internal accounting review and remediation costs.
The quarter ended December 31, 2017 was impacted by impairment charges of $3,449 ($2,593 net of tax) related to the closure
of a facility in the United States, as well as $4,451 ($3,346 net of tax) related to professional fees associated with our internal
accounting review and remediation costs.
The quarter ended September 30, 2017 was impacted by $3,642 ($2,638 net of tax) related to professional fees associated with
our internal accounting review and insurance proceeds of $5,000 ($3,622 net of tax) related to the reimbursement of costs incurred
as part of the internal accounting review and the independent review by the Audit Committee and other related matters.
rr
21.
SUBSEQUENT EVENT
On August 27, 2019, the Company and Ebro Foods S.A. (the “Purchaser”) entered into, and consummated the transactions
contemplated by, an Agreement relating to the sale and purchase of the Tilda operating segment and certain other assets (the “Sale
and Purchase Agreement”). Under the Sale and Purchase Agreement, the Company sold the entities comprising its Tilda operating
segment and certain other assets of the Tilda business to the Purchaser for an aggregate price of $342,000 in cash, subject to
customary post-closing adjustments based on the balance sheets of the Tilda business. The other assets sold in the transaction
consist of raw materials, consumables, packaging, and finished and unfinished goods related to the Tilda business held by other
Company entities that are not Tilda Group Entities.
103
The Sale and Purchase Agreement contains representations, warranties and covenants that are customary for a transaction of this
nature. The Company also entered into certain ancillary agreements with the Purchaser and certain of the Tilda Group Entities in
connection with the Sale and Purchase Agreement, including a transitional services agreement pursuant to which the Company
and the Purchaser will provide transitional services to one another, and business transfer agreements pursuant to which the applicable
Tilda Group Entities will transfer certain non-Tilda assets and liabilities in India and the United Arab Emirates to subsidiaries of
the Company to be formed in those countries.
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934,
as amended (the “Exchange Act”)) are designed to ensure that information required to be disclosed in the reports that we file or
submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and
forms of the Securities and Exchange Commission and to ensure that information required to be disclosed is accumulated and
communicated to management, including our principal executive and financial officers, to allow timely decisions regarding
disclosure. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of
achieving the desired control objectives. The Chief Executive Officer (“CEO”) and the Chief Financial Officer (“CFO”), with
assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as
of June 30, 2019 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of
June 30, 2019.
Management’s Report on Internal Control over Financial Reporting
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting,
as such term is defined in Rule 13a-15(f) of the Exchange Act. Internal control over financial reporting is a process designed to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles.
The Company’s internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made
only in accordance with authorizations of the Company’s management and directors; and (3) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or disposition of assets of the Company that could have a material
effect on the financial statements.
m
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because
of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Under the supervision, and with the participation, of our management, including the CEO and CFO, we conducted an evaluation
of the effectiveness of our internal control over financial reporting as of June 30, 2019. In making this assessment, management
used the criteria established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring
Organizations of the Treadway Commission (“COSO”). Based on this assessment, management, including our CEO and CFO,
has concluded that our internal control over financial reporting was effective as of June 30, 2019.
The effectiveness of the Company’s internal control over financial reporting as of June 30, 2019 has been audited by Ernst &
Young LLP, an independent registered public accounting firm, as stated in their report which appears herein.
104
Changes in Internal Control over Financial Reporting
The Company concluded that the material weakness identified in the 2018 Form 10-K, surrounding controls over the accumulation,
transmission and recording in the general ledger of the physical count results in North America, as well as the documentation
evidencing review of certain inventory reserves, has been remediated (the “Remediated Material Weakness”).
During the quarter ended June 30, 2019, the Company completed the implementation of the following remedial measures designed
to address the Remediated Material Weakness.
• The development of a more comprehensive physical inventory risk and control framework, that resulted in additional internal
controls being added to ensure the completeness and accuracy of inventory uploads to the general ledger, which were agreed
to final physical count sheets for all locations.
• Enhanced communication among operations personnel and the Company-owned and third party locations holding the vast
majority of our inventory. Formal letters of understanding detailing protocols governing the timing, physical count procedures,
record keeping requirements and submissions of results were delivered and acknowledged prior to the physical counts being
conducted.
•
Standardization of processes performed by operations personnel to verify completeness and accuracy of information, including
formal documentation of variances above established thresholds;
• The incorporation of accounting department verification processes to ensure data was completely and accurately reflected in
the general ledger.
The Company implemented additional internal controls to ensure and document the completeness and accuracy of all inventory
balances when performing the reserve calculations and analysis. Such controls included enhanced documentation of management’s
analysis of forecasted sales of inventory subject to SKU rationalization and the performance of subsequent comparisons of actual
inventory movements to forecasts used in the reserve calculations.
Except for the foregoing, there was no change in our internal control over financial reporting that occurred during the quarter
ended June 30, 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial
reporting.
Inherent Limitations on Effectiveness of Controls
The Company’s management, including the Company’s CEO and CFO, recognizes that the Company’s disclosure controls and
procedures and the Company’s internal control over financial reporting cannot prevent or detect all errors and all fraud. A control
system, regardless of how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives
of the control system will be met. These inherent limitations include the following:
•
Judgments in decision-making can be faulty, and control and process breakdowns can occur because of simple errors or
mistakes.
• Controls can be circumvented by individuals, acting alone or in collusion with each other, or by management override.
• The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and
there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
• Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance
with policies or procedures.
Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control
issues and instances of fraud, if any, have been detected.
105
Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of
The Hain Celestial Group, Inc. and Subsidiaries
Opinion on Internal Control over Financial Reporting
We have audited The Hain Celestial Group, Inc. and subsidiaries’ internal control over financial reporting as of June 30, 2019,
based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of
the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, The Hain Celestial Group, Inc. and subsidiaries
(the Company) maintained, in all material respects, effective internal control over financial reporting as of June 30, 2019, based
on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the consolidated balance sheets of the Company as of June 30, 2019 and 2018, the related consolidated statements of
operations, comprehensive income (loss), stockholders’ equity and cash flows for each of the three years in the period ended June uu
30, 2019, and the related notes and schedule (collectively referred to as the “consolidated financial statements”) and our report
dated August 29, 2019 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment
of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal
Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial
reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with
respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.
uu
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material
respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness
exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing
such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for
our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain
to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets
of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are
being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that
could have a material effect on the financial statements.
a
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because
of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Ernst & Young LLP
Jericho, New York
August 29, 2019
106
Item 9B.
Other Information
Sale of Tilda Business
On August 27, 2019, the Company and Ebro Foods S.A. (the “Purchaser”) entered into, and consummated the transactions
contemplated by, an agreement relating to the sale and purchase of the Tilda Group Entities and certain other assets (the “Sale and
Purchase Agreement”). Under the Sale and Purchase Agreement, the Company sold the entities comprising its Tilda basmati and
specialty rice business (the “Tilda Group Entities”) and certain other assets of the Tilda business to the Purchaser for an aggregate
price of $342 million in cash, subject to customary post-closing adjustments based on the balance sheets of the Tilda Group Entities.
The Tilda Group Entities included in the transaction are: (1) Tilda Limited, a company organized under the laws of England and
Wales; (2) Tilda Rice Limited, a company organized under the laws of England and Wales; (3) Tilda International DMCC, a
company organized under the laws of Dubai, United Arab Emirates; (4) Tilda Hain India Private Limited, a company organized
under the laws of India; and (5) Brand Associates Limited, a company organized under the laws of the Isle of Man. The other
assets sold in the transaction consist of raw materials, consumables, packaging, and finished and unfinished goods related to the
Tilda business held by other Company entities that are not Tilda Group Entities.
tt
The Sale and Purchase Agreement contains representations, warranties and covenants that are customary for a transaction of this
nature. The Company also entered into certain ancillary agreements with the Purchaser and certain of the Tilda Group Entities in
connection with the Sale and Purchase Agreement, including a transitional services agreement pursuant to which the Company
and the Purchaser will provide transitional services to one another, and business transfer agreements pursuant to which the applicable
Tilda Group Entities will transfer certain non-Tilda assets and liabilities in India and the United Arab Emirates to subsidiaries of
the Company to be formed in those countries.
The foregoing summary of the Sale and Purchase Agreement does not purport to be complete and is subject to, and qualified in
its entirety by, the full text of the Sale and Purchase Agreement, a copy of which is filed as Exhibit 2.1 to this Form 10-K and
incorporated herein by reference.
Other than with respect to the sale of the Tilda Group Entities, no material relationship exists between the Company and the
Purchaser (or any of their affiliates, directors or officers).
The Company’s unaudited pro forma consolidated financial information giving effect to the sale of the Tilda Group Entities is
filed as Exhibit 99.1 to this Form 10-K.
Resignation of Chief Accounting Officer
On August 26, 2019, Michael McGuinness, the Company’s Senior Vice President and Chief Accounting Officer, informed the
Company of his intention to resign from his position with the Company, effective August 30, 2019, to pursue another opportunity.
James Langrock, the Company’s Executive Vice President and Chief Financial Officer, will assume the responsibilities of principal
accounting officer of the Company on an interim basis until the Company names a successor to Mr. McGuinness. For biographical
information regarding Mr. Langrock, see the Company’s Definitive Proxy Statement for the Company’s 2018 Annual Meeting of
Stockholders, filed with the SEC on October 29, 2018.
107
Item 10.
Directors, Executive Officers and Corporate Governance
PART III
The information required by this item is incorporated by reference to our Proxy Statement for the 2019 Annual Meeting of
Stockholders of the Company to be filed with the SEC within 120 days of the fiscal year ended June 30, 2019.
Item 11.
Executive Compensation
The information required by this item is incorporated by reference to our Proxy Statement for the 2019 Annual Meeting of
Stockholders of the Company to be filed with the SEC within 120 days of the fiscal year ended June 30, 2019.
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required by this item is incorporated by reference to our Proxy Statement for the 2019 Annual Meeting of
Stockholders of the Company to be filed with the SEC within 120 days of the fiscal year ended June 30, 2019.
Item 13.
Certain Relationships and Related Transactions, and Director Independence
The information required by this item is incorporated by reference to our Proxy Statement for the 2019 Annual Meeting of
Stockholders of the Company to be filed with the SEC within 120 days of the fiscal year ended June 30, 2019.
Item 14.
Principal Accountant Fees and Services
The information required by this item is incorporated by reference to our Proxy Statement for the 2019 Annual Meeting of
Stockholders of the Company to be filed with the SEC within 120 days of the fiscal year ended June 30, 2019.
Item 15.
Exhibits and Financial Statement Schedules
PART IV
(a)(1) Financial Statements. The following consolidated financial statements of The Hain Celestial Group, Inc. are filed as part
of this report under Part II, Item 8 - Financial Statements and Supplementary Data:
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets - June 30, 2019 and 2018
Consolidated Statements of Operations - Fiscal Years ended June 30, 2019, 2018 and 2017
Consolidated Statements of Comprehensive Income - Fiscal Years ended June 30, 2019, 2018 and 2017
Consolidated Statements of Stockholders’ Equity - Fiscal Years ended June 30, 2019, 2018 and 2017
Consolidated Statements of Cash Flows - Fiscal Years ended June 30, 2019, 2018 and 2017
Notes to Consolidated Financial Statements
(a)(2) Financial Statement Schedules. The following financial statement schedule should be read in conjunction with the
consolidated financial statements included in Part II, Item 8, of this Annual Report on Form 10-K. All other financial
schedules are not required under the related instructions, or are not applicable and therefore have been omitted.
108
The Hain Celestial Group, Inc. and Subsidiaries
Schedule II - Valuation and Qualifying Accounts
Column A
Column B
Balance at
beginning
of
period
Fiscal Year Ended June 30, 2019:
Allowance for doubtful accounts
Valuation allowance for deferred tax assets
Fiscal Year Ended June 30, 2018:
Allowance for doubtful accounts
Valuation allowance for deferred tax assets
Fiscal Year Ended June 30, 2017:
Allowance for doubtful accounts
$
$
$
$
$
2,086
20,831
1,447
20,712
Charged to
costs and
expenses
$
$
$
$
553
17,773
1,880
1,251
Column C
Additions
Column D
Column E
Charged to
other
accounts -
describe (i)
Deductions
- describe
(ii)
Balance at
end of
period
$
$
$
$
(1,016)
$
— $
(1,035)
(3,692)
$
49
— $
(1,290)
(1,132)
$
$
$
$
$
$
588
34,912
2,086
20,831
1,447
20,712
Valuation allowance for deferred tax assets
$
Amounts above are inclusive our Hain Pure Protein reporting segment classified as discontinued operations
— $
21,172
1,862
$
$
936
$
1,077
$
149
$
(715)
(2,322)
(i) Represents the allowance for doubtful accounts of the business acquired or disposed of during the fiscal year
(ii) Amounts written off and changes in exchange rates
(a)(3) Exhibits. The exhibits filed as part of this Annual Report on Form 10-K are listed on the Exhibit Index immediately
following Item 16. “Form 10-K Summary,” which is incorporated herein by reference.
Item 16.
Form 10-K Summary
None.
109
EXHIBIT INDEX
Description
Agreement relating to the sale and purchase of the Tilda Group Entities and certain other assets dated August
27, 2019, between the Company and Ebro Foods S.A.
Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of Amendment
No. 1 to the Company’s Registration Statement on Form S-4 filed with the SEC on April 24, 2000).
Certificate of Amendment to Amended and Restated Certificate of Incorporation of The Hain Celestial Group,
Inc. (incorporated by reference to Exhibit 3.2(b) of the Company’s Current Report on Form 8-K filed with the
SEC on November 26, 2014).
The Hain Celestial Group, Inc. Amended and Restated By-Laws (incorporated by reference to Exhibit 3.1 of
the Company’s Current Report on Form 8-K filed with the SEC on December 7, 2018).
Specimen of common stock certificate (incorporated by reference to Exhibit 4.1 of Amendment No. 1 to the
Company’s Registration Statement on Form S-4 filed with the SEC on April 24, 2000).
Exhibit
Number
2.1
3.1
3.2
3.3
4.1
4.2
Description of Registrant’s Securities.
10.1.1
10.1.2
10.1.3
10.1.4
10.1.5
Third Amended and Restated Credit Agreement, dated February 6, 2018, among the Company, Hain Pure Protein
Corporation, certain other wholly-owned Subsidiaries of the Company, Bank of America, N.A., as Administrative
Agent, U.S. Swing Line Lender and L/C Issuer, Bank of America Merrill Lynch International Limited and Bank
of America, N.A., Canada Branch, as Global Swing Line Lenders, Wells Fargo Bank, N.A. and Citizens Bank,
N.A., as Co-Syndication Agents, Farm Credit East, ACA and JP Morgan Chase Bank, N.A., as Co-Documentation
Agents, and the other lenders party thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current
Report on Form 8-K filed with the SEC on February 12, 2018).
First Amendment to Third Amendment and Restated Credit Agreement, dated November 7, 2018, by and among
the Company, Hain Pure Protein Corporation, certain wholly-owned subsidiaries of the Company party thereto
from time to time, and Bank of America, N.A. as administrative agent (incorporated by reference to Exhibit
10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 8, 2018).
Second Amendment to Third Amended and Restated Credit Agreement, dated February 6, 2019, by and among
the Company, Hain Pure Protein Corporation, certain wholly-owned subsidiaries of the Company party thereto
from time to time, and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit
10.1 of the Company’s Current Report on Form 8-K filed with the SEC on February 7, 2019).
Third Amendment to Third Amended and Restated Credit Agreement, dated May 8, 2019, by and among the
Company, certain wholly-owned subsidiaries of the Company party thereto from time to time, the Lenders party
thereto and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 of the
Company’s Current Report on Form 8-K filed with the SEC on May 9, 2019).
Security and Pledge Agreement, dated May 8, 2019, by and among the Company, certain wholly-owned
subsidiaries of the Company party thereto from time to time, and Bank of America, N.A., as administrative
agent (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the
SEC on May 9, 2019).
10.2.1*
The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan.
10.2.2*
10.2.3*
Form of Restricted Stock Agreement under the Company’s Amended and Restated 2002 Long Term Incentive
and Stock Award Plan (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-
K/A filed with the SEC on April 7, 2008).
Form of Notice of Grant of Restricted Stock Award under the Company’s Amended and Restated 2002 Long
Term Incentive and Stock Award Plan (incorporated by reference to Exhibit 10.6 to the Company’s Current
Report on Form 8-K/A filed with the SEC on April 7, 2008).
110
10.2.4*
Form of Performance Unit Agreement with the Company’s executive officers under the Company’s Amended
and Restated 2002 Long Term Incentive and Stock Award Plan (2019-2021 Long Term Incentive Plan)
(incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the fiscal
quarter ended March 31, 2019, filed with the SEC on May 9, 2019).
10.3*
The Hain Celestial Group, Inc. Inducement Grant Performance Units Agreement, dated November 6, 2018,
between the Company and Mark L. Schiller (incorporated by reference to Exhibit 10.1 of the Company’s
Registration Statement on Form S-8 filed with the SEC on November 6, 2018).
10.4.1*
The Hain Celestial Group, Inc. 2019 Equity Inducement Award Program (incorporated by reference to Exhibit
10.1 of the Company’s Registration Statement on Form S-8 filed with the SEC on February 19, 2019).
10.4.2*
Form of Inducement Award Agreement under The Hain Celestial Group, Inc. 2019 Equity Inducement Award
Program (incorporated by reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q for the
fiscal quarter ended March 31, 2019, filed with the SEC on May 9, 2019).
10.5*
The Hain Celestial Group, Inc. 2015-2019 Executive Incentive Plan (incorporated by reference to Exhibit 10.1
of the Company’s Current Report on Form 8-K filed with the SEC on November 26, 2014).
10.6*
10.7*
10.8*
Employment Agreement, dated as of October 26, 2018, by and between the Company and Mark L. Schiller
(incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC
on October 29, 2018).
Offer Letter, dated June 22, 2017, between the Company and James M. Langrock (incorporated by reference to
Exhibit 10.24 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017, filed
with the SEC on September 13, 2017).
Offer Letter, dated January 3, 2019, between the Company and Christopher Boever (incorporated by reference
to Exhibit 10.6 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2019,
filed with the SEC on May 9, 2019).
10.9*
Offer Letter, dated May 2, 2019, between the Company and Kevin McGahren.
10.10.1*
10.10.2*
10.10.3*
10.10.4*
10.10.5*
10.10.6*
10.10.7*
Employment Agreement between the Company and Irwin D. Simon, dated July 1, 2003 (incorporated by
reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September
30, 2003, filed with the SEC on November 14, 2003).
Amendment to Employment Agreement between the Company and Irwin D. Simon, dated as of December 31,
2008 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the
SEC on January 7, 2009).
Amendment to Employment Agreement between the Company and Irwin D. Simon, dated as of July 1, 2009
(incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC
on July 2, 2009).
Amendment to Employment Agreement between the Company and Irwin D. Simon, dated as of June 30, 2012
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC
on July 6, 2012).
Amendment to Employment Agreement between the Company and Irwin D. Simon, dated November 2, 2012
(incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC
on November 2, 2012).
Amendment to Employment Agreement between the Company and Irwin D. Simon dated September 23, 2014
(incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC
on September 29, 2014).
Succession Agreement dated as of June 24, 2018, by and between the Company and Irwin D. Simon (incorporated
by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 25,
2018).
111
10.10.8*
Consulting Agreement between the Company and Irwin D. Simon dated October 26, 2018 (incorporated by
reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December
31, 2018, filed with the SEC on February 7, 2019).
10.11*
Separation Agreement, dated as of January 16, 2019, between the Company and Gary Tickle (incorporated by
reference to Exhibit 10.7 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March
31, 2019, filed with the SEC on May 9, 2019).
10.12*
Form of Change in Control Agreement.
10.13*
10.14*
21.1
23.1
31.1
31.2
32.1
32.2
Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly
Report on Form 10-Q for the fiscal quarter ended September 30, 2017, filed with the SEC on November 7,
2017).
Form of Confidentiality, Non-Interference, and Invention Assignment Agreement (incorporated by reference to
Exhibit 10.8 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2019,
filed with the SEC on May 9, 2019).
Subsidiaries of the Company.
Consent of Independent Registered Public Accounting Firm - Ernst & Young LLP.
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities
Exchange Act, as amended.
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange
Act, as amended.
Certification by CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002.
Certification by CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002.
99.1
Unaudited Pro Forma Consolidated Financial Statements.
101
The following materials from the Company’s Annual Report on Form 10-K for the fiscal year ended June 30,
2019, formatted in eXtensible Business Reporting Language (XBRL): (i) the Consolidated Balance Sheets, (ii)
the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the
Consolidated Statements of Stockholders’ Equity, (v) the Consolidated Statements of Cash Flows, (vi) Notes
to Consolidated Financial Statements, and (vii) Financial Statement Schedule.
*
Indicates management contract or compensatory plan or arrangement.
The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other
disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them
for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made
solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the
date they were made or at any other time.
f
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.
SIGNATURES
112
Date: August 29, 2019
Date: August 29, 2019
THE HAIN CELESTIAL GROUP, INC.
/s/ Mark L. Schiller
Mark L. Schiller,
President, Chief Executive Officer
and Director
/s/ James Langrock
James Langrock,
Executive Vice President and
Chief Financial Officer
113
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following
persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature
g
Title
Date
/s/ Mark L. Schiller
Mark L. Schiller
/s/ James Langrock
James Langrock
/s/ Michael McGuinness
Michael McGuinness
/s/ Dean Hollis
Dean Hollis
/s/ Celeste A. Clark
Celeste A. Clark
/s/ Shervin J. Korangy
Shervin J. Korangy
/s/ Roger Meltzer
Roger Meltzer
/s/ Glenn W. Welling
Glenn W. Welling
/s/ Dawn M. Zier
Dawn M. Zier
President, Chief Executive Officer and
Director
August 29, 2019
Executive Vice President and
Chief Financial Officer
August 29, 2019
Senior Vice President and
Chief Accounting Officer
August 29, 2019
Chair of the Board
August 29, 2019
Director
August 29, 2019
Director
August 29, 2019
Director
August 29, 2019
Director
August 29, 2019
Director
August 29, 2019
114